
<html lang="en"     class="pb-page"  data-request-id="f1d440f5-d569-4c52-839a-cc5c0a9ac4be"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/jm401931e;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2014.57.issue-11"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="New Potent Antibacterial Oxazolidinone (MRX-I) with an Improved Class Safety Profile" /></meta><meta name="dc.Creator" content="Mikhail F.  Gordeev" /></meta><meta name="dc.Creator" content="Zhengyu Y.  Yuan" /></meta><meta name="dc.Description" content="Oxazolidinones comprise an important class of antibacterial protein synthesis inhibitors. Myelosuppression and monoamine oxidase inhibition (MAOI) are key independent causes for limiting adverse ef..." /></meta><meta name="Description" content="Oxazolidinones comprise an important class of antibacterial protein synthesis inhibitors. Myelosuppression and monoamine oxidase inhibition (MAOI) are key independent causes for limiting adverse ef..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 16, 2014" /></meta><meta name="dc.Type" content="news" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm401931e" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm401931e" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm401931e" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm401931e" /></link>
        
    
    

<title>New Potent Antibacterial Oxazolidinone (MRX-I) with an Improved Class Safety Profile | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm401931e" /></meta><meta property="og:title" content="New Potent Antibacterial Oxazolidinone (MRX-I) with an Improved Class Safety Profile" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401931e/production/images/large/jm-2013-01931e_0008.jpeg" /></meta><meta property="og:description" content="Oxazolidinones comprise an important class of antibacterial protein synthesis inhibitors. Myelosuppression and monoamine oxidase inhibition (MAOI) are key independent causes for limiting adverse effects in therapy with the sole approved drug of this class, linezolid. This annotation describes a novel oxazolidinone agent, (S)-5-((isoxazol-3-ylamino)methyl)-3-(2,3,5-trifluoro-4-(4-oxo-3,4-dihydropyridin-1(2H)-yl)phenyl)oxazolidin-2-one (MRX-I), distinguished by its high activity against Gram-positive pathogens coupled with markedly reduced potential for myelosuppression and MAOI. The medical need, medicinal chemistry rationale, preclinical data, and phase I clinical trial summary for this new agent are reviewed herein." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm401931e"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm401931e">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm401931e&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm401931e&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm401931e&amp;href=/doi/10.1021/jm401931e" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 11</span><span class="cit-fg-pageRange">, 4487-4497</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/11" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm4014746" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Drug Annotation</span><a href="/doi/10.1021/jm401349g" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">New Potent Antibacterial Oxazolidinone (MRX-I) with an Improved Class Safety Profile</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mikhail+F.++Gordeev">Mikhail F. Gordeev</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"> and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhengyu+Y.++Yuan">Zhengyu Y. Yuan</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">MicuRx Pharmaceuticals Inc., Hayward, California 94545, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 510 782-2022. E-mail: <a href="/cdn-cgi/l/email-protection#1a777d75687e7f7f6c5a7773796f686234797577"><span class="__cf_email__" data-cfemail="d9b4beb6abbdbcbcaf99b4b0baacaba1f7bab6b4">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm401931e&amp;href=/doi/10.1021%2Fjm401931e" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 11</span><span class="cit-pageRange">, 4487–4497</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 2, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>17 December 2013</li><li><span class="item_label"><b>Published</b> online</span>16 April 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 June 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm401931e" title="DOI URL">https://doi.org/10.1021/jm401931e</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4487%26pageCount%3D11%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMikhail%2BF.%2BGordeev%252C%2BZhengyu%2BY.%2BYuan%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D11%26contentID%3Djm401931e%26title%3DNew%2BPotent%2BAntibacterial%2BOxazolidinone%2B%2528MRX-I%2529%2Bwith%2Ban%2BImproved%2BClass%2BSafety%2BProfile%26numPages%3D11%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4497%26publicationDate%3DJune%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm401931e"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">5167</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">50</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm401931e" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;New Potent Antibacterial Oxazolidinone (MRX-I) with an Improved Class Safety Profile&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Mikhail&quot;,&quot;last_name&quot;:&quot;F. Gordeev&quot;},{&quot;first_name&quot;:&quot;Zhengyu&quot;,&quot;last_name&quot;:&quot;Y. Yuan&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;16&quot;,&quot;issue&quot;:&quot;11&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;4487-4497&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm401931e&quot;},&quot;abstract&quot;:&quot;Oxazolidinones comprise an important class of antibacterial protein synthesis inhibitors. Myelosuppression and monoamine oxidase inhibition (MAOI) are key independent causes for limiting adverse effects in therapy with the sole approved drug of this class, linezolid. This annotation describes a novel oxazolidinone agent, (S)-5-((isoxazol-3-ylamino)methyl)-3-(2,3,5-trifluoro-4-(4-oxo-3,4-dihydropyridin-1(2H)-yl)phenyl)oxazolidin-2-one (MRX-I), distinguished by its high activity against Gram-positive pathogens coupled with markedly reduced potential for myelosuppression and MAOI. The medical need, medicinal chemistry rationale, preclinical data, and phase I clinical trial summary for this new agent are reviewed herein.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401931e&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401931e" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401931e&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401931e" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401931e&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401931e" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm401931e&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401931e&amp;href=/doi/10.1021/jm401931e" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm401931e" /></input><a href="/doi/pdf/10.1021/jm401931e" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (691 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm401931e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm401931e%26sid%3Dliteratum%253Aachs%26pmid%3D24694071%26genre%3Darticle%26aulast%3DGordeev%26date%3D2014%26atitle%3DNew%2BPotent%2BAntibacterial%2BOxazolidinone%2B%2528MRX-I%2529%2Bwith%2Ban%2BImproved%2BClass%2BSafety%2BProfile%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D11%26spage%3D4487%26epage%3D4497%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291362" title="Antimicrobial agents">Antimicrobial agents</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a>,</li><li><a href="/action/doSearch?ConceptID=290808" title="Toxicity">Toxicity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/11" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jmcmar.2014.57.issue-11/production/jmcmar.2014.57.issue-11.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401931e/production/images/medium/jm-2013-01931e_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401931e/production/images/large/jm-2013-01931e_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401931e&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Oxazolidinones comprise an important class of antibacterial protein synthesis inhibitors. Myelosuppression and monoamine oxidase inhibition (MAOI) are key independent causes for limiting adverse effects in therapy with the sole approved drug of this class, linezolid. This annotation describes a novel oxazolidinone agent, (<i>S</i>)-5-((isoxazol-3-ylamino)methyl)-3-(2,3,5-trifluoro-4-(4-oxo-3,4-dihydropyridin-1(2<i>H</i>)-yl)phenyl)oxazolidin-2-one (MRX-I), distinguished by its high activity against Gram-positive pathogens coupled with markedly reduced potential for myelosuppression and MAOI. The medical need, medicinal chemistry rationale, preclinical data, and phase I clinical trial summary for this new agent are reviewed herein.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14212" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14212" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In spite of massive scientific and financial investment into preclinical and clinical evaluation of pharmaceuticals, there is an inherent risk that the drug safety may not be fully elucidated in the research and development process. This issue cuts across therapeutic fields and pharmaceutical classes, as illustrated by postmarketing reports of serious adverse effects and call for drugs withdrawal, including examples of antibacterial protein synthesis inhibitors chloramphenicol<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> and telithromycin.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Outside of the anti-infective arena, the COX-2 inhibitor rofecoxib was withdrawn in 2004,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> prompting a Food and Drug Administration (FDA) review of this drug class at large and warnings for related agents. These and other examples provide ample evidence of the need for extensive drug safety evaluation, presently extended into postmarketing surveillance, including the FDA Sentinel Initiative,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> for adverse effects reporting. As a separate, if related issue, this recent history illuminates the critical importance of selecting an optimal strategy toward next-generation pharmaceuticals, necessitating close attention to key limitations for each pharmaceutical class, as required for the critical balance of potency and safety. While it is impossible to forecast all adverse effects that may manifest in a large patient population only post-approval, a case could be made for known class toxicities to be tackled in early phases of research.</div><div class="NLM_p">Thus, the quest for new agents with enhanced biological activity must be weighed against the elevated risk of adverse effects. This consideration is of particular importance if the drug’s intended activity and its mode of action are fundamentally associated with biochemical mechanisms responsible for a potential toxicity in human. Herein, we report progress toward addressing this issue for a class of oxazolidinone antibacterial agents acting via inhibition of protein synthesis in bacteria, with a similar mechanism ascribed to the inhibition of mitochondrial protein synthesis in humans.</div><div class="NLM_p last">The oxazolidinone class of antibacterial protein synthesis inhibitors has attained prominence since the introduction of its first representative drug linezolid (Zyvox) in 2000.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Linezolid is highly active against all major Gram-positive pathogens, including multidrug resistant (MDR) staphylococci, enterococci, streptococci, as well as mycobacterial species. To date, linezolid remains the sole approved antibacterial of the oxazolidinone class of protein synthesis inhibitors. The drug is distinguished by unique binding at a distinct region of 23S RNA adjacent to the peptidyl transferase center of the 50S ribosomal subunit.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> This novel site of action accounts for a remarkable lack of cross-resistance between linezolid and other antibacterials, including essentially all therapeutic protein synthesis inhibitors. An extremely low propensity toward developing bacterial resistance to linezolid in all target pathogens is apparent from both historic and the most recent surveillance data.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The latter indicates virtually no significant resistance to linezolid after nearly 14 years of its clinical use. This feature is of paramount importance due to the widespread emergence of multidrug-resistant (MDR) microorganisms in both hospitals and the community.<a onclick="showRef(event, 'ref6 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref8">(6, 8)</a> The antibacterial coverage of linezolid, coupled with excellent oral bioavailability, accounts for its important role in the treatment of serious Gram-positive infections and for the drug’s blockbuster status among anti-infectives.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Antibacterial Oxazolidinones: Class Safety Limitations and the Medical Need</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63428" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63428" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Despite its undisputed commercial success, linezolid is subject to serious safety limitations, as reviewed by Vinh and Rubinstein.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Primary safety concerns center on myelosuppression and MAOI, which have been recognized as two independent phenomena associated with key adverse effects in linezolid therapy.</div><div class="NLM_p">Myelosuppression, also referred to as bone marrow toxicity, is the chief therapy-limiting effect of the drug.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Importantly, myelosuppression is directly associated with the inhibitory mode of action of linezolid, likely due to a homology between the 23S RNA target in prokaryotes and genetically related mitochondrial protein synthesis machinery in mammals.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><div class="NLM_p">While early clinical data suggested relatively low incidence of myelosuppression, several later reports (see a review<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and references therein) revealed an elevated incidence of myelosuppression-associated effects, including thromobocytopenia, leukopenia, pancytopenia, and anemia. Attassi<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> reported a thrombocytopenia incidence of 32% after over 10 days of the linezolid therapy. While the myelosuppressive effects are generally reversible, occurrences of optical neuropathy<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> with rare but irreversible vision impairments<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> likewise have been ascribed to the mitochondrial toxicity during extended linezolid therapy. Myelosuppression is believed to be generally infrequent in the linezolid treatment of duration ≤14 days, but this issue has prompted a black box warning in the drug’s prescription information.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> This concern limits the approved duration of linezolid therapy to 14 days, with an exception of 28 days made for use against serious infections due to vancomycin-resistant enterococci (VRE). Furthermore, a complete blood count analysis is mandated for linezolid therapy with duration over 14 days.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p">Historical efforts toward a safer oxazolidinone agent targeting long-term therapy are illustrated by the agent PF-03315011, a compound that originated at Vicuron<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and was advanced into development by Pfizer.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Huband<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> described the improved selectivity of this compound, including its attenuated myelosuppression and MAOI compared to linezolid. No subsequent clinical progression of this agent has been reported. Furthermore, no intrinsically (either at the target or cellular level) safer drug candidates of this class have entered clinical trials, even as recent expert opinions reveal that a standard linezolid regimen may be insufficient in certain patient populations.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The drug’s dosing directly relates to its myelosuppressive potential, which limits the approved therapeutic dose and safe in vivo exposure for linezolid.</div><div class="NLM_p">Separately, MAOI of linezolid is associated with its potential for drug–drug interactions as well as central nervous system and blood pressure effects.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Dietary limitations on ingestion of common thyramine-containing foods are required. While the toxicity due to MAOI is arguably not as serious as myelosuppression, it is still a concern for linezolid therapy, as reflected in the drug’s prescribing information. This consideration is of particular importance due to the fast onset of MAOI toxicity when a patient requires a serotonergic drug therapy concomitant to the administration of linezolid.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><div class="NLM_p">The majority of recent efforts in the antibacterial oxazolidinone field are aimed at enhancing the potency of new compounds rather than addressing class safety issues. Some examples include clinical and investigational agents tedizolid, radezolid, posizolid, and LCB01-0371 (as reviewed by Pucci and Bush<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a>). Thus, recent clinical trials of tedizolid phosphate (TR-701, a phosphate prodrug of the active moiety TR-700)<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> by the Trius group explored an opportunity for an optimized therapeutic index through enhanced in vitro and in vivo activity of the agent. This is achieved via a once-daily tedizolid dosing of 200 mg/day (in contrast to the twice-daily linezolid dose of 2 × 600 mg) and with a shortened treatment duration compared to linezolid, possibly limited by the time frame of hematopoietic and blood cells’ life cycles. This short-term therapy is succeeding in clinical trials of acute bacterial skin and skin structure infections, with apparent amelioration of the intrinsic myelosuppressive potential of tedizolid due to a truncated dosing regimen and the generally reversible nature of myelosuppression, with normalized platelet counts reported 5–6 days post-therapy.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><div class="NLM_p">While no tedizolid binding to mitochondria was detected,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> it remains to be established whether it is safe in expanded patient populations, especially if a longer treatment is required such as seen with off-label or compassionate linezolid therapy. This will be conclusively determined only after the anticipated regulatory approval of tedizolid and the wide introduction of this promising new agent into hospital formularies.</div><div class="NLM_p">To the best of our knowledge, no other work has described efforts directly targeting a safer oxazolidinone antibacterial. Ideally, the next-generation drug of this class would maintain high levels of antibacterial activity in vitro and in vivo while exhibiting a superior (vs linezolid) safety profile. Such an agent should offer a significantly reduced propensity for myelosuppression as well as for MAOI to reduce the adverse effects potential and thereby permit the longer-term therapy required for hard-to-treat Gram-positive infections, such as diabetic foot infection and osteomyelitis.</div><div class="NLM_p last">Herein, we review the preclinical and early clinical progress toward identification of a novel oxazolidinone agent that maintains high antibacterial activity while potentially addressing some of the key toxicity issues associated with linezolid therapy.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> With aforementioned class limitations in mind, our research strategy specifically targeted improving the oxazolidinone safety profile rather than merely enhancing the antibacterial potency of a new agent.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Medicinal Chemistry toward the Design and Identification of the New Clinical Oxazolidinone</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77604" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77604" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The antibacterial oxazolidinone class presents a paradoxical challenge for medicinal chemists due to unique structure–activity relationship (SAR) restrictions. Many researchers have been lured into the oxazolidinone field by the apparent ease of synthesizing “new active compounds”, largely due to the relatively flexible SAR vis-à-vis the left-side C-ring structure (the Pharmacia and Upjohn substructure designation,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> as illustrated in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, is used herein). Since the pioneering discovery of antibacterial oxazolidinones by the Du Pont Merck Pharmaceutical Co.,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> most global pharmaceutical companies and many other groups have been involved in this research area.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401931e/production/images/medium/jm-2013-01931e_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401931e/production/images/large/jm-2013-01931e_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Linezolid and the new clinical agent, (<i>S</i>)-5-((isoxazol-3-ylamino)methyl)-3-(2,3,5-trifluoro-4-(4-oxo-3,4-dihydropyridin-1(2<i>H</i>)-yl)phenyl)oxazolidin-2-one.<a onclick="showRef(event, 'cit23a'); return false;" href="javascript:void(0);" class="ref cit23a">(23a)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401931e/production/images/large/jm-2013-01931e_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401931e&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">However, most of the new molecules offered no potential for clinical advantage over linezolid, with the majority of the active analogues found to be significantly more toxic than this drug,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> as illustrated by a negligible number of clinical investigational oxazolidinones, obviously disproportional to the multitude of research and patent publications on the topic. As noted by Renslo<a onclick="showRef(event, 'cit26b'); return false;" href="javascript:void(0);" class="ref cit26b">(26b)</a> in 2010, “A highly potent and...selective oxazolidinone is...the ideal choice, but no such analogue has yet been disclosed...”. Despite the relatively simple oxazolidinone structure, linezolid remains the only approved drug of the class nearly 14 years since its clinical introduction.</div><div class="NLM_p">Importantly, SAR modifications at structural sites other than the C-ring structural have proven to be far more restrictive, limiting opportunities to derive a selective antibacterial molecule. Thus, in a seminal publication, Park<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> ascertained critical SAR limitations governing substitutions in the aromatic B-ring. Specifically, substitutions in a position 2 (i.e., <i>ortho</i> in relation to the oxazolidinine ring) were deemed prohibited: “The 2-substituted compounds have, at best, weak activity”, and “... 2,4,6-trisubstituted derivatives are devoid of antibacterial activity”. Notably, examples by Park included 2-fluorophenyl analogues, likewise found inactive. This SAR restriction was further restated by other groups (see, for example, a review by Ford<a onclick="showRef(event, 'cit5a'); return false;" href="javascript:void(0);" class="ref cit5a">(5a)</a>). Subsequently, the vast majority of later studies avoided the disfavored structures, as apparent from multiple publications explicitly limiting any aromatic <i>ortho</i>-substituents to the sole hydrogen atom (see, for example, representative patent publications<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and SAR reviews<a onclick="showRef(event, 'cit26a ref28'); return false;" href="javascript:void(0);" class="ref cit26a ref28">(26a, 28)</a>).</div><div class="NLM_p">In 2005, Barbachyn<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> described a set of new oxazolidinones incorporating the 2,4,6-trifluorophenyl B-ring. In a remarkable deviation from the classical SAR, the new examples maintained good antibacterial activity, with only marginal reduction in activity compared to des-<i>ortho</i>-fluoro B-ring progenitors. Thus, a <i>Staphylococccus aureus</i> MIC<sub>90</sub> (minimum concentration to inhibit the growth of 90% strains tested) of 8 μg/mL was determined for trifluorophenyl linezolid analogue (PF-00987296), a value close to the MIC<sub>90</sub> of 4 μg/mL for the comparator linezolid. Notably, the new compound was also reported to display a reduced MAO-A inhibition compared to linezolid.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The unique nature of this observation is apparent from the narrow set of closely related structures described. Indeed, all examples therein featured the acetamidomethyl C-5 group in combination with a few saturated six-member heterocycles including morpholine, piperazine, tetrahydropyran, and tetrahydrothiopyran C-rings (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401931e/production/images/medium/jm-2013-01931e_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401931e/production/images/large/jm-2013-01931e_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. General structures for trifluorophenyl oxazolidinones of Barbachyn<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and the advanced lead<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> of this series.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401931e/production/images/large/jm-2013-01931e_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401931e&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The limited scope of this discovery is in line with the established SAR, effectively making this an exception from the general restriction for <i>ortho</i> substitutions in the aromatic B-ring.</div><div class="NLM_p">Inspired by this intriguing SAR observation, our group has embarked on extensive exploration of novel <i>ortho</i>-fluorophenyl oxazolidinones in the hope of arriving at other unique structures that might combine the desired antibacterial potency and attenuated MAOI potential. We rationalized that a distinctly nonplanar A- and B-rings disposition forced by the <i>ortho</i>-fluoro substituent may allow for differentiation of such structures from the classical oxazolidinones in their propensity toward the inherent class effects of MAOI and myelosuppression, with the latter often observed for cytotoxic structures<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> such as conjugated and planar biaryl derivatives. This structural differentiation between linezolid and its trifluoro analogue was noted by Barbachyn<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> despite the absence of an explicit correlation with improved MAO safety.</div><div class="NLM_p">Among several C-ring classes evaluated in our work, new analogues of known highly potent structures featuring a pyridine C-ring were included as well as a series of novel compounds incorporating the dihydropyridone C-ring. Notably, any <i>ortho</i>-substututed structures were deliberately excluded from these two series in a prior research by the Dong-A and Vicuron–Pfizer groups, respectively.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The bis-heteroaryl C-ring series originated at Dong-A has subsequently yielded the clinical candidate tedizolid.<a onclick="showRef(event, 'cit20b'); return false;" href="javascript:void(0);" class="ref cit20b">(20b)</a> The novel <i>ortho</i>-fluorophenyl oxazolidinones discussed herein were prepared by modifications of chemistry previously described for des-<i>ortho</i>-fluoro progenitors, as illustrated in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> (additional syntheses and specific examples are detailed in ref <a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">32</a>).</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401931e/production/images/medium/jm-2013-01931e_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401931e/production/images/large/jm-2013-01931e_0004.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Representative Synthesis of Dihydropyridone Oxazolidinones Derivatives: The First Preparation of the New Clinical Agent<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401931e/production/images/large/jm-2013-01931e_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401931e&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) piperidine-4-one hydrochloride, DIEA, NMP, −5 °C to rt, 90%; (ii) trimethylsilyl triflate, TEA, THF, 0 °C to rt, 98%; (iii) allyl methyl carbonate, Pd(OAc)<sub>2</sub>, DMSO, 60 °C, 95%; (iv) Fe, NH<sub>4</sub>Cl, aq EtOH, 100 °C, 95%; (v) isobutyl chloroformate, Py, DCM, 0 °C to rt, 82%; (vi) (<i>R</i>)-oxiran-2-ylmethyl butyrate, LiOBu-t, THF, MeCN, 0 °C to rt, 74%; (vii) MsCl, TEA, DCM, rt, 90%; (viii) <i>tert</i>-butyl isoxazole-3-ylcarbamate, KOBu-t, DMF, rt, 75%; (ix) aq HCl, EtOH, EtOAc, rt, 80%</p></p></figure><div class="NLM_p">To identify whether a select class of <i>ortho</i>-fluorophenyl oxazolidinones displayed appreciable antibacterial potency, a primary in vitro assessment initially was performed against a panel of Gram-positive bacterial strains including <i>S. aureus</i>. As illustrated in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, respective pairs of compound <b>1</b> and <b>2</b> either lacking or incorporating the <i>ortho</i>-fluoro substituent have been compared to assess SAR effects of this structure variation.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Representative SAR towards Selection of the Dihydropyridone Oxazolidinone Series with <i>ortho</i>-Fluorophenyl Substitutions: Related Compounds <b>1</b> and <b>2</b> Are Compared</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401931e/production/images/medium/jm-2013-01931e_0005.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Minimum inhibitory concentration (MIC) against methicillin-resistant <i>S. aureus</i> (MRSA) strain SAU1009, except for the literature data<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> for compounds <b>1a</b> and <b>2a</b>.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Reported MIC data for compounds from ref <a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">25</a>.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">Compared to self.</p></div></div><div></div></div><div class="NLM_p">As anticipated, our initial results have followed the established SAR trend, with about a 4-fold drop in the antimicrobial potency for <i>ortho</i>-fluoro compounds <b>2b</b>–<b>2d</b> when compared to the respective des-<i>ortho</i>-fluoro progenitors <b>1b</b>–<b>1d</b>, as illustrated by the data in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> (representative literature data from Park<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> are included therein as compounds <b>1a</b> and <b>2a</b>). However, the compounds featuring the dihydropyridone C-ring suffered only about 2-fold decline in potency against <i>S. aureus</i>, with MIC values of 0.5 and 1 μg/mL for oxazolidinones <b>1e</b> and <b>2e</b>, respectively (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><div class="NLM_p">It may be reasoned that the dihydropyridone heterocycle bears a general resemblance to the morpholine C-ring featured in linezolid and, by extension, to the aforementioned trifluorophenyl analogue of linezolid of Barbachyn.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> In addition, the relatively more planar (vs the morpholine heterocycle) dihydropyridone C-ring likely contributes to an increased antibacterial activity of the respective oxazolidinones vs linezolid, while the increased polar surface area of the dihydropyridone structure may partially compensate for a more lipophilic di- or trifluorinated B-ring, as compared to the non-dihydropyridone examples of Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>.</div><div class="NLM_p">This encouraging result has prompted an optimization round with a focus on the dihydropyridone C-ring derivatives incorporating up to three fluorine atoms in the phenyl B-ring structure. In vitro tests included antibacterial potency and MAOI evaluation, as well as in vivo efficacy determination in the <i>S. aureus</i> mouse septicemia model (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. B-Ring and C-5 Group SAR for Preliminary Selection of the Clinical Compound <b>7</b>: Potency, MAOI, and Efficacy in the Mouse <i>S. aureus</i> Septicemia Model</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401931e/production/images/medium/jm-2013-01931e_0006.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">MIC against MRSA strain SAU1009.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">MAO-A inhibition assay of ref <a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">33</a>. Values in parentheses are for linezolid control.</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">Efficacy in murine <i>S. aureus</i> septicemia model with oral drug administration. Values in parentheses are for linezolid control.</p></div><div class="footnote" id="t2fn4"><sup>Table d</sup><p class="last">A comparator compound of ref <a onclick="showRef(event, 'cit27a'); return false;" href="javascript:void(0);" class="ref cit27a">27a</a>.</p></div><div class="footnote" id="t2fn5"><sup>Table e</sup><p class="last">Linezolid.</p></div></div><div></div></div><div class="NLM_p">As illustrated by the data of Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, the <i>ortho</i>-fluoro substitution was reasonably well tolerated across several dihydropyridone-containing structures including both di- and trifluoro derivatives. Interestingly, difluorophenyl derivatives were generally more potent than respective trifluorophenyl analogues, as illustrated by MIC values of 1 and 2 μg/mL for compounds <b>2e</b> and <b>3</b>, respectively. However, in spite of the high potency (similar to that of linezolid), these compounds displayed oral efficacy inferior to the drug in the mouse infection model (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><div class="NLM_p">To improve in vivo activity, a survey of additional C-5 group analogues incorporating amide, carbamate, triazole, isoxazole ether, and isoxazole amine derivatives was performed. This resulted in the identification of compounds with efficacy similar or even superior to that of linezolid, such as compounds <b>4</b>, <b>5</b>, and <b>7</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><div class="NLM_p">Importantly, the new <i>ortho</i>-fluoro dihydropyridone series represented by compounds of Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> exhibited significantly reduced MAOI compared to linezolid. Surprisingly, some compounds displayed MAOI attenuated over 20-fold as compared to the corresponding des-<i>ortho</i>-fluoro analog (for example, IC<sub>50</sub> >100 μg/mL for compounds <b>2e</b> and <b>5</b>). This dramatic effect was not anticipated based on the prior data of Barbachyn, wherein the trifluorophenyl analogue of linezolid exhibited about 5-fold reduced MAOI compared to the reference drug.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The compound <b>7</b>, (<i>S</i>)-5-((isoxazol-3-ylamino)methyl)-3-(2,3,5-trifluoro-4-(4-oxo-3,4-dihydropyridin-1(2<i>H</i>)-yl)phenyl)oxazolidin-2-one (MRX-I), was selected for further evaluation.</div><div class="NLM_p">A separate testing has revealed that the aforementioned lead exhibits distinctly attenuated over linezolid cytotoxicity in the human bone marrow CD34<sup>+</sup> test, an assay that has been reported to be predictive of the myelosuppressive toxicity of oxazolidinones.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div><div class="NLM_p">Thus, the bone marrow CD34<sup>+</sup> inhibition for compound <b>7</b> compared to linezolid and the clinical oxazolidinone tedizolid indicated a distinctly reduced toxicity for the new agent compared to linezolid, with even more pronounced differentiation from tedizolid, the active form of its phosphate prodrug (TR-701)<a onclick="showRef(event, 'cit20b'); return false;" href="javascript:void(0);" class="ref cit20b">(20b)</a> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Admittedly, the intrinsic bone marrow cytotoxicity of an oxazolidinone agent may not always manifest in vivo or reveal itself in every patient population. The tedizolid therapy was well tolerated in a phase III trial, even if with a 6-fold reduced daily dosing and ca. 2-fold shorter treatment regimen (from 14 to 6 days) compared to linezolid.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. In Vitro MAOI and Human CD34<sup>+</sup> Bone Marrow Cells Growth Inhibition for Compound <b>7</b> Compared to Linezolid and Tedizolid Controls</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401931e/production/images/medium/jm-2013-01931e_0007.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">MAOI assay of ref <a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">33</a>.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">CD34<sup>+</sup> assay of ref <a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">34</a>.</p></div><div class="footnote" id="t3fn3"><sup>Table c</sup><p class="last">Data of ref <a onclick="showRef(event, 'cit23a'); return false;" href="javascript:void(0);" class="ref cit23a">23a</a>.</p></div><div class="footnote" id="t3fn4"><sup>Table d</sup><p class="last">Values in parentheses are for linezolid control in a side-by-side test.</p></div><div class="footnote" id="t3fn5"><sup>Table e</sup><p class="last">Linezolid, data of ref <a onclick="showRef(event, 'cit7a'); return false;" href="javascript:void(0);" class="ref cit7a">7a</a>.</p></div><div class="footnote" id="t3fn6"><sup>Table f</sup><p class="last">Tedizolid, data of ref <a onclick="showRef(event, 'cit20b'); return false;" href="javascript:void(0);" class="ref cit20b">20b</a>.</p></div></div><div></div></div><div class="NLM_p last">The high anti-MRSA potency of compound <b>7</b>, along with its reduced toxicities in bone marrow CD34<sup>+</sup> and MAOI assays, have prompted the advance of this candidate into further preclinical and clinical evaluation (the original reports preceding this perspective are cited in ref <a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">23</a>).</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Preclinical Profile of Compound <b>7</b>: Microbiology</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44352" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44352" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The clinical compound <b>7</b> is highly potent against all Gram-positive clinical isolates of staphylococci, streptococci, and enterococci, including MDR organisms such as MRSA, methicilline-resistant <i>Streptococcus epidermidis</i> (MRSE), penicillin-resistant Streptococci (PRSP), and VRE (as originally reported by Zhu<a onclick="showRef(event, 'cit23a'); return false;" href="javascript:void(0);" class="ref cit23a">(23a)</a>).</div><div class="NLM_p">Antibacterial activity of compound <b>7</b> against Gram-positive pathogens is generally comparable to that for linezolid, as illustrated in Tables <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>–<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>. Similar to linezolid, the new agent is inactive against Gram-negative bacteria.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. In Vitro Antimicrobial Activity of Compound <b>7</b> against Staphylococci</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="–" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">organism<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center" char="–">MIC range (μg/mL)</th><th class="colsep0 rowsep0" align="center" char=".">MIC<sub>50</sub></th><th class="colsep0 rowsep0" align="center" char=".">MIC<sub>90</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MRSA (104)</td><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="char" char="–">0.25–1</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">linezolid</td><td class="colsep0 rowsep0" align="char" char="–">0.5–1</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MSSA (64)</td><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="char" char="–">0.5–1</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">linezolid</td><td class="colsep0 rowsep0" align="char" char="–">0.5–1</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MRSE (50)</td><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="char" char="–">0.125–1</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">linezolid</td><td class="colsep0 rowsep0" align="char" char="–">0.25–1</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MSSE (35)</td><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="char" char="–">0.25–0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">linezolid</td><td class="colsep0 rowsep0" align="char" char="–">0.25–1</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>Staphylococcus hemolyticus</i> (32)</td><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="char" char="–">0.25–0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">linezolid</td><td class="colsep0 rowsep0" align="char" char="–">0.5–1</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>Staphylococcus saprophyticus</i> (20)</td><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="char" char="–">0.25–1</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">linezolid</td><td class="colsep0 rowsep0" align="char" char="–">0.5–1</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">coagulase-negative Staphylococci (23)</td><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="char" char="–">0.25–0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">linezolid</td><td class="colsep0 rowsep0" align="char" char="–">0.25–1</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">β-lactamase-negative Staphylococci (20)</td><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="char" char="–">0.25–1</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">linezolid</td><td class="colsep0 rowsep0" align="char" char="–">0.25–1</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Number of bacterial strains tested are given in parentheses.</p></div></div></div><div class="NLM_p">Significantly, the potency of the new agent against MRSA in the agar dilution assay was 2-fold higher than that of linezolid: MIC<sub>90</sub> values were 0.5 and 1 μg/mL for compound <b>7</b> and the comparator drug, respectively (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>).</div><div class="NLM_p">Similar to linezolid, the new agent exhibits high activity against multiple strains of enterococci and streptococci species (Tables <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> and <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. In Vitro Antimicrobial Activity of Compound <b>7</b> against Enterococci</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">organism<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">MIC range (μg/mL)</th><th class="colsep0 rowsep0" align="center" char=".">MIC<sub>50</sub></th><th class="colsep0 rowsep0" align="center" char=".">MIC<sub>90</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>Enterococcus faecalis</i> VAN-S (52)</td><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="center">0.5–1</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">linezolid</td><td class="colsep0 rowsep0" align="center">0.5–1</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">vancomycin</td><td class="colsep0 rowsep0" align="center">0.125–2</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">teicoplanin</td><td class="colsep0 rowsep0" align="center">≤0.06–0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.125</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>Enterococcus faecium</i> VAN-S (50)</td><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="center">0.5–2</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">linezolid</td><td class="colsep0 rowsep0" align="center">0.5–2</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">vancomycin</td><td class="colsep0 rowsep0" align="center">0.25–1</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">teicoplanin</td><td class="colsep0 rowsep0" align="center">≤0.06–1</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">enterococci, other VAN-S (16)</td><td class="colsep0 rowsep0" align="left">(a) <b>7</b></td><td class="colsep0 rowsep0" align="center">0.5–1</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">linezolid</td><td class="colsep0 rowsep0" align="center">0.5–1</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">vancomycin</td><td class="colsep0 rowsep0" align="center">0.25–4</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">teicoplanin</td><td class="colsep0 rowsep0" align="center">0.125–0.25</td><td class="colsep0 rowsep0" align="char" char=".">0.125</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>Enterococcus faecium</i> VRE (20)</td><td class="colsep0 rowsep0" align="left">(b) <b>7</b></td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">linezolid</td><td class="colsep0 rowsep0" align="center">1–2</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">vancomycin</td><td class="colsep0 rowsep0" align="center">64→128</td><td class="colsep0 rowsep0" align="char" char=".">>128</td><td class="colsep0 rowsep0" align="char" char=".">>128</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">teicoplanin</td><td class="colsep0 rowsep0" align="center">32→ 128</td><td class="colsep0 rowsep0" align="char" char=".">32</td><td class="colsep0 rowsep0" align="char" char=".">128</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Number of bacterial strains tested are given in parentheses. VAN-S: vancomycin-sensitive.</p></div></div></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. In Vitro Antimicrobial Activity of Compound <b>7</b> against Streptococci</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">organism<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">MIC range (μg/mL)</th><th class="colsep0 rowsep0" align="center" char=".">MIC<sub>50</sub></th><th class="colsep0 rowsep0" align="center" char=".">MIC<sub>90</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PSSP (40)</td><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="center">0.125–1</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">linezolid</td><td class="colsep0 rowsep0" align="center">0.125–1</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PISP (45)</td><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="center">0.125–1</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">linezolid</td><td class="colsep0 rowsep0" align="center">0.125–1</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PRSP (40)</td><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="center">≤0.015–0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">linezolid</td><td class="colsep0 rowsep0" align="center">0.06–0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>Streptococcus pyogenes</i> (35)</td><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="center">0.25–1</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">linezolid</td><td class="colsep0 rowsep0" align="center">0.5–1</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>Streptococcus agalactiae</i> (25)</td><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="center">0.5–1</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">linezolid</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>Streptococcus equisimilis</i> (11)</td><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">linezolid</td><td class="colsep0 rowsep0" align="center">0.5–1</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>Streptococcus mitis</i> (10)</td><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="center">0.125–1</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">linezolid</td><td class="colsep0 rowsep0" align="center">0.25–1</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>Streptococcus constellatus</i> (11)</td><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="center">0.25–1</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">linezolid</td><td class="colsep0 rowsep0" align="center">0.25–1</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>Streptococcus anginosus</i> (10)</td><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="center">0.25–1</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">linezolid</td><td class="colsep0 rowsep0" align="center">0.25–1</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>Streptococcus sanguis</i> (5)</td><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="center">0.25–1</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">linezolid</td><td class="colsep0 rowsep0" align="center">0.06–1</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Number of bacterial strains tested are given in parentheses. PISP: penicillin intermediate-sensitive <i>S. pneumoniae.</i> PSSP: penicillin-sensitive <i>S. pneumoniae</i>.</p></div></div></div><div class="NLM_p">Similar to the comparator drug, compound <b>7</b> displays bacteriostatic activity against enterococci. The agent exhibits bactericidal activity against <i>Streptococcus pneumoniae</i>, and modest bactericidal activity against some <i>S. aureus</i> and <i>Streptococcus pyogenes</i> strains.</div><div class="NLM_p">The new agent exhibited a significant postantibiotic effect (PAE) against <i>S. aureus</i> and <i>S. pneumoniae</i>: 1.6 and 1.8 h, respectively. These results are comparable to the PAE for linezolid.<a onclick="showRef(event, 'cit23a'); return false;" href="javascript:void(0);" class="ref cit23a">(23a)</a></div><div class="NLM_p">As typical for the class, the compound <b>7</b> exhibits an extremely low resistance potential with respect to both spontaneous and multistep selection resistance (as originally reported by Huang<a onclick="showRef(event, 'cit23b'); return false;" href="javascript:void(0);" class="ref cit23b">(23b)</a>). In line with the oxazolidinone mode of action, bacterial strains resistant to linezolid are cross-resistant to the new agent, with an MIC >16 μg/mL against the clinical isolate <i>S. aureus</i> 4184 for both compound <b>7</b> and the comparator drug. Similar to linezolid, the new agent exhibits an extremely low frequency of spontaneous resistance, with values in <i>S. aureus</i> of <8 × 10<sup>–12</sup> for both compound <b>7</b> and linezolid. Early results suggest that U2504A transversion occurs in 23S rRNA of <i>S. aureus</i> mutants resistant to the new agent.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a><i>S. aureus</i> mutations were also detected in the gene encoding the L3 ribosomal protein but not in the genes encoding L4 and L22 proteins.</div><div class="NLM_p">Interestingly, the serial passaging resistance development study revealed a distinction between compound <b>7</b> and linezolid, with a notably slower MIC creep observed for the former as compared to the reference drug. Specifically, a doubling of MIC values, indicative of a reduced antibacterial potency, was observed after six passages with linezolid but required 10 passages in the case of compound <b>7</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). Further studies are under way to elucidate possible reasons for this interesting phenomenon and to characterize the resistant mutants.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Slow MIC Creep in a Serial Passaging Study for Compound <b>7</b> and Linezolid</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">serial passage no.</th><th class="colsep0 rowsep0" align="center" char=".">compound 7 MIC (μg/mL)</th><th class="colsep0 rowsep0" align="center" char=".">linezolid MIC (μg/mL)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">parent</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">P1</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">P2</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">P3</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">P4</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">P5</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">P6</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">P7</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">P8</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">P9</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">P10</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr></tbody></table></div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Preclinical Profile of the Compound <b>7</b>: Efficacy in Animal Infection Models</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60041" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60041" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Orally administered compound <b>7</b> displayed high antimicrobial activity in multiple animal models, with efficacy generally similar to that for linezolid in tests against select bacterial isolates that exhibit similar MICs for both agents (as originally reported by Li<a onclick="showRef(event, 'cit23c'); return false;" href="javascript:void(0);" class="ref cit23c">(23c)</a>).</div><div class="NLM_p">In systemic mouse septicemia models with 11 Gram-positive strains of <i>S. aureus</i>, <i>S. pneumoniae</i>, <i>Enterococcus faecalis</i>, and <i>S. pyogenes</i>, including resistant clinical isolates of MRSA, PRSP, VRE, and high-level gentamycin resistant (HLGR) <i>E. faecalis</i>, compound <b>7</b> exhibited high efficacy against all strains tested (Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>).</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Efficacy of Compound <b>7</b> in Mouse Systemic Infection Models</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="center" /></col><col align="char" char="." /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">compound 7</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">linezolid</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">organism</th><th class="colsep0 rowsep0" align="center" char=".">MIC (μg/mL)</th><th class="colsep0 rowsep0" align="center">ED<sub>50</sub> (range) (mg/kg)</th><th class="colsep0 rowsep0" align="center" char=".">MIC (μg/mL)</th><th class="colsep0 rowsep0" align="center">ED<sub>50</sub> (range) (mg/kg)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>S. aureus</i> ATCC 29213 (MSSA)</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="center">8.0 (5.2–12.3)</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="center">9.0 (7.1–11.5)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>S. aureus</i> 0612 (MRSA)</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="center">7.2 (5.2–10.0)</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="center">8.7 (6.3–11.8)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>S. aureus</i> 0605 (MRSA)</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="center">12.0 (8.4–17.1)</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="center">10.2 (7.8–13.3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>S. aureus</i> 15 (MSSA)</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="center">5.7 (4.2–7.9)</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="center">5.9 (4.6–7.5)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>S. pneumoniae</i> ATCC 49619 (PISP)</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="center">8.1 (6.1–10.7)</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="center">8.17 (6.5–10.3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>S. pneumoniae</i> 0806 (PSSP)</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="center">22.0 (18.4–26.3)</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="center">16.8 (14.7–19.1)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>S. pneumoniae</i> 0613 (PRSP)</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="center">10.5 (7.8–14.0)</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="center">9.3 (7.1–12.3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>E. faecalis</i> ATCC 29212 (VSE)</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="center">14.1 (6.9–28.7)</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="center">13.4 (9.3–19.5)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>E. faecalis</i> EFL 4041 (VRE)</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="center">6.2 (4.8–7.9)</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="center">6.0 (4.7–7.5)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>E. faecalis</i> HH22 (VSE, HLGR)</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="center">7.4 (6.0–9.2)</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="center">5.6 (4.0–7.9)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>S. pyogenes</i> 556</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="center">8.9 (6.9–11.4)</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="center">7.8 (6.0–10.1)</td></tr></tbody></table></div></div><div class="NLM_p">Observed ED<sub>50</sub> values were 5.7–12.0 mg/kg against <i>S. aureus</i> strains, 8.1–22.0 mg/kg against <i>S. pneumoniae</i> strains, 6.2–14.1 against <i>E. faecalis</i> strains, and 8.9 mg/kg against a <i>S. pyogenes</i> strain in multiple tests performed (Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>).</div><div class="NLM_p">Likewise, the new agent displayed high efficacy in animal models of localized bacterial infections, as illustrated by data for MSSA and MRSA mouse thigh infection models (Tables <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a> and <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a>).</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Efficacy of Compound <b>7</b> in <i>S. aureus</i> ATCC29213 (MSSA) Mouse Thigh Infection Model: Colony-Forming Units (CFU) Reduction Post-Treatment, 10 Animals Per Dosing Group</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="." /></col><col align="char" char="±" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">compound 7 (MIC 1 μg/mL)</th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">linezolid (MIC 1 μg/mL)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center" char="±">LogCFU/thigh</th><th class="colsep0 rowsep0" align="center" char=".">ΔLogCFU/thigh</th><th class="colsep0 rowsep0" align="center" char="±">LogCFU/thigh</th><th class="colsep0 rowsep0" align="center" char=".">ΔLogCFU/thigh</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="char" char="±">7.19 ± 0.66</td><td class="colsep0 rowsep0" align="char" char=".">0.95</td><td class="colsep0 rowsep0" align="char" char="±">7.09 ± 1.46</td><td class="colsep0 rowsep0" align="char" char=".">1.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="char" char="±">4.85 ± 0.94</td><td class="colsep0 rowsep0" align="char" char=".">3.29</td><td class="colsep0 rowsep0" align="char" char="±">5.45 ± 1.37</td><td class="colsep0 rowsep0" align="char" char=".">2.69</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="char" char="±">4.81 ± 1.13</td><td class="colsep0 rowsep0" align="char" char=".">3.33</td><td class="colsep0 rowsep0" align="char" char="±">5.32 ± 1.39</td><td class="colsep0 rowsep0" align="char" char=".">2.82</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="char" char="±">4.72 ± 0.78</td><td class="colsep0 rowsep0" align="char" char=".">3.42</td><td class="colsep0 rowsep0" align="char" char="±">4.50 ± 0.47</td><td class="colsep0 rowsep0" align="char" char=".">3.64</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">80</td><td class="colsep0 rowsep0" align="char" char="±">4.41 ± 0.43</td><td class="colsep0 rowsep0" align="char" char=".">3.73</td><td class="colsep0 rowsep0" align="char" char="±">4.44 ± 1.27</td><td class="colsep0 rowsep0" align="char" char=".">3.70</td></tr></tbody></table></div></div><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. Efficacy of Compound <b>7</b> in <i>S. aureus</i> 0605 (MRSA) mouse thigh infection model: CFU reduction post-treatment, 10 animals per dosing group</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="." /></col><col align="char" char="±" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">compound 7 (MIC 2 μg/mL)</th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">linezolid (MIC 2 μg/mL)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">dose mg/kg</th><th class="colsep0 rowsep0" align="center" char="±">LogCFU/thigh</th><th class="colsep0 rowsep0" align="center" char=".">ΔLogCFU/thigh</th><th class="colsep0 rowsep0" align="center" char="±">LogCFU/thigh</th><th class="colsep0 rowsep0" align="center" char=".">ΔLogCFU/thigh</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="char" char="±">5.61 ± 1.68</td><td class="colsep0 rowsep0" align="char" char=".">2.45</td><td class="colsep0 rowsep0" align="char" char="±">7.86 ± 0.77</td><td class="colsep0 rowsep0" align="char" char=".">0.20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="char" char="±">5.59 ± 1.70</td><td class="colsep0 rowsep0" align="char" char=".">2.47</td><td class="colsep0 rowsep0" align="char" char="±">4.55 ± 1.45</td><td class="colsep0 rowsep0" align="char" char=".">3.51</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="char" char="±">4.46 ± 1.44</td><td class="colsep0 rowsep0" align="char" char=".">3.60</td><td class="colsep0 rowsep0" align="char" char="±">3.99 ± 1.55</td><td class="colsep0 rowsep0" align="char" char=".">4.07</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="char" char="±">3.93 ± 0.62</td><td class="colsep0 rowsep0" align="char" char=".">4.13</td><td class="colsep0 rowsep0" align="char" char="±">3.66 ± 0.49</td><td class="colsep0 rowsep0" align="char" char=".">4.40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">80</td><td class="colsep0 rowsep0" align="char" char="±">3.53 ± 0.75</td><td class="colsep0 rowsep0" align="char" char=".">4.53</td><td class="colsep0 rowsep0" align="char" char="±">3.57 ± 1.59</td><td class="colsep0 rowsep0" align="char" char=".">4.49</td></tr></tbody></table></div></div><div class="NLM_p">The new agent exhibited a dose-dependent antibacterial effect in thigh infections caused by staphylococci isolates, with an excellent pathogen eradication of 2.45–4.53 units for MRSA infection in neutropenic rodent (Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a>). Its efficacy was similar to that of linezolid in localized tissue infections caused by <i>S. aureus</i> isolates.</div><div class="NLM_p last">Thus, across a broad range of animal infection models, the oral efficacy for compound <b>7</b> was comparable to that of linezolid against multiple Gram-positive bacterial strains.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Preclinical Profile of Compound <b>7</b>: Pharmacokinetics (PK)</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64560" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64560" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Oral absorption of compound <b>7</b> occurred rapidly in mouse, rat, and dog, with peak plasma concentrations observed at 0.5–2.6 h postdose (as originally reported by Chen;<a onclick="showRef(event, 'cit23d'); return false;" href="javascript:void(0);" class="ref cit23d">(23d)</a> Table <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">11</a>). In mouse, rat, and dog, respectively, PK parameters were determined as follows: dose-normalized <i>C</i><sub>max</sub>/dose was 524, 1065, and 259 ng/mL/(mg/kg); dose-normalized AUC<sub>0–<i>t</i></sub>/dose was 1654, 3703, and 1664 ng·h/mL/(mg/kg); <i>T</i><sub>1/2</sub> was 1, 1.5, and 3 h; and the oral bioavailability was 69%, 109%, and 37%.</div><div class="NLM_table-wrap" id="tbl11"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 11. PK Parameters of the Compound <b>7</b> in Rat</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">dose (mg/kg) (route)</th><th class="colsep0 rowsep0" align="center">gender</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (μg/mL)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>0–<i>t</i></sub> (μg·h/mL)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5 (oral)</td><td class="colsep0 rowsep0" align="left">M</td><td class="colsep0 rowsep0" align="char" char=".">0.50</td><td class="colsep0 rowsep0" align="char" char=".">4.60</td><td class="colsep0 rowsep0" align="char" char=".">1.08</td><td class="colsep0 rowsep0" align="char" char=".">10.16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char=".">0.67</td><td class="colsep0 rowsep0" align="char" char=".">9.39</td><td class="colsep0 rowsep0" align="char" char=".">2.07</td><td class="colsep0 rowsep0" align="char" char=".">31.47</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">average</td><td class="colsep0 rowsep0" align="char" char=".">0.58</td><td class="colsep0 rowsep0" align="char" char=".">7.00</td><td class="colsep0 rowsep0" align="char" char=".">1.57</td><td class="colsep0 rowsep0" align="char" char=".">20.81</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">15 (oral)</td><td class="colsep0 rowsep0" align="left">M</td><td class="colsep0 rowsep0" align="char" char=".">1.00</td><td class="colsep0 rowsep0" align="char" char=".">10.71</td><td class="colsep0 rowsep0" align="char" char=".">1.18</td><td class="colsep0 rowsep0" align="char" char=".">34.31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char=".">1.17</td><td class="colsep0 rowsep0" align="char" char=".">17.23</td><td class="colsep0 rowsep0" align="char" char=".">1.47</td><td class="colsep0 rowsep0" align="char" char=".">64.71</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">average</td><td class="colsep0 rowsep0" align="char" char=".">1.08</td><td class="colsep0 rowsep0" align="char" char=".">13.97</td><td class="colsep0 rowsep0" align="char" char=".">1.32</td><td class="colsep0 rowsep0" align="char" char=".">49.51</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">45 (oral)</td><td class="colsep0 rowsep0" align="left">M</td><td class="colsep0 rowsep0" align="char" char=".">1.00</td><td class="colsep0 rowsep0" align="char" char=".">27.82</td><td class="colsep0 rowsep0" align="char" char=".">1.07</td><td class="colsep0 rowsep0" align="char" char=".">93.75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char=".">1.67</td><td class="colsep0 rowsep0" align="char" char=".">49.99</td><td class="colsep0 rowsep0" align="char" char=".">1.87</td><td class="colsep0 rowsep0" align="char" char=".">229.92</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">average</td><td class="colsep0 rowsep0" align="char" char=".">1.33</td><td class="colsep0 rowsep0" align="char" char=".">38.91</td><td class="colsep0 rowsep0" align="char" char=".">1.47</td><td class="colsep0 rowsep0" align="char" char=".">161.83</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5 (iv)</td><td class="colsep0 rowsep0" align="left">M</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">0.99</td><td class="colsep0 rowsep0" align="char" char=".">12.93</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">1.51</td><td class="colsep0 rowsep0" align="char" char=".">25.15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">average</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">1.25</td><td class="colsep0 rowsep0" align="char" char=".">19.04</td></tr></tbody></table></div></div><div class="NLM_p">Similar to linezolid, a gender bias was observed in rat, with somewhat higher exposure in females vs males. No gender difference was observed in mouse or dog.</div><div class="NLM_p last">No significant drug accumulation was observed during 7-days repeated dose studies in either rat or dog.</div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Preclinical Safety Profile for Compound <b>7</b></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10417" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10417" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compound <b>7</b> was evaluated with a close attention to the oxazolidinone-class toxicity effects. In vitro bone marrow myelosuppression CD34<sup>+</sup> data were noted above (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) in the context of the lead selection and the apparent differentiation of compound <b>7</b> from both linezolid and the newer clinical candidate tedizolid.<a onclick="showRef(event, 'cit20b'); return false;" href="javascript:void(0);" class="ref cit20b">(20b)</a></div><div class="NLM_p">To ascertain myelosuppressive potential of compound <b>7</b> in vivo, a 4-week repeated dose study in rat was performed (as originally reported by Qiu<a onclick="showRef(event, 'cit23f'); return false;" href="javascript:void(0);" class="ref cit23f">(23f)</a>). The study was designed to maximize the potential toxicity within a broad range of the drug exposure. Compound <b>7</b> was administered orally twice daily (10 rats/gender/group) at doses of 20, 100, and 200/300 mg/kg/day for 4 weeks, followed by a 4-week recovery period. Because of a lack of apparent toxicity, the top dose of 200 mg/kg/day was escalated to 300 mg/kg/day on day 15. The linezolid comparator was dosed in a similar manner at 100 and 200 mg/kg/day. Blood samples were collected for toxicokinetic (TK) analysis on days 1, 14, and 28.</div><div class="NLM_p">Notably, no mortality was observed in any of compound <b>7</b> groups. In contrast, all female rats in the linezolid 200 mg/kg/day group were deceased by day 14, with apparent signs of myelosuppression, including cachexia and pronounced body weight loss. In the linezolid 100 mg/kg/day cohort, female rats exhibited notably reduced weight gain during the first 2 weeks and stopped gaining weight thereafter. In contrast, female rats dosed with 20 and 100 mg/kg/day of compound <b>7</b> maintained normal rate of weight gain throughout 4 weeks of the test period.</div><div class="NLM_p">Furthermore, a hematologic analysis has revealed a pronounced drop in the white blood cell (WBC) count in 100 mg/kg/day female and in 200 mg/kg/day male rat cohorts for linezolid (Table <a class="ref showTableEvent internalNav" data-ID="tbl12" href="#tbl12">12</a>). In contrast, this decline was attenuated for compound <b>7</b> in the 200–300 mg/kg/day female rat group, and no WBC decline was observed in any of the other compound <b>7</b> test groups. Reductions in platelet counts were observed at 100 mg/kg/day linezolid, but not at 100 mg/kg/day for compound <b>7</b>, indicating a lower thrombocytopenia potential for the new agent (Table <a class="ref showTableEvent internalNav" data-ID="tbl12" href="#tbl12">12</a>). The data indicate a significantly attenuated hematological toxicity for compound <b>7</b> as compared to linezolid, including the propensity to cause thrombocytopenia noted as a warning in the prescribing information for linezolid.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_table-wrap" id="tbl12"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 12. Compound <b>7</b> Repeated Dose Toxicity: Hematology Parameters in Female Rat<a class="ref internalNav" href="#t12fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">compound 7</th><th class="rowsep1 colsep0" align="center" char=".">linezolid</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center" char=".">0</th><th class="colsep0 rowsep0" align="center" char=".">20 (mg/kg/day)</th><th class="colsep0 rowsep0" align="center" char=".">100 (mg/kg/day)</th><th class="colsep0 rowsep0" align="center" char=".">200–300 (mg/kg/day)</th><th class="colsep0 rowsep0" align="center" char=".">100 (mg/kg/day)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">WBC (10<sup>9</sup>/L)</td><td class="colsep0 rowsep0" align="char" char=".">3.66</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td><td class="colsep0 rowsep0" align="char" char=".">3.14</td><td class="colsep0 rowsep0" align="char" char=".">2.72</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RBC (10<sup>12</sup>/L)</td><td class="colsep0 rowsep0" align="char" char=".">7.28</td><td class="colsep0 rowsep0" align="char" char=".">6.82</td><td class="colsep0 rowsep0" align="char" char=".">6.67</td><td class="colsep0 rowsep0" align="char" char=".">5.77</td><td class="colsep0 rowsep0" align="char" char=".">5.52</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HB (g/L)</td><td class="colsep0 rowsep0" align="char" char=".">141.8</td><td class="colsep0 rowsep0" align="char" char=".">137.8</td><td class="colsep0 rowsep0" align="char" char=".">134.8</td><td class="colsep0 rowsep0" align="char" char=".">117.6</td><td class="colsep0 rowsep0" align="char" char=".">112.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HCT (%)</td><td class="colsep0 rowsep0" align="char" char=".">39.08</td><td class="colsep0 rowsep0" align="char" char=".">37.16</td><td class="colsep0 rowsep0" align="char" char=".">36.48</td><td class="colsep0 rowsep0" align="char" char=".">30.6</td><td class="colsep0 rowsep0" align="char" char=".">30.18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MCV (fL)</td><td class="colsep0 rowsep0" align="char" char=".">53.72</td><td class="colsep0 rowsep0" align="char" char=".">54.52</td><td class="colsep0 rowsep0" align="char" char=".">54.78</td><td class="colsep0 rowsep0" align="char" char=".">53.02</td><td class="colsep0 rowsep0" align="char" char=".">54.74</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MCH (pg)</td><td class="colsep0 rowsep0" align="char" char=".">19.5</td><td class="colsep0 rowsep0" align="char" char=".">20.2</td><td class="colsep0 rowsep0" align="char" char=".">20.28</td><td class="colsep0 rowsep0" align="char" char=".">20.48</td><td class="colsep0 rowsep0" align="char" char=".">20.52</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PLT (10<sup>9</sup>/L)</td><td class="colsep0 rowsep0" align="char" char=".">654.6</td><td class="colsep0 rowsep0" align="char" char=".">638.2</td><td class="colsep0 rowsep0" align="char" char=".">636.2</td><td class="colsep0 rowsep0" align="char" char=".">464.2</td><td class="colsep0 rowsep0" align="char" char=".">487.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">N (%)</td><td class="colsep0 rowsep0" align="char" char=".">22.4</td><td class="colsep0 rowsep0" align="char" char=".">15.4</td><td class="colsep0 rowsep0" align="char" char=".">18.4</td><td class="colsep0 rowsep0" align="char" char=".">26.4</td><td class="colsep0 rowsep0" align="char" char=".">13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">L (%)</td><td class="colsep0 rowsep0" align="char" char=".">74.8</td><td class="colsep0 rowsep0" align="char" char=".">83.4</td><td class="colsep0 rowsep0" align="char" char=".">78.8</td><td class="colsep0 rowsep0" align="char" char=".">71.8</td><td class="colsep0 rowsep0" align="char" char=".">86.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RET (%)</td><td class="colsep0 rowsep0" align="char" char=".">1.48</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">1.46</td><td class="colsep0 rowsep0" align="char" char=".">1.26</td><td class="colsep0 rowsep0" align="char" char=".">1.64</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t12fn1"><div class="footnote" id="t12fn1"><sup>a</sup><p class="last">WBC, white blood cells; RBC, red blood cells; HB, hemoglobin; HCT, hematocrit;. MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; PLT, platelets; N, neutrophils; L, lymphocytes; RET, reticulocytes.</p></div></div></div><div class="NLM_p">The histopathology revealed apparent changes in the bone marrow for linezolid in 100 mg/kg/day female and 200 mg/kg/day male rat groups. Some bone marrow changes were noted for compound <b>7</b> in the 200–300 mg/kg/day female rat group only, with no abnormality observed after the recovery period.</div><div class="NLM_p">TK analysis confirmed the high exposure to compound <b>7</b> throughout the 4-week repeated dose study, with <i>C</i><sub>max</sub> and AUC<sub>0–<i>t</i></sub> increasing in a dose-proportional manner. No drug accumulation was noted after 28 days of the repeat dosing. Consistent with the gender drug effect, the exposure to compound <b>7</b> was somewhat higher in female rats compared to male rats. Female rat AUC<sub>0–24</sub> values were within the range of 319–357 μg·h/mL for 100 mg/kg/day dosing and 626–650 μg·h/mL for 200 mg/kg/day dosing. Importantly, compound <b>7</b> exposure at 100 mg/kg/day was similar to that reported for linezolid at 125 mg/kg/day, with AUC value of 373 μg·h/mL reported<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> for the comparator drug. The repeat-dose no observed adverse effects level (NOAEL) for compound <b>7</b> was determined as 100 mg/kg/day. Single-dose acute toxicity in rat for this agent was determined as 5000 mg/kg.</div><div class="NLM_p">Thus, consistent with the attenuated cytotoxicity of the new agent in the human bone marrow CD34<sup>+</sup> assay, the preclinical animal data also suggest a notably reduced myelosuppressive potential for compound <b>7</b> as compared to linezolid, with similar exposure for the two agents.</div><div class="NLM_p">As noted already, MAOI is independent of the myelosuppression toxicity. The attenuated MAOI for compound <b>7</b> was additionally confirmed in a fluorescent assay<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> (as originally reported by Wang;<a onclick="showRef(event, 'cit23e'); return false;" href="javascript:void(0);" class="ref cit23e">(23e)</a> Table <a class="ref showTableEvent internalNav" data-ID="tbl13" href="#tbl13">13</a>). These results are in general agreement with the data from independently performed bioluminescent assay.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div><div class="NLM_table-wrap" id="tbl13"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 13. MAO-A Inhibition of Compound <b>7</b> and Comparator Linezolid</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">MAO-A IC<sub>50</sub> (μg/mL) (mean ± SD)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">assay system</th><th class="colsep0 rowsep0" align="center" char="±">compound 7</th><th class="colsep0 rowsep0" align="center" char="±">linezolid</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">bioluminscent<a class="ref internalNav" href="#t13fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char="±">12.3 ± 1.1</td><td class="colsep0 rowsep0" align="char" char="±">4.1 ± 1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">fluorescent<a class="ref internalNav" href="#t13fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">41.9 ± 1.3</td><td class="colsep0 rowsep0" align="char" char="±">8.1 ± 1.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t13fn1"><div class="footnote" id="t13fn1"><sup>a</sup><p class="last">MAO assay of ref <a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">33</a>.</p></div><div class="footnote" id="t13fn2"><sup>b</sup><p class="last">MAO assay of ref <a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">37</a>.</p></div></div></div><div class="NLM_p">Thus, MAOI for the new agent is 3–5-fold reduced over the comparator linezolid, as confirmed in two in vitro MAO-A assays.</div><div class="NLM_p">The data indicate a significantly improved safety potential for the compound <b>7</b> with respect to its potential for adverse effects and/or drug–drug interactions due to the MAOI listed in the prescribing information for linezolid.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p last">Preclinical toxicity evaluation also included CYP450 enzymes inhibition assay (at 0–200 μM of compound <b>7</b>), chromosomal aberration testing with Chinese hamster lung (CHL) cells (at 50–400 μg/mL of compound <b>7</b> over 6 h and at 25–200 μg/mL of compound <b>7</b> over 24 h), and mutagenic potential assessment in L5178Y tk± mouse lymphoma cell assay (with and without S9 factor, at 62.5–1000 μg/mL of compound <b>7</b>).<a onclick="showRef(event, 'cit23e'); return false;" href="javascript:void(0);" class="ref cit23e">(23e)</a> The new agent did not exhibit significant inhibition of CYP3A4, CYP1A2, CYP2C9, CYP2C19, and CYP2D6. For CYP2E1, a modest inhibition was detected, with IC<sub>50</sub> value of 9.6 μM. In the chromosomal aberration study, compound <b>7</b> did not induce structural chromosome aberration in CHL cells with or without metabolic activation. No increase in the gene mutation frequency was observed. Thus, compound <b>7</b> did not exhibit any apparent toxicity in CYP inhibition, clastogenicity, and mutagenicity assays.</div></div><div id="sec8" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Early Clinical Safety and Tolerability of Compound <b>7</b> in Phase I Trial</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30460" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30460" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The distinct safety potential of the new oxazolidinone established in preclinical studies warranted its advance into the clinical evaluation. Phase I clinical trial of compound <b>7</b> was designed as a single-dose study followed by multiple dose evaluations, with attention to drug exposure, food effects, safety, and tolerability.</div><div class="NLM_p">The single ascending dose tolerability study was a randomized, double-blind, placebo-controlled study in healthy Chinese subjects (as originally reported by Zhang<a onclick="showRef(event, 'cit23g'); return false;" href="javascript:void(0);" class="ref cit23g">(23g)</a>). Eight treatment groups were administered oral compound <b>7</b> at doses ranging from 50 to 1800 mg under fasting conditions (50, 100, 200, 400, 800, 1200, 1600, and 1800 mg). The new agent was well tolerated in all dosing groups.</div><div class="NLM_p">In a single-dose, three-period, Latin-square crossover study, 12 healthy volunteers (six of each gender) received (under fasting conditions) single oral doses of 300, 600, and 900 mg of compound <b>7</b>, with a 1-week washout between doses. In a separate crossover study, 12 subjects (six of each gender) received a single oral dose of 900 mg of the agent either under fasting condition or 30 min after a meal.</div><div class="NLM_p">Compound <b>7</b> was quickly absorbed, achieving a peak concentration within 1–2 h of the oral administration. In fasting subjects, mean <i>T</i><sub>max</sub> values ranged from 1.3 to 2.0 h, and mean <i>T</i><sub>1/2</sub> ranged from 2.2 to 4.9 h (Table <a class="ref showTableEvent internalNav" data-ID="tbl14" href="#tbl14">14</a>). The mean <i>C</i><sub>max</sub> and AUC<sub>0–inf</sub> values increased with escalated dosing, ranging from 8.1 to 15.3 μg/mL and 29.2 to 59.2 μg·h/mL, respectively.</div><div class="NLM_table-wrap" id="tbl14"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 14. Single-Dose Human PK for the Compound <b>7</b> in Fasting Subjects, Noncompartmental Model</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center" char=".">300 mg dose</th><th class="colsep0 rowsep0" align="center" char=".">600 mg dose</th><th class="colsep0 rowsep0" align="center" char=".">900 mg dose</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (μg/mL)</td><td class="colsep0 rowsep0" align="char" char=".">8.07</td><td class="colsep0 rowsep0" align="char" char=".">12.24</td><td class="colsep0 rowsep0" align="char" char=".">15.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub> (h)</td><td class="colsep0 rowsep0" align="char" char=".">1.25</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0–inf</sub> (μg·h/mL)</td><td class="colsep0 rowsep0" align="char" char=".">29.22</td><td class="colsep0 rowsep0" align="char" char=".">48.26</td><td class="colsep0 rowsep0" align="char" char=".">59.16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="char" char=".">2.18</td><td class="colsep0 rowsep0" align="char" char=".">3.31</td><td class="colsep0 rowsep0" align="char" char=".">4.94</td></tr></tbody></table></div></div><div class="NLM_p">Consumption of a fat-containing meal facilitated compound <b>7</b> absorption, with AUC<sub>0–inf</sub> values increased from 66.6 μg·h/mL under fasting condition to 141.1 μg·h/mL for fed subjects and with a concomitant <i>C</i><sub>max</sub> increase from 18.1 to 42.3 μg/mL (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>).</div><div class="NLM_table-wrap" id="tbl15"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 15. Single-Dose Human PK for Compound <b>7</b>: Food Effect at 900 mg/kg Dosing</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center" char=".">without food</th><th class="colsep0 rowsep0" align="center" char=".">with food</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (μg/mL)</td><td class="colsep0 rowsep0" align="char" char=".">18.1</td><td class="colsep0 rowsep0" align="char" char=".">42.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub> (h)</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char=".">1.63</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0-inf</sub> (μg·h/mL)</td><td class="colsep0 rowsep0" align="char" char=".">66.57</td><td class="colsep0 rowsep0" align="char" char=".">141.14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="char" char=".">4.9</td><td class="colsep0 rowsep0" align="char" char=".">2.7</td></tr></tbody></table></div></div><div class="NLM_p">Thus, the oral absorption and elimination half-life of compound <b>7</b> increased with escalating single dosing in the range of 300–900 mg. Meal consumption significantly increased the oral absorption without affecting the time required to achieve the peak concentration of the drug.</div><div class="NLM_p">Next, a randomized, double-blind, placebo-controlled multiple-dose safety and PK study was conducted in 32 healthy subjects, half male and half female (as originally reported by Zhang<a onclick="showRef(event, 'cit23h'); return false;" href="javascript:void(0);" class="ref cit23h">(23h)</a>). Each cohort of four subjects (two of each gender) received placebo, and 12 received 28 doses of 600 or 800 mg of compound <b>7</b> over 15 days, with each dose taken with a meal. Single dose of the agent was administered on days 1 and 15 for full PK determination, followed by two doses administered Q12h (BID) from day 2 to day 14. Clinical observations including vital signs and physical examination, and laboratory tests including hematology and blood chemistry were performed throughout the study course.</div><div class="NLM_p">Compound <b>7</b> was well tolerated in healthy subjects at 600 mg and 800 mg BID dosing for 15 days with no serious adverse events. PK parameters are illustrated in Table <a class="ref showTableEvent internalNav" data-ID="tbl16" href="#tbl16">16</a> below.</div><div class="NLM_table-wrap" id="tbl16"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 16. Compound <b>7</b> PK in Multiple Ascending Oral Dose Study: Day 1 and Day 15</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">600 mg</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">800 mg</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter/day</th><th class="colsep0 rowsep0" align="center" char=".">day 1</th><th class="colsep0 rowsep0" align="center" char=".">day 15</th><th class="colsep0 rowsep0" align="center" char=".">day 1</th><th class="colsep0 rowsep0" align="center" char=".">day 15</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (μg/mL)</td><td class="colsep0 rowsep0" align="char" char=".">20.34</td><td class="colsep0 rowsep0" align="char" char=".">20.61</td><td class="colsep0 rowsep0" align="char" char=".">27.8</td><td class="colsep0 rowsep0" align="char" char=".">26.45</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub> (h)</td><td class="colsep0 rowsep0" align="char" char=".">0.65</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td><td class="colsep0 rowsep0" align="char" char=".">0.85</td><td class="colsep0 rowsep0" align="char" char=".">0.57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0–24</sub> (μg·h/mL)</td><td class="colsep0 rowsep0" align="char" char=".">68.61</td><td class="colsep0 rowsep0" align="char" char=".">72.91</td><td class="colsep0 rowsep0" align="char" char=".">91.85</td><td class="colsep0 rowsep0" align="char" char=".">90.38</td></tr></tbody></table></div></div><div class="NLM_p">As clear from the data, the new agent exhibited high exposure levels at 600 and 800 mg BID dosing for 15 days, with values similar to those reported for linezolid. The mean <i>C</i><sub>max</sub> and AUC values increased proportionally with escalating dose, reaching a steady state on day 3. No drug accumulation was observed. Exposure levels of compound <b>7</b> on day 1 and day 15 were similar. The mean AUC values on days 1 and 15 were 68.61 and 72.91 μg·h/mL (respectively) for 600 mg group, and 91.85 vs 90.38 μg·h/mL (respectively) for the 800 mg cohort.</div><div class="NLM_p">Importantly, the key hematology parameters remained unchanged during the entire course of the study, suggesting a low propensity of compound <b>7</b> to induce myelosuppresion. No significant changes in hematologic parameters, including platelet, reticulocyte, neutrophil, and red blood cell counts, were detected over the course of the study, as illustrated by the representative data of Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401931e/production/images/medium/jm-2013-01931e_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401931e/production/images/large/jm-2013-01931e_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Hematology for compound <b>7</b> in the human multiple oral dose study: platelet and reticulocyte markers of the myelosuppression toxicity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401931e/production/images/large/jm-2013-01931e_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401931e&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Thus, compound <b>7</b> was well tolerated in a human phase I clinical trial, with key hematology markers indicating a notably attenuated myelosuppression potential compared to that reported for linezolid<a onclick="showRef(event, 'ref9 ref38'); return false;" href="javascript:void(0);" class="ref ref9 ref38">(9, 38)</a> and consistent with preclinical data for the agent, including reduced human bone marrow toxicity and MAOI.</div></div><div id="sec9" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15050" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15050" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Clinical compound <b>7</b> is a novel oxazolidinone with a broad Gram-positive antibacterial spectrum and an improved over linezolid potency against widespread pathogen MRSA. Notably, the high activity and oral bioavailability of the new agent are coupled with markedly attenuated myelosuppression and MAOI. This long sought-after feature in a new oxazolidinone offers a potential to minimize the limiting adverse effects encountered in linezolid therapy, primarily associated with the bone marrow toxicity and serotonergic drug–drug interactions. Initial clinical data for compound <b>7</b> warrant its further evaluation as a next-generation oxazolidinone that may supplant current linezolid therapy. The new agent may fulfill the need for a safer oxazolidinone for the long-term treatment of persistent Gram-positive infections. This clinical agent may prove particularly useful in patient populations where myelosuppression and MAOI must be avoided, including patients predisposed to myelosuppression, such as HIV patients, and subjects receiving a concomitant therapy with bone marrow suppressive drugs, such as cancer patients.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm401931e" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17327" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17327" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mikhail F. Gordeev</span> - <span class="hlFld-Affiliation affiliation">MicuRx
Pharmaceuticals Inc., Hayward, California 94545, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#117c767e6375747467517c78726463693f727e7c"><span class="__cf_email__" data-cfemail="1d707a726f7978786b5d70747e686f65337e7270">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhengyu Y. Yuan</span> - <span class="hlFld-Affiliation affiliation">MicuRx
Pharmaceuticals Inc., Hayward, California 94545, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d1392e3853-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17535" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17535" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The work reviewed herein was performed by several teams of MicuRx scientists and collaborators both in the USA and P.R. China. Critical contributions were made by our MicuRx colleagues Wen Wang, Jinqian (Jim) Liu, Yanqing (Amy) Huang, Hong Yuan, Feng Zhou, Chun Liu, Changqing Wang, Shicong Liu, Yunhua Xu, Hailing Wang, Huiping Liu, Tony Fu, Qiang Wang, and our collaborators at the HuaShan Hospital of Fudan University (led by Yingyuan Zhang, Jing Zhang, and Demei Zhu), the Institute of Medicinal Biotechnology at Chinese Academy of Medical Sciences (Xuefu Liu), the Shanghai Institute of Materia Medica at Chinese Academy of Sciences (led by Dafang Zhong and Xiaoyan Chen), and the National Shanghai Center for Drug Safety Evaluation & Research (led by Jin Ma). We express deep gratitude for their scientific insight and the diligent efforts that made this progress possible. Edits by A. M. Gordeev and P. S. Margolis are also acknowledged.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i28" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i28"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i29" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i29"> Abbreviations Used</h2><tr><td class="NLM_term">MAOI</td><td class="NLM_def"><p class="first last">monoamine oxidase inhibition</p></td></tr><tr><td class="NLM_term">COX-2</td><td class="NLM_def"><p class="first last">cyclooxygenase-2</p></td></tr><tr><td class="NLM_term">FDA</td><td class="NLM_def"><p class="first last">the Food and Drug Administration</p></td></tr><tr><td class="NLM_term">MDR</td><td class="NLM_def"><p class="first last">multidrug-resistant</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">MIC<sub>90</sub></td><td class="NLM_def"><p class="first last">minimum concentration to inhibit the growth of 90% strains tested</p></td></tr><tr><td class="NLM_term">MRSA</td><td class="NLM_def"><p class="first last">methicillin-resistant <i>Staphylococcus aureus</i></p></td></tr><tr><td class="NLM_term">MIC</td><td class="NLM_def"><p class="first last">minimum inhibitory concentration</p></td></tr><tr><td class="NLM_term">MIC<sub>90</sub></td><td class="NLM_def"><p class="first last">minimum inhibitory concentration to inhibit the growth of 90% strains tested</p></td></tr><tr><td class="NLM_term">VRE</td><td class="NLM_def"><p class="first last">vancomycin-resistant enterococci</p></td></tr><tr><td class="NLM_term">MAO</td><td class="NLM_def"><p class="first last">monoamine oxidase</p></td></tr><tr><td class="NLM_term">MAO-A</td><td class="NLM_def"><p class="first last">monoamine oxidase subtype A</p></td></tr><tr><td class="NLM_term">ED<sub>50</sub></td><td class="NLM_def"><p class="first last">effective dose for 50% survival</p></td></tr><tr><td class="NLM_term">CD34<sup>+</sup></td><td class="NLM_def"><p class="first last">human bone marrow cells</p></td></tr><tr><td class="NLM_term">ATCC</td><td class="NLM_def"><p class="first last">American Type Culture Collection</p></td></tr><tr><td class="NLM_term">MSSA</td><td class="NLM_def"><p class="first last">methicillin-sensitive <i>Staphylococcus aureus</i></p></td></tr><tr><td class="NLM_term">MRSE</td><td class="NLM_def"><p class="first last">methicillin-resistant <i>Staphylococcus epidermidis</i></p></td></tr><tr><td class="NLM_term">PISP</td><td class="NLM_def"><p class="first last">penicillin intermediate-sensitive <i>Streptococcus pneumoniae</i></p></td></tr><tr><td class="NLM_term">PRSP</td><td class="NLM_def"><p class="first last">penicillin-resistant <i>Streptococcus pneumoniae</i></p></td></tr><tr><td class="NLM_term">PSSP</td><td class="NLM_def"><p class="first last">penicillin-sensitive <i>Streptococcus pneumoniae</i></p></td></tr><tr><td class="NLM_term">VSE</td><td class="NLM_def"><p class="first last">vancomycin-sensitive Enterococci</p></td></tr><tr><td class="NLM_term">HLGR</td><td class="NLM_def"><p class="first last">high-level gentamycin-resistant</p></td></tr><tr><td class="NLM_term">VAN-S</td><td class="NLM_def"><p class="first last">vancomycin-sensitive</p></td></tr><tr><td class="NLM_term">PAE</td><td class="NLM_def"><p class="first last">postantibiotic effect</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">CFU</td><td class="NLM_def"><p class="first last">colony-forming units</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">WBC</td><td class="NLM_def"><p class="first last">white blood cells</p></td></tr><tr><td class="NLM_term">RBC</td><td class="NLM_def"><p class="first last">red blood cells</p></td></tr><tr><td class="NLM_term">HB</td><td class="NLM_def"><p class="first last">hemoglobin</p></td></tr><tr><td class="NLM_term">HCT</td><td class="NLM_def"><p class="first last">hematocrit</p></td></tr><tr><td class="NLM_term">MCV</td><td class="NLM_def"><p class="first last">mean corpuscular volume</p></td></tr><tr><td class="NLM_term">MCH</td><td class="NLM_def"><p class="first last">mean corpuscular hemoglobin</p></td></tr><tr><td class="NLM_term">PLT</td><td class="NLM_def"><p class="first last">platelets</p></td></tr><tr><td class="NLM_term">N</td><td class="NLM_def"><p class="first last">neutrophils</p></td></tr><tr><td class="NLM_term">L</td><td class="NLM_def"><p class="first last">lymphocytes</p></td></tr><tr><td class="NLM_term">RET</td><td class="NLM_def"><p class="first last">reticulocytes</p></td></tr><tr><td class="NLM_term">NOAEL</td><td class="NLM_def"><p class="first last">no observed adverse effects level</p></td></tr><tr><td class="NLM_term">BID</td><td class="NLM_def"><p class="first last">twice daily</p></td></tr><tr><td class="NLM_term">Q12h</td><td class="NLM_def"><p class="first last">administration with 12 h interval between doses</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73867" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73867" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 38 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Rich, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritterhoff, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, R.J. M.D.</span><span> </span><span class="NLM_article-title">A fatal case of aplastic anemia following chloramphenicol (chloromycetin) therapy</span> <span class="citation_source-journal">Ann. Int. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1950</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1459</span><span class="NLM_x">–</span> <span class="NLM_lpage">1467</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm401931e&amp;key=10.7326%2F0003-4819-33-6-1459" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm401931e&amp;key=14790529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm401931e&amp;key=1%3ACAS%3A280%3ADyaG3M%252FitVSkuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1950&pages=1459-1467&author=M.+L.+Richauthor=R.+J.+Ritterhoffauthor=R.J.+M.D.+Hoffmann&title=A+fatal+case+of+aplastic+anemia+following+chloramphenicol+%28chloromycetin%29+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">A fatal case of aplastic anemia following chloramphenicol (chloromycetin) therapy</span></div><div class="casAuthors">RICH M L; RITTERHOFF R J; HOFFMANN R J</div><div class="citationInfo"><span class="NLM_cas:title">Annals of internal medicine</span>
        (<span class="NLM_cas:date">1950</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1459-67</span>
        ISSN:<span class="NLM_cas:issn">0003-4819</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCwygu9vnLPMuCWE5mhx1RfW6udTcc2eZURUJFRwazbLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaG3M%252FitVSkuw%253D%253D&md5=afb77b43213d214e70aa5987e77cc620</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.7326%2F0003-4819-33-6-1459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7326%252F0003-4819-33-6-1459%26sid%3Dliteratum%253Aachs%26aulast%3DRich%26aufirst%3DM.%2BL.%26aulast%3DRitterhoff%26aufirst%3DR.%2BJ.%26aulast%3DHoffmann%26aufirst%3DR.J.%2BM.D.%26atitle%3DA%2520fatal%2520case%2520of%2520aplastic%2520anemia%2520following%2520chloramphenicol%2520%2528chloromycetin%2529%2520therapy%26jtitle%3DAnn.%2520Int.%2520Med.%26date%3D1950%26volume%3D33%26spage%3D1459%26epage%3D1467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kux, L.</span><span> </span><span class="NLM_article-title">Determination that chloromycetin (chloramphenicol) capsules, 250 mg, were withdrawn from sale for reasons of safety or effectiveness</span>.  <span class="citation_source-journal">Fed. Regist. Not.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span>, Friday, <span class="NLM_month">July</span><span class="NLM_day">13</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2012&author=L.+Kux&title=Determination+that+chloromycetin+%28chloramphenicol%29+capsules%2C+250+mg%2C+were+withdrawn+from+sale+for+reasons+of+safety+or+effectiveness"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKux%26aufirst%3DL.%26atitle%3DDetermination%2520that%2520chloromycetin%2520%2528chloramphenicol%2529%2520capsules%252C%2520250%2520mg%252C%2520were%2520withdrawn%2520from%2520sale%2520for%2520reasons%2520of%2520safety%2520or%2520effectiveness%26jtitle%3DFed.%2520Regist.%2520Not.%26date%3D2012%26volume%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Ross, D. B.</span><span> </span><span class="NLM_article-title">The FDA and the case of Ketek</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">356</span><span class="NLM_x">, </span> <span class="NLM_fpage">1601</span><span class="NLM_x">–</span> <span class="NLM_lpage">1604</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm401931e&amp;key=10.1056%2FNEJMp078032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm401931e&amp;key=17442902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm401931e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksFCgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=2007&pages=1601-1604&author=D.+B.+Ross&title=The+FDA+and+the+case+of+Ketek"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Perspective: the FDA and the case of Ketek</span></div><div class="casAuthors">Ross, David B.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">356</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1601-1604</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxg3oJZMs06LVg90H21EOLACvtfcHk0lhuTB4uEwwDjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksFCgtb4%253D&md5=f077976e1f2d38a66f7730fe4e6fb184</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1056%2FNEJMp078032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMp078032%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DD.%2BB.%26atitle%3DThe%2520FDA%2520and%2520the%2520case%2520of%2520Ketek%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2007%26volume%3D356%26spage%3D1601%26epage%3D1604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Paul A Dieppe, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebrahim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jüni, P.</span><span> </span><span class="NLM_article-title">Lessons from the withdrawal of rofecoxib</span> <span class="citation_source-journal">Br. Med. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">329</span><span class="NLM_x">, </span> <span class="NLM_fpage">867</span><span class="NLM_x">–</span> <span class="NLM_lpage">868</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm401931e&amp;key=10.1136%2Fbmj.329.7471.867" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=2004&pages=867-868&author=P.+A.+Paul+A+Dieppeauthor=S.+Ebrahimauthor=P.+J%C3%BCni&title=Lessons+from+the+withdrawal+of+rofecoxib"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1136%2Fbmj.329.7471.867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbmj.329.7471.867%26sid%3Dliteratum%253Aachs%26aulast%3DPaul%2BA%2BDieppe%26aufirst%3DP.%2BA.%26aulast%3DEbrahim%26aufirst%3DS.%26aulast%3DJ%25C3%25BCni%26aufirst%3DP.%26atitle%3DLessons%2520from%2520the%2520withdrawal%2520of%2520rofecoxib%26jtitle%3DBr.%2520Med.%2520J.%26date%3D2004%26volume%3D329%26spage%3D867%26epage%3D868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span>FDA’s Sentinel Initiative; <span class="NLM_publisher-name">U.S. Food and Drug Administration</span>: <span class="NLM_publisher-loc">Silver Spring, MD</span>; <a href="http://www.fda.gov/Safety/FDAsSentinelinitiative/ucm2007250.htm" class="extLink">http://www.fda.gov/Safety/FDAsSentinelinitiative/ucm2007250.htm</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=FDA%E2%80%99s+Sentinel+Initiative%3B+U.S.+Food+and+Drug+Administration%3A+Silver+Spring%2C+MD%3B+http%3A%2F%2Fwww.fda.gov%2FSafety%2FFDAsSentinelinitiative%2Fucm2007250.htm."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DFDA%25E2%2580%2599s%2520Sentinel%2520Initiative%26pub%3DU.S.%2520Food%2520and%2520Drug%2520Administration" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ford, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zurenko, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbachyn, M. R.</span><span> </span><span class="NLM_article-title">The discovery of linezolid, the first oxazolidinone antibacterial agent</span> <span class="citation_source-journal">Curr. Drug Targets Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">199</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm401931e&amp;key=10.2174%2F1568005014606099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm401931e&amp;key=12455414" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&pages=181-199&author=C.+W.+Fordauthor=G.+E.+Zurenkoauthor=M.+R.+Barbachyn&title=The+discovery+of+linezolid%2C+the+first+oxazolidinone+antibacterial+agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.2174%2F1568005014606099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568005014606099%26sid%3Dliteratum%253Aachs%26aulast%3DFord%26aufirst%3DC.%2BW.%26aulast%3DZurenko%26aufirst%3DG.%2BE.%26aulast%3DBarbachyn%26aufirst%3DM.%2BR.%26atitle%3DThe%2520discovery%2520of%2520linezolid%252C%2520the%2520first%2520oxazolidinone%2520antibacterial%2520agent%26jtitle%3DCurr.%2520Drug%2520Targets%2520Infect.%2520Dis.%26date%3D2001%26spage%3D181%26epage%3D199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Brickner, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbachyn, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manninen, P. R.</span><span> </span><span class="NLM_article-title">Linezolid (Zyvox), the first member of a completely new class of antibacterial agents for treatment of serious Gram-positive infections</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1981</span><span class="NLM_x">–</span> <span class="NLM_lpage">1990</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800038g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1981-1990&author=S.+J.+Bricknerauthor=M.+R.+Barbachynauthor=D.+K.+Hutchinsonauthor=P.+R.+Manninen&title=Linezolid+%28Zyvox%29%2C+the+first+member+of+a+completely+new+class+of+antibacterial+agents+for+treatment+of+serious+Gram-positive+infections"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1021%2Fjm800038g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800038g%26sid%3Dliteratum%253Aachs%26aulast%3DBrickner%26aufirst%3DS.%2BJ.%26aulast%3DBarbachyn%26aufirst%3DM.%2BR.%26aulast%3DHutchinson%26aufirst%3DD.%2BK.%26aulast%3DManninen%26aufirst%3DP.%2BR.%26atitle%3DLinezolid%2520%2528Zyvox%2529%252C%2520the%2520first%2520member%2520of%2520a%2520completely%2520new%2520class%2520of%2520antibacterial%2520agents%2520for%2520treatment%2520of%2520serious%2520Gram-positive%2520infections%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1981%26epage%3D1990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Shinabarger, D.</span><span> </span><span class="NLM_article-title">Mechanism of action of the oxazolidinone antibacterial agents</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1195</span><span class="NLM_x">–</span> <span class="NLM_lpage">1202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm401931e&amp;key=10.1517%2F13543784.8.8.1195" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm401931e&amp;key=15992144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm401931e&amp;key=1%3ACAS%3A528%3ADyaK1MXltFGgsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1999&pages=1195-1202&author=D.+Shinabarger&title=Mechanism+of+action+of+the+oxazolidinone+antibacterial+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of action of the oxazolidinone antibacterial agents</span></div><div class="casAuthors">Shinabarger, Dean</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1195-1202</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications</span>)
        </div><div class="casAbstract">A review with 32 refs.  Oxazolidinones represent a new class of synthetic antibacterial agents active against multiply-resistant Gram-pos. pathogens, including methicillin-resistant Staphylococcus aureus (MRSA), penicillin-resistant streptococci and vancomycin-resistant enterococci.  Eperezolid and linezolid are two novel analogs, which have resp. completed Phase I and Phase II clin. testing.  The lack of cross-resistance between oxazolidinones and other antibiotics supports a novel mechanism of action.  Oxazolidinones are protein synthesis inhibitors which target an early step involving the binding of N-formylmethionyl-tRNA to the ribosome.  Binding studies demonstrate that these agents interact with the 50S subunit, but not the 30S subunit of the ribosome.  Crosslinking expts. provide evidence for an interaction with both the 16S rRNA of the small subunit and the 23S rRNA of the large subunit.  Development of resistance in the lab. is slow, resulting in two independently isolated point mutations at G2447U and G2576U of the 23S rRNA.  This review discusses the results of published studies involving oxazolidinone mechanism of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKfanYf7ZBSLVg90H21EOLACvtfcHk0lg-qhZ8rmOsHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltFGgsrs%253D&md5=1d77f29c48f50440e68559c712ddc984</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1517%2F13543784.8.8.1195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.8.8.1195%26sid%3Dliteratum%253Aachs%26aulast%3DShinabarger%26aufirst%3DD.%26atitle%3DMechanism%2520of%2520action%2520of%2520the%2520oxazolidinone%2520antibacterial%2520agents%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D1999%26volume%3D8%26spage%3D1195%26epage%3D1202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Jones, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Utsuki, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fumiaki, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turnidge, J. D.</span><span> </span><span class="NLM_article-title">Zyvox annual appraisal of potency and spectrum program: linezolid surveillance program results for 2008</span> <span class="citation_source-journal">Diagn. Microb. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">404</span><span class="NLM_x">–</span> <span class="NLM_lpage">413</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Fjm401931e&amp;key=10.1016%2Fj.diagmicrobio.2009.10.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Fjm401931e&amp;key=19913683" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=404-413&author=R.+N.+Jonesauthor=J.+E.+Rossauthor=J.+M.+Bellauthor=U.+Utsukiauthor=I.+Fumiakiauthor=I.+Kobayashiauthor=J.+D.+Turnidge&title=Zyvox+annual+appraisal+of+potency+and+spectrum+program%3A+linezolid+surveillance+program+results+for+2008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1016%2Fj.diagmicrobio.2009.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.diagmicrobio.2009.10.001%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DR.%2BN.%26aulast%3DRoss%26aufirst%3DJ.%2BE.%26aulast%3DBell%26aufirst%3DJ.%2BM.%26aulast%3DUtsuki%26aufirst%3DU.%26aulast%3DFumiaki%26aufirst%3DI.%26aulast%3DKobayashi%26aufirst%3DI.%26aulast%3DTurnidge%26aufirst%3DJ.%2BD.%26atitle%3DZyvox%2520annual%2520appraisal%2520of%2520potency%2520and%2520spectrum%2520program%253A%2520linezolid%2520surveillance%2520program%2520results%2520for%25202008%26jtitle%3DDiagn.%2520Microb.%2520Infect.%2520Dis.%26date%3D2009%26volume%3D65%26spage%3D404%26epage%3D413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ross, J. E.; Flamm, R. K.; Sader, H. S.; Hogan, P. A.; Jones, R. N.</span><span> </span><span class="NLM_article-title">Report of linezolid activity from the Zyvox annual appraisal of potency and spectrum (ZAAPS) program 2012 (Europe, Latin America, Asia Pacific, Canada)</span>. <span class="NLM_conf-name">53rd Interscience Conference on Antimicrobial Agents and Chemotherapy</span>, <span class="NLM_conf-loc">Denver, CO</span>, <span class="NLM_conf-date">September 10–13, 2013</span>,  <span class="NLM_fpage"> Poster C2–088</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Ross%2C+J.+E.%3B+Flamm%2C+R.+K.%3B+Sader%2C+H.+S.%3B+Hogan%2C+P.+A.%3B+Jones%2C+R.+N.+Report+of+linezolid+activity+from+the+Zyvox+annual+appraisal+of+potency+and+spectrum+%28ZAAPS%29+program+2012+%28Europe%2C+Latin+America%2C+Asia+Pacific%2C+Canada%29.+53rd+Interscience+Conference+on+Antimicrobial+Agents+and+Chemotherapy%2C+Denver%2C+CO%2C+September+10%E2%80%9313%2C+2013%2C+Poster+C2%E2%80%93088."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DJ.%2BE.%26atitle%3DReport%2520of%2520linezolid%2520activity%2520from%2520the%2520Zyvox%2520annual%2520appraisal%2520of%2520potency%2520and%2520spectrum%2520%2528ZAAPS%2529%2520program%25202012%2520%2528Europe%252C%2520Latin%2520America%252C%2520Asia%2520Pacific%252C%2520Canada%2529%26spage%3DPoster%2520C2%25E2%2580%2593088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Pucci, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, K.</span><span> </span><span class="NLM_article-title">Investigational antimicrobial agents of 2013</span> <span class="citation_source-journal">Clin. Microb. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">792</span><span class="NLM_x">–</span> <span class="NLM_lpage">821</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm401931e&amp;key=10.1128%2FCMR.00033-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm401931e&amp;key=24092856" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2013&pages=792-821&author=M.+J.+Pucciauthor=K.+Bush&title=Investigational+antimicrobial+agents+of+2013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1128%2FCMR.00033-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FCMR.00033-13%26sid%3Dliteratum%253Aachs%26aulast%3DPucci%26aufirst%3DM.%2BJ.%26aulast%3DBush%26aufirst%3DK.%26atitle%3DInvestigational%2520antimicrobial%2520agents%2520of%25202013%26jtitle%3DClin.%2520Microb.%2520Rev.%26date%3D2013%26volume%3D26%26spage%3D792%26epage%3D821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Vinh, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubinstein, E.</span><span> </span><span class="NLM_article-title">Linezolid: a review of safety and tolerability</span> <span class="citation_source-journal">J. Infect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">S59</span><span class="NLM_x">–</span> <span class="NLM_lpage">S74</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2009&pages=S59-S74&author=D.+C.+Vinhauthor=E.+Rubinstein&title=Linezolid%3A+a+review+of+safety+and+tolerability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVinh%26aufirst%3DD.%2BC.%26aulast%3DRubinstein%26aufirst%3DE.%26atitle%3DLinezolid%253A%2520a%2520review%2520of%2520safety%2520and%2520tolerability%26jtitle%3DJ.%2520Infect.%26date%3D2009%26volume%3D59%26spage%3DS59%26epage%3DS74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Nagiec, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chosay, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brieland, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, K. L.</span><span> </span><span class="NLM_article-title">Oxazolidinones inhibit cellular proliferation via inhibition of mitochondrial protein synthesis</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_fpage">3896</span><span class="NLM_x">–</span> <span class="NLM_lpage">3902</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&pages=3896-3902&author=E.+E.+Nagiecauthor=L.+Wuauthor=J.+G.+Chosayauthor=D.+E.+Rossauthor=J.+K.+Brielandauthor=K.+L.+Leach&title=Oxazolidinones+inhibit+cellular+proliferation+via+inhibition+of+mitochondrial+protein+synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNagiec%26aufirst%3DE.%2BE.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DChosay%26aufirst%3DJ.%2BG.%26aulast%3DRoss%26aufirst%3DD.%2BE.%26aulast%3DBrieland%26aufirst%3DJ.%2BK.%26aulast%3DLeach%26aufirst%3DK.%2BL.%26atitle%3DOxazolidinones%2520inhibit%2520cellular%2520proliferation%2520via%2520inhibition%2520of%2520mitochondrial%2520protein%2520synthesis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2005%26spage%3D3896%26epage%3D3902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Attassi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hershberger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alam, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zervos, M. J.</span><span> </span><span class="NLM_article-title">Thrombocytopenia associated with linezolid therapy</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">695</span><span class="NLM_x">–</span> <span class="NLM_lpage">698</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm401931e&amp;key=10.1086%2F338403" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm401931e&amp;key=11803505" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm401931e&amp;key=1%3ACAS%3A280%3ADC%252BD38%252FpsVSlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2002&pages=695-698&author=K.+Attassiauthor=E.+Hershbergerauthor=R.+Alamauthor=M.+J.+Zervos&title=Thrombocytopenia+associated+with+linezolid+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Thrombocytopenia associated with linezolid therapy</span></div><div class="casAuthors">Attassi Kinan; Hershberger Ellie; Alam Rabiul; Zervos Marcus J</div><div class="citationInfo"><span class="NLM_cas:title">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">695-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">We evaluated the incidence and clinical characteristics of linezolid-induced thrombocytopenia in 19 patients who were treated with linezolid.  Overall, thrombocytopenia (platelet count, <100,000 platelets/mm(3)) was observed in 32% of patients who received linezolid for >10 days; gastrointestinal bleeding was observed in 1 patient and 4 patients required platelet transfusions.  These data suggest that even patients who are not considered to be at risk for development of thrombocytopenia should be monitored closely if linezolid therapy is continued for >10 days.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSIIyZakd2UiZggzHGM8X5CfW6udTcc2eYfyCDLFW25yrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38%252FpsVSlsA%253D%253D&md5=be07b767a34bffcea4e16105cf1993fa</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1086%2F338403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F338403%26sid%3Dliteratum%253Aachs%26aulast%3DAttassi%26aufirst%3DK.%26aulast%3DHershberger%26aufirst%3DE.%26aulast%3DAlam%26aufirst%3DR.%26aulast%3DZervos%26aufirst%3DM.%2BJ.%26atitle%3DThrombocytopenia%2520associated%2520with%2520linezolid%2520therapy%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2002%26volume%3D34%26spage%3D695%26epage%3D698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tripathi, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tripathi, B. J.</span><span> </span><span class="NLM_article-title">Drug-induced ocular disorders</span> <span class="citation_source-journal">Drug Saf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">141</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm401931e&amp;key=10.2165%2F00002018-200831020-00003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm401931e&amp;key=18217789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm401931e&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjslWlurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2008&pages=127-141&author=J.+Liauthor=R.+C.+Tripathiauthor=B.+J.+Tripathi&title=Drug-induced+ocular+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-induced ocular disorders</span></div><div class="casAuthors">Li, Junping; Tripathi, Ramesh C.; Tripathi, Brenda J.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Safety</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">127-141</span>CODEN:
                <span class="NLM_cas:coden">DRSAEA</span>;
        ISSN:<span class="NLM_cas:issn">0114-5916</span>.
    
            (<span class="NLM_cas:orgname">Wolters Kluwer Health</span>)
        </div><div class="casAbstract">A review.  While beneficial therapeutically, almost all medications have untoward effects on various body tissues and functions, including the eye in which organ toxic reactions are readily detectable.  Every part of the eye and all ocular functions could be affected adversely.  In this review, we describe the most commonly recognized drug-induced ocular disorders, their specific clin. features, the medications that can cause the problem, the differential diagnosis and possible mechanisms of action, as well as guidelines for the management of the adverse reactions.  The eyelids are most frequently involved in drug toxicity that commonly manifests as inflammation, hypersensitivity reaction or dermatitis.  Drug-induced keratoconjunctival disorders present mainly as conjunctival hyperemia (red eye), with or without superficial corneal involvement.  Frequently, drug preservatives in topical ocular medications induce these adverse effects.  Treatment of blepharospasm with Botox may lead to drooping of the eyelids and corneal exposure.  Intraoperative floppy iris syndrome is a drug-induced reaction in patients treated with tamsulosin and who undergo cataract surgery.  Certain sulfa-based drugs can cause swelling of the ciliary body and lead to the development of angle-closure glaucoma.  In addn., adrenergic agents, certain β2-adrenergic agonists and anticholinergic agents may induce pupillary dilation and ppt. angle-closure glaucoma in susceptible patients.  Glucocorticoids administered systemically, topically or intravitreally are known to increase intraocular pressure, which can lead to the development of open-angle glaucoma in susceptible patients.  This painless form of glaucoma has also been assocd. with the use of the anticancer agents docetaxel and paclitaxel.  The toxic effects of systemic and topically applied drugs may manifest as cloudiness of the lens.  Long-term use of glucocorticoids produces a characteristic posterior subcapsular cataract and, although the opacities may remain stationary or progress, they rarely regress upon drug withdrawal.  Systemic administration of phenothiazines or busulfan induce cataractous changes in the anterior or posterior cortex, resp.  Many systemic drugs reach the retina through the vascular supply.  Aminoquinolines induce a characteristic bull's eye maculopathy.  Phenothiazines bind to melanin granules and can cause a severe phototoxic retinopathy.  Typical tamoxifen retinopathy manifests as cryst. deposits in the inner retina.  Some patients treated with retinoids have decreased night vision and abnormal dark-adaptation.  Patients on long-term treatment with linezolid may develop an optic neuropathy (swollen or pale optic disk), sym. painless decrease of visual acuity and color vision, and bilateral visual field defects.  A probable link exists between amiodarone and a bilateral optic neuropathy that is very similar to nonarteritic ischemic optic neuropathy (NAION).  The most common adverse effects of cGMP-specific phosphodiesterase type 5 inhibitors (erectile dysfunction drugs) are changes in color perception, blurry vision and increased light sensitivity; recently these drugs have been also implicated in the development of NAION.  A bilateral, retrobulbar optic neuropathy that manifests as loss of visual acuity or color vision and visual field defect is assocd. with the use of ethambutol.  Many different kinds of medications can cause similar ocular adverse reactions.  Conversely, a single medication may affect more than one ocular structure and cause multiple, clin. recognizable disorders.  Clinicians should be mindful of drug-induced ocular disorders, whether or not listed in product package inserts and, if in doubt, consult with an ophthalmologist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFW-s5JUwWrLVg90H21EOLACvtfcHk0lgwRnHtbqhIrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjslWlurg%253D&md5=4f77e1c0686921aa85cae59048d7bb02</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2165%2F00002018-200831020-00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00002018-200831020-00003%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DTripathi%26aufirst%3DR.%2BC.%26aulast%3DTripathi%26aufirst%3DB.%2BJ.%26atitle%3DDrug-induced%2520ocular%2520disorders%26jtitle%3DDrug%2520Saf.%26date%3D2008%26volume%3D31%26spage%3D127%26epage%3D141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kulkarni, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Priore, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, K.</span><span> </span><span class="NLM_article-title">Linezolid induced toxic optic neuropathy</span> <span class="citation_source-journal">Br. J. Opthalmol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">1664</span><span class="NLM_x">–</span> <span class="NLM_lpage">1665</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Fjm401931e&amp;key=10.1136%2Fbjo.2005.074237" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=8&amp;doi=10.1021%2Fjm401931e&amp;key=16299156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Fjm401931e&amp;key=1%3ACAS%3A280%3ADC%252BD2Mnhs1aqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2005&pages=1664-1665&author=K.+Kulkarniauthor=L.+V.+Del+Prioreauthor=K.+Kulkarni&title=Linezolid+induced+toxic+optic+neuropathy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">Linezolid induced toxic optic neuropathy</span></div><div class="casAuthors">Kulkarni K; Del Priore L V</div><div class="citationInfo"><span class="NLM_cas:title">The British journal of ophthalmology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1664-5</span>
        ISSN:<span class="NLM_cas:issn">0007-1161</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTpfN8oT4Fdi7qxQ2mb9Pu8fW6udTcc2eYfyCDLFW25yrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2Mnhs1aqtw%253D%253D&md5=dfb50fc5f2aab247d733e6ebb8b75209</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1136%2Fbjo.2005.074237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbjo.2005.074237%26sid%3Dliteratum%253Aachs%26aulast%3DKulkarni%26aufirst%3DK.%26aulast%3DDel%2BPriore%26aufirst%3DL.%2BV.%26aulast%3DKulkarni%26aufirst%3DK.%26atitle%3DLinezolid%2520induced%2520toxic%2520optic%2520neuropathy%26jtitle%3DBr.%2520J.%2520Opthalmol.%26date%3D2005%26volume%3D89%26spage%3D1664%26epage%3D1665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rucker, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardenstein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isada, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. S.</span><span> </span><span class="NLM_article-title">Linezolid-associated toxic optic neuropathy</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">595</span><span class="NLM_x">–</span> <span class="NLM_lpage">598</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=595-598&author=J.+C.+Ruckerauthor=S.+R.+Hamiltonauthor=D.+Bardensteinauthor=C.+M.+Isadaauthor=M.+S.+Lee&title=Linezolid-associated+toxic+optic+neuropathy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRucker%26aufirst%3DJ.%2BC.%26aulast%3DHamilton%26aufirst%3DS.%2BR.%26aulast%3DBardenstein%26aufirst%3DD.%26aulast%3DIsada%26aufirst%3DC.%2BM.%26aulast%3DLee%26aufirst%3DM.%2BS.%26atitle%3DLinezolid-associated%2520toxic%2520optic%2520neuropathy%26jtitle%3DNeurology%26date%3D2006%26volume%3D66%26spage%3D595%26epage%3D598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Azamfirei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copotoiu, S.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branzanuic, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szederjesi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copotoiu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berteanu, C.</span><span> </span><span class="NLM_article-title">Complete blindness after optic neuropathy induced by short-term linezolid treatment in a patient suffering from muscle dystrophy</span> <span class="citation_source-journal">Pharmacoepidemiol. Drug Saf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">402</span><span class="NLM_x">–</span> <span class="NLM_lpage">404</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=16&amp;doi=10.1021%2Fjm401931e&amp;key=10.1002%2Fpds.1320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=8&amp;doi=10.1021%2Fjm401931e&amp;key=16998949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=32&amp;doi=10.1021%2Fjm401931e&amp;key=1%3ACAS%3A280%3ADC%252BD2s7ptl2itw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2007&pages=402-404&author=L.+Azamfireiauthor=S.-M.+Copotoiuauthor=K.+Branzanuicauthor=J.+Szederjesiauthor=R.+Copotoiuauthor=C.+Berteanu&title=Complete+blindness+after+optic+neuropathy+induced+by+short-term+linezolid+treatment+in+a+patient+suffering+from+muscle+dystrophy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13cR"><div class="casContent"><span class="casTitleNuber">13c</span><div class="casTitle"><span class="NLM_cas:atitle">Complete blindness after optic neuropathy induced by short-term linezolid treatment in a patient suffering from muscle dystrophy</span></div><div class="casAuthors">Azamfirei Leonard; Copotoiu Sanda-Maria; Branzaniuc Klara; Szederjesi Janos; Copotoiu Ruxandra; Berteanu Cristina</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacoepidemiology and drug safety</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">402-4</span>
        ISSN:<span class="NLM_cas:issn">1053-8569</span>.
    </div><div class="casAbstract">We present a case of severe optic neuropathy following linezolid treatment, which led to complete irreversible blindness, in a patient with progressive muscular dystrophy, treated with linezolid for 16 days for methicillin-resistant Staphylococcus aureus (MRSA) pneumonia.  Interruption of antibiotic therapy did not lead to remission of ocular symptoms.  Administration of linezolid may lead to severe neuropathy even in the case of short-term treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTLwM2fYg7sUpotVjB3IRIyfW6udTcc2eYJVHayuhrydrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s7ptl2itw%253D%253D&md5=fed33f2874e780316cf832a2c4da5167</span></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=10.1002%2Fpds.1320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpds.1320%26sid%3Dliteratum%253Aachs%26aulast%3DAzamfirei%26aufirst%3DL.%26aulast%3DCopotoiu%26aufirst%3DS.-M.%26aulast%3DBranzanuic%26aufirst%3DK.%26aulast%3DSzederjesi%26aufirst%3DJ.%26aulast%3DCopotoiu%26aufirst%3DR.%26aulast%3DBerteanu%26aufirst%3DC.%26atitle%3DComplete%2520blindness%2520after%2520optic%2520neuropathy%2520induced%2520by%2520short-term%2520linezolid%2520treatment%2520in%2520a%2520patient%2520suffering%2520from%2520muscle%2520dystrophy%26jtitle%3DPharmacoepidemiol.%2520Drug%2520Saf.%26date%3D2007%26volume%3D16%26spage%3D402%26epage%3D404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span>Prescribing Information for Zyvox, <span class="NLM_edition">LAB-0139-20.0, revised June 2010</span>; <span class="NLM_publisher-name">Pfizer</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Prescribing+Information+for+Zyvox%2C+LAB-0139-20.0%2C+revised+June+2010%3B+Pfizer%3A+New+York%2C+2010."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26jtitle%3DPrescribing%2520Information%2520for%2520Zyvox%26pub%3DPfizer%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Gordeev, M. F.; Prasad, J. V. N.; Luehr, G. W.</span><span> </span><span class="NLM_article-title">7-Fluoro-1,3-Dihydroindol-2-one oxazolidinones as antibacterial agents</span>. PCT WO 2006/106427, <span class="NLM_month">Oct</span><span class="NLM_day">12</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=M.+F.+Gordeev&author=J.+V.+N.+Prasad&author=G.+W.+Luehr&title=7-Fluoro-1%2C3-Dihydroindol-2-one+oxazolidinones+as+antibacterial+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGordeev%26aufirst%3DM.%2BF.%26atitle%3D7-Fluoro-1%252C3-Dihydroindol-2-one%2520oxazolidinones%2520as%2520antibacterial%2520agents%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Choy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colbry, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pamment, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Duine, J.</span><span> </span><span class="NLM_article-title">Development of a synthesis for a long-term oxazolidinone antibacterial</span> <span class="citation_source-journal">Org. Process Res. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">884</span><span class="NLM_x">–</span> <span class="NLM_lpage">887</span></span><div class="citationLinks">[<a href="/doi/10.1021/op8001195" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=884-887&author=A.+Choyauthor=N.+Colbryauthor=M.+Pammentauthor=J.+Van+Duine&title=Development+of+a+synthesis+for+a+long-term+oxazolidinone+antibacterial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fop8001195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop8001195%26sid%3Dliteratum%253Aachs%26aulast%3DChoy%26aufirst%3DA.%26aulast%3DColbry%26aufirst%3DN.%26aulast%3DPamment%26aufirst%3DM.%26aulast%3DVan%2BDuine%26aufirst%3DJ.%26atitle%3DDevelopment%2520of%2520a%2520synthesis%2520for%2520a%2520long-term%2520oxazolidinone%2520antibacterial%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2008%26volume%3D12%26spage%3D884%26epage%3D887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Huband, M. D.; Mullins, L. M.; Pagano, P. J.; Penzie, J. B.; McCurdy, S. P.; Lemmon, M. M.; Gibson, G. W; Leach, K.; Qiu, L.; Vara Prasad, J. V. N.; Renslo, A.; Luehr, G. W.; Jain, R.; Gordeev, M. F.</span><span> </span><span class="NLM_article-title">In vitro and in vivo activity of PF-03315011: a new oxazolidinone antibacterial versus recent bacterial clinical isolates. </span>. <span class="NLM_conf-name">20th European Congress of Clinical Microbiology and Infectious Diseases</span>, <span class="NLM_conf-loc">Vienna</span>, <span class="NLM_conf-date">April 10–13, 2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Huband%2C+M.+D.%3B+Mullins%2C+L.+M.%3B+Pagano%2C+P.+J.%3B+Penzie%2C+J.+B.%3B+McCurdy%2C+S.+P.%3B+Lemmon%2C+M.+M.%3B+Gibson%2C+G.+W%3B+Leach%2C+K.%3B+Qiu%2C+L.%3B+Vara+Prasad%2C+J.+V.+N.%3B+Renslo%2C+A.%3B+Luehr%2C+G.+W.%3B+Jain%2C+R.%3B+Gordeev%2C+M.+F.+In+vitro+and+in+vivo+activity+of+PF-03315011%3A+a+new+oxazolidinone+antibacterial+versus+recent+bacterial+clinical+isolates.+.+20th+European+Congress+of+Clinical+Microbiology+and+Infectious+Diseases%2C+Vienna%2C+April+10%E2%80%9313%2C+2010."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DHuband%26aufirst%3DM.%2BD.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520activity%2520of%2520PF-03315011%253A%2520a%2520new%2520oxazolidinone%2520antibacterial%2520versus%2520recent%2520bacterial%2520clinical%2520isolates.%2520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Dryden, M. S.</span><span> </span><span class="NLM_article-title">Linezolid pharmacokinetics and pharmacodynamics in clinical treatment</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 4</span><span class="NLM_x">) </span> <span class="NLM_fpage">iv7</span><span class="NLM_x">–</span> <span class="NLM_lpage">iv17</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm401931e&amp;key=21521707" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2011&pages=iv7-iv17&issue=Suppl+4&author=M.+S.+Dryden&title=Linezolid+pharmacokinetics+and+pharmacodynamics+in+clinical+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDryden%26aufirst%3DM.%2BS.%26atitle%3DLinezolid%2520pharmacokinetics%2520and%2520pharmacodynamics%2520in%2520clinical%2520treatment%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2011%26volume%3D66%26issue%3DSuppl%25204%26spage%3Div7%26epage%3Div17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Huang, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gortney, J. S.</span><span> </span><span class="NLM_article-title">Risk of serotonin syndrome with concomitant administration of linezolid and serotonin agonists</span> <span class="citation_source-journal">Pharmacotherapy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1784</span><span class="NLM_x">–</span> <span class="NLM_lpage">1793</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=1784-1793&author=V.+Huangauthor=J.+S.+Gortney&title=Risk+of+serotonin+syndrome+with+concomitant+administration+of+linezolid+and+serotonin+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DV.%26aulast%3DGortney%26aufirst%3DJ.%2BS.%26atitle%3DRisk%2520of%2520serotonin%2520syndrome%2520with%2520concomitant%2520administration%2520of%2520linezolid%2520and%2520serotonin%2520agonists%26jtitle%3DPharmacotherapy%26date%3D2006%26volume%3D26%26spage%3D1784%26epage%3D1793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Im, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, S.-H.</span><span> </span><span class="NLM_article-title">Discovery of torezolid as a novel 5-hydroxymethyl-oxazolidinone antibacterial agent</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1027</span><span class="NLM_x">–</span> <span class="NLM_lpage">1039</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=1027-1039&author=W.+B.+Imauthor=S.+H.+Choiauthor=J.-Y.+Parkauthor=S.+H.+Choiauthor=J.+Finnauthor=S.-H.+Yoon&title=Discovery+of+torezolid+as+a+novel+5-hydroxymethyl-oxazolidinone+antibacterial+agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIm%26aufirst%3DW.%2BB.%26aulast%3DChoi%26aufirst%3DS.%2BH.%26aulast%3DPark%26aufirst%3DJ.-Y.%26aulast%3DChoi%26aufirst%3DS.%2BH.%26aulast%3DFinn%26aufirst%3DJ.%26aulast%3DYoon%26aufirst%3DS.-H.%26atitle%3DDiscovery%2520of%2520torezolid%2520as%2520a%2520novel%25205-hydroxymethyl-oxazolidinone%2520antibacterial%2520agent%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D1027%26epage%3D1039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kanafani, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corey, G. R.</span><span> </span><span class="NLM_article-title">Tedizolid (TR-701): a new oxazolidinone with enhanced potency</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">515</span><span class="NLM_x">–</span> <span class="NLM_lpage">522</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=515-522&author=Z.+A.+Kanafaniauthor=G.+R.+Corey&title=Tedizolid+%28TR-701%29%3A+a+new+oxazolidinone+with+enhanced+potency"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKanafani%26aufirst%3DZ.%2BA.%26aulast%3DCorey%26aufirst%3DG.%2BR.%26atitle%3DTedizolid%2520%2528TR-701%2529%253A%2520a%2520new%2520oxazolidinone%2520with%2520enhanced%2520potency%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs.%26date%3D2012%26volume%3D21%26spage%3D515%26epage%3D522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Fang, E.; De Anda, C.; Das, A.; Prokocimer, P.</span><span> </span><span class="NLM_article-title">. Safety profile of tedizolid phosphate compared to linezolid in a Phase 3 ABSSSI study. 52nd Intersci. Conf</span>. <span class="NLM_conf-name">52nd Interscience Conference on Antimicrobial Agents and Chemotherapy</span>, <span class="NLM_conf-loc">San Francisco</span>, <span class="NLM_conf-date">Sept 9–12, 2012</span>,  <span class="NLM_fpage">Poster L1-1664</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Fang%2C+E.%3B+De+Anda%2C+C.%3B+Das%2C+A.%3B+Prokocimer%2C+P.+.+Safety+profile+of+tedizolid+phosphate+compared+to+linezolid+in+a+Phase+3+ABSSSI+study.+52nd+Intersci.+Conf.+52nd+Interscience+Conference+on+Antimicrobial+Agents+and+Chemotherapy%2C+San+Francisco%2C+Sept+9%E2%80%9312%2C+2012%2C+Poster+L1-1664."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DE.%26atitle%3D.%2520Safety%2520profile%2520of%2520tedizolid%2520phosphate%2520compared%2520to%2520linezolid%2520in%2520a%2520Phase%25203%2520ABSSSI%2520study.%252052nd%2520Intersci.%2520Conf%26spage%3DPoster%2520L1-1664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Das, D.; Lambert, A.; Tulkens, P. M.; Muccioli, G. G.; Van Bembeke, F.</span><span> </span><span class="NLM_article-title">Study of the cellular uptake and subcellular distribution of the oxazolidinone tedizolid (TZD) in murine J774 macrophages: lack of association with mitochondria</span>. <span class="NLM_conf-name">52nd Interscience Conference on Antimicrobial Agents and Chemotherapy</span>, <span class="NLM_conf-loc">San Francisco</span>, <span class="NLM_conf-date">Sept 9–12, 2012</span>,  <span class="NLM_fpage">Poster A-1291</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Das%2C+D.%3B+Lambert%2C+A.%3B+Tulkens%2C+P.+M.%3B+Muccioli%2C+G.+G.%3B+Van+Bembeke%2C+F.+Study+of+the+cellular+uptake+and+subcellular+distribution+of+the+oxazolidinone+tedizolid+%28TZD%29+in+murine+J774+macrophages%3A+lack+of+association+with+mitochondria.+52nd+Interscience+Conference+on+Antimicrobial+Agents+and+Chemotherapy%2C+San+Francisco%2C+Sept+9%E2%80%9312%2C+2012%2C+Poster+A-1291."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DD.%26atitle%3DStudy%2520of%2520the%2520cellular%2520uptake%2520and%2520subcellular%2520distribution%2520of%2520the%2520oxazolidinone%2520tedizolid%2520%2528TZD%2529%2520in%2520murine%2520J774%2520macrophages%253A%2520lack%2520of%2520association%2520with%2520mitochondria%26spage%3DPoster%2520A-1291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="note"><p class="first last">This perspective is preceded by several symposium disclosures:</p></div><div class="NLM_citation" id="cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zhu, D. M.; Wang, W.; Huang, Y. Q.; Zhang, Y. Y.</span><span> </span><span class="NLM_article-title">Antibacterial spectrum of oxazolidinone MRX-I: potent activity against multidrug-resistant Gram-positive pathogens</span>. <span class="NLM_conf-name">52nd Interscience Conference on Antimicrobial Agents and Chemotherapy</span>, <span class="NLM_conf-loc">San Francisco</span>, <span class="NLM_conf-date">Sept 9–12, 2012</span>,  <span class="NLM_fpage">Poster F-1497</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Zhu%2C+D.+M.%3B+Wang%2C+W.%3B+Huang%2C+Y.+Q.%3B+Zhang%2C+Y.+Y.+Antibacterial+spectrum+of+oxazolidinone+MRX-I%3A+potent+activity+against+multidrug-resistant+Gram-positive+pathogens.+52nd+Interscience+Conference+on+Antimicrobial+Agents+and+Chemotherapy%2C+San+Francisco%2C+Sept+9%E2%80%9312%2C+2012%2C+Poster+F-1497."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DD.%2BM.%26atitle%3DAntibacterial%2520spectrum%2520of%2520oxazolidinone%2520MRX-I%253A%2520potent%2520activity%2520against%2520multidrug-resistant%2520Gram-positive%2520pathogens%26spage%3DPoster%2520F-1497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Huang, Y. Q.; Wang, W.; Li, Y.; Wang, H. L.; Xu, Y. H.; Liu, C.; Zhou, F.; Wang, C. Q.; Liu, J.; Wang, Q.</span><span> </span><span class="NLM_article-title">Antimicrobial profile of MRX-I: resistance and drug combination studies</span>. <span class="NLM_conf-name">52nd Interscience Conference on Antimicrobial Agents and Chemotherapy</span>, <span class="NLM_conf-loc">San Francisco</span>, <span class="NLM_conf-date">Sept 9–12, 2012</span>,  <span class="NLM_fpage">Poster F-1498</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Huang%2C+Y.+Q.%3B+Wang%2C+W.%3B+Li%2C+Y.%3B+Wang%2C+H.+L.%3B+Xu%2C+Y.+H.%3B+Liu%2C+C.%3B+Zhou%2C+F.%3B+Wang%2C+C.+Q.%3B+Liu%2C+J.%3B+Wang%2C+Q.+Antimicrobial+profile+of+MRX-I%3A+resistance+and+drug+combination+studies.+52nd+Interscience+Conference+on+Antimicrobial+Agents+and+Chemotherapy%2C+San+Francisco%2C+Sept+9%E2%80%9312%2C+2012%2C+Poster+F-1498."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.%2BQ.%26atitle%3DAntimicrobial%2520profile%2520of%2520MRX-I%253A%2520resistance%2520and%2520drug%2520combination%2520studies%26spage%3DPoster%2520F-1498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Li, C. R.; Li, G. Q.; Hu, X. X.; Zhang, W. X.; Wang, X. K.; Pang, J.; Lu, X.; Zhai, Q. Q.; Yuan, H.; Gordeev, M. F.; Yang, X. Y.; You, X. F.</span><span> </span><span class="NLM_article-title">Novel oxazolidinone MRX-I is efficacious in mouse models of Gram-positive bacterial infections</span>. <span class="NLM_conf-name">52nd Interscience Conference on Antimicrobial Agents and Chemotherapy</span>, <span class="NLM_conf-loc">San Francisco</span>, <span class="NLM_conf-date">Sept 9–12, 2012</span>,  <span class="NLM_fpage">Poster F-1499</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Li%2C+C.+R.%3B+Li%2C+G.+Q.%3B+Hu%2C+X.+X.%3B+Zhang%2C+W.+X.%3B+Wang%2C+X.+K.%3B+Pang%2C+J.%3B+Lu%2C+X.%3B+Zhai%2C+Q.+Q.%3B+Yuan%2C+H.%3B+Gordeev%2C+M.+F.%3B+Yang%2C+X.+Y.%3B+You%2C+X.+F.+Novel+oxazolidinone+MRX-I+is+efficacious+in+mouse+models+of+Gram-positive+bacterial+infections.+52nd+Interscience+Conference+on+Antimicrobial+Agents+and+Chemotherapy%2C+San+Francisco%2C+Sept+9%E2%80%9312%2C+2012%2C+Poster+F-1499."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DC.%2BR.%26atitle%3DNovel%2520oxazolidinone%2520MRX-I%2520is%2520efficacious%2520in%2520mouse%2520models%2520of%2520Gram-positive%2520bacterial%2520infections%26spage%3DPoster%2520F-1499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Chen, X. Y.; Gao, Z. W.; Yuan, H.; Yuan, Z. Y.; Zhong, D. F.</span><span> </span><span class="NLM_article-title">Pre-clinical pharmacokinetics of MRX-I in rodents and dogs</span>. <span class="NLM_conf-name">52nd Interscience Conference on Antimicrobial Agents and Chemotherapy</span>, <span class="NLM_conf-loc">San Francisco</span>, <span class="NLM_conf-date">Sept 9–12, 2012</span>,  <span class="NLM_fpage">Poster F-1500</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Chen%2C+X.+Y.%3B+Gao%2C+Z.+W.%3B+Yuan%2C+H.%3B+Yuan%2C+Z.+Y.%3B+Zhong%2C+D.+F.+Pre-clinical+pharmacokinetics+of+MRX-I+in+rodents+and+dogs.+52nd+Interscience+Conference+on+Antimicrobial+Agents+and+Chemotherapy%2C+San+Francisco%2C+Sept+9%E2%80%9312%2C+2012%2C+Poster+F-1500."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%2BY.%26atitle%3DPre-clinical%2520pharmacokinetics%2520of%2520MRX-I%2520in%2520rodents%2520and%2520dogs%26spage%3DPoster%2520F-1500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Wang, W.; Wang, Z.; Chang, Y.; Yuan, H.; Yuan, Z. Y.; Zhou, J. L.; Zhong, D. F.</span><span> </span><span class="NLM_article-title">In vitro safety study of MRX-I, a safer oxazolidinone antibacterial agent</span>. <span class="NLM_conf-name">52nd Interscience Conference on Antimicrobial Agents and Chemotherapy</span>, <span class="NLM_conf-loc">San Francisco</span>, <span class="NLM_conf-date">Sept 9–12, 2012</span>,  <span class="NLM_fpage">Poster F-1501</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Wang%2C+W.%3B+Wang%2C+Z.%3B+Chang%2C+Y.%3B+Yuan%2C+H.%3B+Yuan%2C+Z.+Y.%3B+Zhou%2C+J.+L.%3B+Zhong%2C+D.+F.+In+vitro+safety+study+of+MRX-I%2C+a+safer+oxazolidinone+antibacterial+agent.+52nd+Interscience+Conference+on+Antimicrobial+Agents+and+Chemotherapy%2C+San+Francisco%2C+Sept+9%E2%80%9312%2C+2012%2C+Poster+F-1501."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%26atitle%3DIn%2520vitro%2520safety%2520study%2520of%2520MRX-I%252C%2520a%2520safer%2520oxazolidinone%2520antibacterial%2520agent%26spage%3DPoster%2520F-1501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Qiu, Y. L.; Jiang, J. Q.; Huang, H. X.; Hsu, C. H.; Ma, J.; Yuan, H.; Gordeev, M. F.</span><span> </span><span class="NLM_article-title">Acute and repeat dose toxicity of MRX-I in rat</span>. <span class="NLM_conf-name">52nd Interscience Conference on Antimicrobial Agents and Chemotherapy</span>, <span class="NLM_conf-loc">San Francisco</span>, <span class="NLM_conf-date">Sept 9–12, 2012</span>,  <span class="NLM_fpage">Poster F-1502</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Qiu%2C+Y.+L.%3B+Jiang%2C+J.+Q.%3B+Huang%2C+H.+X.%3B+Hsu%2C+C.+H.%3B+Ma%2C+J.%3B+Yuan%2C+H.%3B+Gordeev%2C+M.+F.+Acute+and+repeat+dose+toxicity+of+MRX-I+in+rat.+52nd+Interscience+Conference+on+Antimicrobial+Agents+and+Chemotherapy%2C+San+Francisco%2C+Sept+9%E2%80%9312%2C+2012%2C+Poster+F-1502."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DY.%2BL.%26atitle%3DAcute%2520and%2520repeat%2520dose%2520toxicity%2520of%2520MRX-I%2520in%2520rat%26spage%3DPoster%2520F-1502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Zhang, J.; Wu, X. J.; Huang, J.; Yu, J. C.; Guo, B. N.; Cao, G. Y.; Wu, J. F.; Zhang, K. J.; Yuan, H.; Yuan, Z. Y.; Shi, Y. G.; Zhang, Y. Y.</span><span> </span><span class="NLM_article-title">Single oral dose pharmacokinetics of MRX-I in healthy subjects</span>. <span class="NLM_conf-name">52nd Interscience Conference on Antimicrobial Agents and Chemotherapy</span>, <span class="NLM_conf-loc">San Francisco</span>, <span class="NLM_conf-date">Sept 9–12, 2012</span>,  <span class="NLM_fpage">Poster F-1503</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Zhang%2C+J.%3B+Wu%2C+X.+J.%3B+Huang%2C+J.%3B+Yu%2C+J.+C.%3B+Guo%2C+B.+N.%3B+Cao%2C+G.+Y.%3B+Wu%2C+J.+F.%3B+Zhang%2C+K.+J.%3B+Yuan%2C+H.%3B+Yuan%2C+Z.+Y.%3B+Shi%2C+Y.+G.%3B+Zhang%2C+Y.+Y.+Single+oral+dose+pharmacokinetics+of+MRX-I+in+healthy+subjects.+52nd+Interscience+Conference+on+Antimicrobial+Agents+and+Chemotherapy%2C+San+Francisco%2C+Sept+9%E2%80%9312%2C+2012%2C+Poster+F-1503."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DSingle%2520oral%2520dose%2520pharmacokinetics%2520of%2520MRX-I%2520in%2520healthy%2520subjects%26spage%3DPoster%2520F-1503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Zhang, J.; Wu, X. J.; Huang, J.; Yu, J. C.; Guo, B. N.; Cao, G. Y.; Wu, J. F.; Yuan, H.; Yuan, Z. Y.; Shi, Y. G.; Zhang, Y. Y.</span><span> </span><span class="NLM_article-title">Hematological effect and pharmacokinetics of multiple oral dose MRX-I in healthy subjects</span>. <span class="NLM_conf-name">52nd Interscience Conference on Antimicrobial Agents and Chemotherapy</span>, <span class="NLM_conf-loc">San Francisco</span>, <span class="NLM_conf-date">Sept 9–12, 2012</span>,  <span class="NLM_fpage">Poster F-1504</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Zhang%2C+J.%3B+Wu%2C+X.+J.%3B+Huang%2C+J.%3B+Yu%2C+J.+C.%3B+Guo%2C+B.+N.%3B+Cao%2C+G.+Y.%3B+Wu%2C+J.+F.%3B+Yuan%2C+H.%3B+Yuan%2C+Z.+Y.%3B+Shi%2C+Y.+G.%3B+Zhang%2C+Y.+Y.+Hematological+effect+and+pharmacokinetics+of+multiple+oral+dose+MRX-I+in+healthy+subjects.+52nd+Interscience+Conference+on+Antimicrobial+Agents+and+Chemotherapy%2C+San+Francisco%2C+Sept+9%E2%80%9312%2C+2012%2C+Poster+F-1504."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DHematological%2520effect%2520and%2520pharmacokinetics%2520of%2520multiple%2520oral%2520dose%2520MRX-I%2520in%2520healthy%2520subjects%26spage%3DPoster%2520F-1504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Brickner, S. J.</span><span> </span><span class="NLM_article-title">Oxazolidinone antibacterial agents</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">194</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm401931e&amp;key=1%3ACAS%3A528%3ADyaK28XjslGrurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1996&pages=175-194&author=S.+J.+Brickner&title=Oxazolidinone+antibacterial+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Oxazolidinone antibacterial agents</span></div><div class="casAuthors">Brickner, Steven J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">175-194</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review, with 138 refs., on the antibacterial activity, mechanism of action studies, toxicity issues, and structure-activity relationships of oxazolidinones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokm5Pl0jckp7Vg90H21EOLACvtfcHk0lgjNmaNIdVxxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjslGrurc%253D&md5=7f59c1f76d6eebae539904fbf94f770c</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrickner%26aufirst%3DS.%2BJ.%26atitle%3DOxazolidinone%2520antibacterial%2520agents%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D1996%26volume%3D2%26spage%3D175%26epage%3D194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Park, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Britelli, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C. L.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregory, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wuonola, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McRipley, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eberly, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slee, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forbes, M.</span><span> </span><span class="NLM_article-title">Antibacterials. Synthesis and structure–activity studies of 3-aryl-2-oxooxazolidines. 4. Multiply-substituted aryl derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1156</span><span class="NLM_x">–</span> <span class="NLM_lpage">1165</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00084a022" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=1156-1165&author=C.-H.+Parkauthor=D.+R.+Britelliauthor=C.+L.-J.+Wangauthor=F.+D.+Marshauthor=W.+A.+Gregoryauthor=M.+A.+Wuonolaauthor=R.+J.+McRipleyauthor=V.+S.+Eberlyauthor=A.+M.+Sleeauthor=M.+Forbes&title=Antibacterials.+Synthesis+and+structure%E2%80%93activity+studies+of+3-aryl-2-oxooxazolidines.+4.+Multiply-substituted+aryl+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm00084a022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00084a022%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DC.-H.%26aulast%3DBritelli%26aufirst%3DD.%2BR.%26aulast%3DWang%26aufirst%3DC.%2BL.-J.%26aulast%3DMarsh%26aufirst%3DF.%2BD.%26aulast%3DGregory%26aufirst%3DW.%2BA.%26aulast%3DWuonola%26aufirst%3DM.%2BA.%26aulast%3DMcRipley%26aufirst%3DR.%2BJ.%26aulast%3DEberly%26aufirst%3DV.%2BS.%26aulast%3DSlee%26aufirst%3DA.%2BM.%26aulast%3DForbes%26aufirst%3DM.%26atitle%3DAntibacterials.%2520Synthesis%2520and%2520structure%25E2%2580%2593activity%2520studies%2520of%25203-aryl-2-oxooxazolidines.%25204.%2520Multiply-substituted%2520aryl%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26spage%3D1156%26epage%3D1165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hutchinson, D. K.</span><span> </span><span class="NLM_article-title">Oxazolidinone antibacterial agents: a critical review</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1021</span><span class="NLM_x">–</span> <span class="NLM_lpage">1042</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=16&amp;doi=10.1021%2Fjm401931e&amp;key=10.2174%2F1568026033452195" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=8&amp;doi=10.1021%2Fjm401931e&amp;key=12678835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=32&amp;doi=10.1021%2Fjm401931e&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjt1Gltrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=1021-1042&author=D.+K.+Hutchinson&title=Oxazolidinone+antibacterial+agents%3A+a+critical+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26aR"><div class="casContent"><span class="casTitleNuber">26a</span><div class="casTitle"><span class="NLM_cas:atitle">Oxazolidinone antibacterial agents: A critical review</span></div><div class="casAuthors">Hutchinson, Douglas K.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1021-1042</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">This review covers recent developments in several important aspects of research on oxazolidinone antibacterial agents.  Structure-activity relationships are first discussed, emphasizing bioisosteric replacements for the both the oxazolidinone ring and the N-acetylaminomethyl group at C-5.  The oxazolidinones have a mechanism of action that is distinct from other antibacterial agents, whereby protein synthesis is inhibited prior to initiation.  Studies aimed at detg. how the oxazolidinones bind to the bacterial ribosome and interfere with peptidyl transferase activity are described in detail, and are then related to the nature of the changes in the rRNA leading to resistance.  Toxicity of the oxazolidinones remains a crit. issue, in that early lead compds. exhibited lethal toxicity in animal studies.  Preclin. and clin. safety studies of both eperezolid and linezolid are summarized, giving emphasis to histopathol. effects obsd. in early animal studies.  These studies are then related to thrombocytopenia and pancytopenia obsd. in patients treated with linezolid for extended time periods.  Finally, studies to det. the nature and potential severity of drug-drug interactions in patients undergoing linezolid therapy are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLktXTQ9Ws-bVg90H21EOLACvtfcHk0lhHCNDqwZqiTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjt1Gltrg%253D&md5=b986cac2af85c8c39d7b271a4930844d</span></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.2174%2F1568026033452195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026033452195%26sid%3Dliteratum%253Aachs%26aulast%3DHutchinson%26aufirst%3DD.%2BK.%26atitle%3DOxazolidinone%2520antibacterial%2520agents%253A%2520a%2520critical%2520review%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2003%26volume%3D3%26spage%3D1021%26epage%3D1042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit26b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Renslo, A. R.</span><span> </span><span class="NLM_article-title">Antibacterial oxazolidinones: emerging structure–toxicity relationships</span> <span class="citation_source-journal">Expert. Rev. Anti-infect. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">565</span><span class="NLM_x">–</span> <span class="NLM_lpage">574</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=16&amp;doi=10.1021%2Fjm401931e&amp;key=10.1586%2Feri.10.26" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=8&amp;doi=10.1021%2Fjm401931e&amp;key=20455685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=32&amp;doi=10.1021%2Fjm401931e&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvVWltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=565-574&author=A.+R.+Renslo&title=Antibacterial+oxazolidinones%3A+emerging+structure%E2%80%93toxicity+relationships"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26bR"><div class="casContent"><span class="casTitleNuber">26b</span><div class="casTitle"><span class="NLM_cas:atitle">Antibacterial oxazolidinones: emerging structure-toxicity relationships</span></div><div class="casAuthors">Renslo, Adam R.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anti-Infective Therapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">565-574</span>CODEN:
                <span class="NLM_cas:coden">ERATCK</span>;
        ISSN:<span class="NLM_cas:issn">1478-7210</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  The oxazolidinones are an important class of synthetic bacterial protein synthesis inhibitors with activity against Gram-pos. and some fastidious Gram-neg. bacteria.  Key toxicol. issues with the class include reversible inhibition of monoamine oxidase enzymes and reversible myelosuppression that can occur in patients treated for longer than the recommended course of therapy.  Recent studies have uncovered the likely mol. mechanism underlying oxazolidinone-related myelosuppression and other toxicities, and these will be discussed here.  Also reviewed are recent reports of structural modifications that can attenuate one or more of the undesired effects of oxazolidinones, while retaining the desired antibacterial effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon96V7VuRPMrVg90H21EOLACvtfcHk0lhHCNDqwZqiTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvVWltrY%253D&md5=ccd4e7ac03bc12898efdacf048047850</span></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=10.1586%2Feri.10.26&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Feri.10.26%26sid%3Dliteratum%253Aachs%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26atitle%3DAntibacterial%2520oxazolidinones%253A%2520emerging%2520structure%25E2%2580%2593toxicity%2520relationships%26jtitle%3DExpert.%2520Rev.%2520Anti-infect.%2520Ther.%26date%3D2010%26volume%3D8%26spage%3D565%26epage%3D574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gordeev, M. F.; Upinder, S.; Patel, D. V.; May, P. D.</span><span> </span><span class="NLM_article-title">Antimicrobial 1-aryl dihydropyridone compounds</span>. PCT WO 2004/033449, <span class="NLM_month">Apr</span><span class="NLM_day">22</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=M.+F.+Gordeev&author=S.+Upinder&author=D.+V.+Patel&author=P.+D.+May&title=Antimicrobial+1-aryl+dihydropyridone+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGordeev%26aufirst%3DM.%2BF.%26atitle%3DAntimicrobial%25201-aryl%2520dihydropyridone%2520compounds%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit27b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rhee, J. K.; Im, W. B.; Cho, C. H.; Choi, S. H.; Lee, T. H.</span><span> </span><span class="NLM_article-title">Novel oxazolidinone derivatives</span>. PCT WO 2005/058886, <span class="NLM_month">Jun</span><span class="NLM_day">30</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=J.+K.+Rhee&author=W.+B.+Im&author=C.+H.+Cho&author=S.+H.+Choi&author=T.+H.+Lee&title=Novel+oxazolidinone+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRhee%26aufirst%3DJ.%2BK.%26atitle%3DNovel%2520oxazolidinone%2520derivatives%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Renslo, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luehr, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordeev, M. F.</span><span> </span><span class="NLM_article-title">Recent developments in the identification of novel oxazolidinone antibacterial agents</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">4227</span><span class="NLM_x">–</span> <span class="NLM_lpage">4240</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=4227-4240&author=A.+R.+Rensloauthor=G.+W.+Luehrauthor=M.+F.+Gordeev&title=Recent+developments+in+the+identification+of+novel+oxazolidinone+antibacterial+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26aulast%3DLuehr%26aufirst%3DG.%2BW.%26aulast%3DGordeev%26aufirst%3DM.%2BF.%26atitle%3DRecent%2520developments%2520in%2520the%2520identification%2520of%2520novel%2520oxazolidinone%2520antibacterial%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26spage%3D4227%26epage%3D4240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Barbachyn, M. R.; Harris, C. R.; Vara Prasad, J. V. N.</span><span> </span><span class="NLM_article-title">Substituted 2,3,5-trifluorphenyl oxazolidinones for use as antibacterial agents</span>. PCT WO 2005/113520, <span class="NLM_month">Dec</span><span class="NLM_day">1</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=M.+R.+Barbachyn&author=C.+R.+Harris&author=J.+V.+N.+Vara+Prasad&title=Substituted+2%2C3%2C5-trifluorphenyl+oxazolidinones+for+use+as+antibacterial+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBarbachyn%26aufirst%3DM.%2BR.%26atitle%3DSubstituted%25202%252C3%252C5-trifluorphenyl%2520oxazolidinones%2520for%2520use%2520as%2520antibacterial%2520agents%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Harris, C. R.; Barbachyn, M. R.; Vara Prasad, J. V. N.; Angell, P.; Fusen Han; Sulavik, M. C.; Gibson, G. W.; Gage, G. W.; Lockard, M.; Ford, C. W.; Hamel, J. C.; Stapert, M. D.; Huband, M. D.; Pagano, P. J.; Zurenko, G. E.; Schaadt, R. D.; Yagi, B. H.; Ogden, A. G.; Lepsy, C. S.; Ashton, B.; Hollembaek, J. M.; Brodfuehrer, J. I.; Adams, W. J.; Martin,  Jr., J. P.; Blackburn, A. C.; Spence, J.</span><span> </span><span class="NLM_article-title">Identification of a new trifluorophenyl oxazolidinone, PF-00987296.</span>. <span class="NLM_conf-name">46th Interscience Conference on Antimicrobial Agents and Chemotherapy</span>, <span class="NLM_conf-loc">San Francisco</span>, <span class="NLM_conf-date">Sept 27–30, 2006</span>,  <span class="NLM_fpage">Poster F1–0971</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Harris%2C+C.+R.%3B+Barbachyn%2C+M.+R.%3B+Vara+Prasad%2C+J.+V.+N.%3B+Angell%2C+P.%3B+Fusen+Han%3B+Sulavik%2C+M.+C.%3B+Gibson%2C+G.+W.%3B+Gage%2C+G.+W.%3B+Lockard%2C+M.%3B+Ford%2C+C.+W.%3B+Hamel%2C+J.+C.%3B+Stapert%2C+M.+D.%3B+Huband%2C+M.+D.%3B+Pagano%2C+P.+J.%3B+Zurenko%2C+G.+E.%3B+Schaadt%2C+R.+D.%3B+Yagi%2C+B.+H.%3B+Ogden%2C+A.+G.%3B+Lepsy%2C+C.+S.%3B+Ashton%2C+B.%3B+Hollembaek%2C+J.+M.%3B+Brodfuehrer%2C+J.+I.%3B+Adams%2C+W.+J.%3B+Martin%2C+Jr.%2C+J.+P.%3B+Blackburn%2C+A.+C.%3B+Spence%2C+J.+Identification+of+a+new+trifluorophenyl+oxazolidinone%2C+PF-00987296..+46th+Interscience+Conference+on+Antimicrobial+Agents+and+Chemotherapy%2C+San+Francisco%2C+Sept+27%E2%80%9330%2C+2006%2C+Poster+F1%E2%80%930971."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DC.%2BR.%26atitle%3DIdentification%2520of%2520a%2520new%2520trifluorophenyl%2520oxazolidinone%252C%2520PF-00987296.%26spage%3DPoster%2520F1%25E2%2580%25930971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Parchment, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grieshaber, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sessa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghielmini, M.</span><span> </span><span class="NLM_article-title">Predicting hematological toxicity (myelosuppression) of cytotoxic drug therapy from in vitro tests</span> <span class="citation_source-journal">Ann. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm401931e&amp;key=10.1023%2FA%3A1008245906772" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm401931e&amp;key=9636825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm401931e&amp;key=1%3ACAS%3A280%3ADyaK1czgtVCmtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1998&pages=357-364&author=R.+E.+Parchmentauthor=M.+Gordonauthor=C.+K.+Grieshaberauthor=C.+Sessaauthor=D.+Volpeauthor=M.+Ghielmini&title=Predicting+hematological+toxicity+%28myelosuppression%29+of+cytotoxic+drug+therapy+from+in+vitro+tests"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Predicting hematological toxicity (myelosuppression) of cytotoxic drug therapy from in vitro tests</span></div><div class="casAuthors">Parchment R E; Gordon M; Grieshaber C K; Sessa C; Volpe D; Ghielmini M</div><div class="citationInfo"><span class="NLM_cas:title">Annals of oncology : official journal of the European Society for Medical Oncology / ESMO</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">357-64</span>
        ISSN:<span class="NLM_cas:issn">0923-7534</span>.
    </div><div class="casAbstract">Several clinical oncology units are studying the roles of in vitro hematotoxicology in phase I evaluations.  At the same time, the European Center for the Validation of Alternative Methods (ECVAM) is supporting a validation study of the CFU-GM assay.  It is important that these activities be coordinated so that high performance, optimized technical protocols are used for prospective and retrospective clinical evaluations.  The EROTC, the NCI and ECVAM could provide support for these coordinated efforts.  There is an opportunity for medical oncologists involved in early clinical trials to participate in the evaluation of in vitro tests and their clinical application .  Fundamental to acceptance of these assays by oncologists and regulatory scientists, they must predict clinical outcome for myelosuppressive agents and then improve phase I design and performance.  These achievements would justify more aggressive dose escalation schemes using guidance from in vitro studies without compromising patient safety.  Success in predicting neutropenia might also stimulate the research required to understand how to predict other hematologic toxicities, such as a thrombocytopenia.  The complexity of a validation study in hematotoxicology is that it seeks to predict the level of exposure that causes neutropenia, in contrast to other validation studies that have sought to classify a xenobiotic as toxic or not.  It may be that the clinical relevance of a new assay is not just a yes-no answer.  This important distinction came from the realization that the xenobiotic tolerance in other organ systems of the body must be the same or greater than marrow in order for myelosuppression to be a clinical consequence of exposure.  Pharmacological principles of system exposure and toxicity that are integrated into the prediction model provide the links to clinical oncology.  It is also important to anticipate future applications of in vitro hematotoxicology.  If the maximum tolerated level of drug exposure for human hematopoietic cells can be predicted, then in vitro hematotoxicology could play an important role in new drug discovery.  One concept involves screening for compounds that show efficacy at the IC level that predicts maximum tolerated exposure levels in the human. 'Therapeutic index based' drug discovery has been applied to the tallimustine family with some success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSl_8jLbgQpKEwlCcfExbvbfW6udTcc2eZT7U5L1V9bw7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1czgtVCmtg%253D%253D&md5=1573e2eb4fa7fc341f6d3ea3659cfe45</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1023%2FA%3A1008245906772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1008245906772%26sid%3Dliteratum%253Aachs%26aulast%3DParchment%26aufirst%3DR.%2BE.%26aulast%3DGordon%26aufirst%3DM.%26aulast%3DGrieshaber%26aufirst%3DC.%2BK.%26aulast%3DSessa%26aufirst%3DC.%26aulast%3DVolpe%26aufirst%3DD.%26aulast%3DGhielmini%26aufirst%3DM.%26atitle%3DPredicting%2520hematological%2520toxicity%2520%2528myelosuppression%2529%2520of%2520cytotoxic%2520drug%2520therapy%2520from%2520in%2520vitro%2520tests%26jtitle%3DAnn.%2520Oncol.%26date%3D1998%26volume%3D9%26spage%3D357%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Gordeev, M. F.</span><span> </span><span class="NLM_article-title">Antimicrobial <i>ortho</i>-fluorophenyl oxazolidinones for treatment of bacterial infections</span>. PCT WO 2009/020616, <span class="NLM_month">Feb</span><span class="NLM_day">12</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=M.+F.+Gordeev&title=Antimicrobial+ortho-fluorophenyl+oxazolidinones+for+treatment+of+bacterial+infections"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGordeev%26aufirst%3DM.%2BF.%26atitle%3DAntimicrobial%2520ortho-fluorophenyl%2520oxazolidinones%2520for%2520treatment%2520of%2520bacterial%2520infections%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span>Technical Bulletin “MAO-Glo Assay”; <span class="NLM_publisher-name">Promega Co.</span>: <span class="NLM_publisher-loc">Madison, WI</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Technical+Bulletin+%E2%80%9CMAO-Glo+Assay%E2%80%9D%3B+Promega+Co.%3A+Madison%2C+WI."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26jtitle%3DTechnical%2520Bulletin%2520%25E2%2580%259CMAO-Glo%2520Assay%25E2%2580%259D%26pub%3DPromega%2520Co" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Leach, K. L.</span><span> </span><span class="NLM_article-title">Assay for myelosuppression</span>. PCT WO 2006/097828, <span class="NLM_month">Sept</span><span class="NLM_day">21</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=K.+L.+Leach&title=Assay+for+myelosuppression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLeach%26aufirst%3DK.%2BL.%26atitle%3DAssay%2520for%2520myelosuppression%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Huang, Y.-Q.; Xu, Y.-H.; Liu, S.-C.; Wang, H.-L.; Xu, X.-G.; Guo, Q.-L.; Wu, B.-X.; Gordeev, M. F.; Wang, W.; Yuan, Z. Y.; Wang, M.-G.</span><span> </span><span class="NLM_article-title">Selection and characterization of <i>Staphylococcus aureus</i> mutants with reduced susceptibility to the investigational oxazolidinone MRX-I</span>.  <span class="citation_source-journal">Int. J. Antimicrob. Agents</span>,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.1016/j.ijantimicag.2014.02.008</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm401931e&amp;key=10.1016%2Fj.ijantimicag.2014.02.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=Y.-Q.+Huang&author=Y.-H.+Xu&author=S.-C.+Liu&author=H.-L.+Wang&author=X.-G.+Xu&author=Q.-L.+Guo&author=B.-X.+Wu&author=M.+F.+Gordeev&author=W.+Wang&author=Z.+Y.+Yuan&author=M.-G.+Wang&title=Selection+and+characterization+of+Staphylococcus+aureus+mutants+with+reduced+susceptibility+to+the+investigational+oxazolidinone+MRX-I&doi=10.1016%2Fj.ijantimicag.2014.02.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.ijantimicag.2014.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijantimicag.2014.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.-Q.%26atitle%3DSelection%2520and%2520characterization%2520of%2520Staphylococcus%2520aureus%2520mutants%2520with%2520reduced%2520susceptibility%2520to%2520the%2520investigational%2520oxazolidinone%2520MRX-I%26jtitle%3DInt.%2520J.%2520Antimicrob.%2520Agents%26date%3D2014%26doi%3D10.1016%2Fj.ijantimicag.2014.02.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Slatter, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">L. A. Adams, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiba, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daley-Yates, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feenstra, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koike, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sams, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuette, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, S.</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">907</span><span class="NLM_x">–</span> <span class="NLM_lpage">924</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Slatter%2C+J.+G.%3B+L.+A.+Adams%2C+L.+A.%3B+Bush%2C+E.+C.%3B+Chiba%2C+K.%3B+Daley-Yates%2C+P.+T.%3B+Feenstra%2C+K.+L.%3B+Koike%2C+S.%3B+Ozawa%2C+N.%3B+Peng%2C+G.+W.%3B+Sams%2C+J.+P.%3B+Schuette%2C+M.+R.%3B+Yamazaki%2C+S.Xenobiotica+2002%2C+32%2C+907%E2%80%93924"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSlatter%26aufirst%3DJ.%2BG.%26aulast%3DL.%2BA.%2BAdams%26aufirst%3DL.%2BA.%26aulast%3DBush%26aufirst%3DE.%2BC.%26aulast%3DChiba%26aufirst%3DK.%26aulast%3DDaley-Yates%26aufirst%3DP.%2BT.%26aulast%3DFeenstra%26aufirst%3DK.%2BL.%26aulast%3DKoike%26aufirst%3DS.%26aulast%3DOzawa%26aufirst%3DN.%26aulast%3DPeng%26aufirst%3DG.%2BW.%26aulast%3DSams%26aufirst%3DJ.%2BP.%26aulast%3DSchuette%26aufirst%3DM.%2BR.%26aulast%3DYamazaki%26aufirst%3DS.%26jtitle%3DXenobiotica%26date%3D2002%26volume%3D32%26spage%3D907%26epage%3D924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span>Technical Bulletin “Fluoro-MAOTM Assay”; <span class="NLM_publisher-name">Peninsula Laboratories, Inc. (USA)</span>: <span class="NLM_publisher-loc">San Carlos, CA</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Technical+Bulletin+%E2%80%9CFluoro-MAOTM+Assay%E2%80%9D%3B+Peninsula+Laboratories%2C+Inc.+%28USA%29%3A+San+Carlos%2C+CA."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26jtitle%3DTechnical%2520Bulletin%2520%25E2%2580%259CFluoro-MAOTM%2520Assay%25E2%2580%259D%26pub%3DPeninsula%2520Laboratories%252C%2520Inc.%2520%2528USA%2529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Fang, E.; De Anda, C.; Prokocimer, P.</span><span> </span><span class="NLM_article-title">Safety profile of tedizolid phosphate compared to linezolid in a phase 3 ABSSSI study</span>. <span class="NLM_conf-name">52nd Interscience Conference on Antimicrobial Agents and Chemotherapy</span>, <span class="NLM_conf-loc">San Francisco</span>, <span class="NLM_conf-date">Sept 9–12, 2012</span>,  <span class="NLM_fpage">Poster L1–1664</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Fang%2C+E.%3B+De+Anda%2C+C.%3B+Prokocimer%2C+P.+Safety+profile+of+tedizolid+phosphate+compared+to+linezolid+in+a+phase+3+ABSSSI+study.+52nd+Interscience+Conference+on+Antimicrobial+Agents+and+Chemotherapy%2C+San+Francisco%2C+Sept+9%E2%80%9312%2C+2012%2C+Poster+L1%E2%80%931664."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DE.%26atitle%3DSafety%2520profile%2520of%2520tedizolid%2520phosphate%2520compared%2520to%2520linezolid%2520in%2520a%2520phase%25203%2520ABSSSI%2520study%26spage%3DPoster%2520L1%25E2%2580%25931664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5a','cit5b'],'ref6':['cit6'],'ref7':['cit7a','cit7b'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13a','cit13b','cit13c'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20a','cit20b'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23a','cit23b','cit23c','cit23d','cit23e','cit23f','cit23g','cit23h'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26a','cit26b'],'ref27':['cit27a','cit27b'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 50 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Wen Wang, Kate M. Voss, Jinqian Liu, <span class="NLM_string-name hlFld-ContribAuthor">Mikhail F. Gordeev</span>. </span><span class="cited-content_cbyCitation_article-title">Nonclinical Evaluation of Antibacterial Oxazolidinones Contezolid and Contezolid Acefosamil with Low Serotonergic Neurotoxicity. </span><span class="cited-content_cbyCitation_journal-name">Chemical Research in Toxicology</span><span> <strong>2021,</strong> <em>34 </em>
                                    (5)
                                     , 1348-1354. <a href="https://doi.org/10.1021/acs.chemrestox.0c00524" title="DOI URL">https://doi.org/10.1021/acs.chemrestox.0c00524</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrestox.0c00524&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrestox.0c00524%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Research%2520in%2520Toxicology%26atitle%3DNonclinical%252BEvaluation%252Bof%252BAntibacterial%252BOxazolidinones%252BContezolid%252Band%252BContezolid%252BAcefosamil%252Bwith%252BLow%252BSerotonergic%252BNeurotoxicity%26aulast%3DWang%26aufirst%3DWen%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D14122020%26date%3D29042021%26volume%3D34%26issue%3D5%26spage%3D1348%26epage%3D1354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yongqi Wu, Bin Wang, Haijia Lu, Hongyi Zhao, Beibei Yang, Li Li, Yu Lu, Dongfeng Zhang, Ning Sun, <span class="NLM_string-name hlFld-ContribAuthor">Haihong Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Novel Tricyclic Benzo[1,3]oxazinyloxazolidinones as Potent Antibacterial Agents with Excellent Pharmacokinetic Profiles against Drug-Resistant Pathogens. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (6)
                                     , 3234-3248. <a href="https://doi.org/10.1021/acs.jmedchem.0c02153" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02153</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02153%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BNovel%252BTricyclic%252BBenzo%25255B1%25252C3%25255Doxazinyloxazolidinones%252Bas%252BPotent%252BAntibacterial%252BAgents%252Bwith%252BExcellent%252BPharmacokinetic%252BProfiles%252Bagainst%252BDrug-Resistant%252BPathogens%26aulast%3DWu%26aufirst%3DYongqi%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D14122020%26date%3D11032021%26volume%3D64%26issue%3D6%26spage%3D3234%26epage%3D3248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hongyi Zhao, Bin Wang, Lei Fu, Gang Li, Haijia Lu, Yuke Liu, Li Sheng, Yan Li, Baoxi Zhang, Yang Lu, Chen Ma, Haihong Huang, Dongfeng Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Yu Lu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Conformationally Constrained Oxazolidinone with Improved Safety and Efficacy Profiles for the Treatment of Multidrug-Resistant Tuberculosis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (17)
                                     , 9316-9339. <a href="https://doi.org/10.1021/acs.jmedchem.0c00500" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00500</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00500%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BConformationally%252BConstrained%252BOxazolidinone%252Bwith%252BImproved%252BSafety%252Band%252BEfficacy%252BProfiles%252Bfor%252Bthe%252BTreatment%252Bof%252BMultidrug-Resistant%252BTuberculosis%26aulast%3DZhao%26aufirst%3DHongyi%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D27032020%26date%3D05082020%26date%3D15072020%26volume%3D63%26issue%3D17%26spage%3D9316%26epage%3D9339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Alexander Wright, Kieran Deane-Alder, Edward Marschall, Rebecca Bamert, Hari Venugopal, Trevor Lithgow, David W. Lupton, <span class="NLM_string-name hlFld-ContribAuthor">Matthew J. Belousoff</span>. </span><span class="cited-content_cbyCitation_article-title">Characterization of the Core Ribosomal Binding Region for the Oxazolidone Family of Antibiotics Using Cryo-EM. </span><span class="cited-content_cbyCitation_journal-name">ACS Pharmacology & Translational Science</span><span> <strong>2020,</strong> <em>3 </em>
                                    (3)
                                     , 425-432. <a href="https://doi.org/10.1021/acsptsci.0c00041" title="DOI URL">https://doi.org/10.1021/acsptsci.0c00041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsptsci.0c00041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsptsci.0c00041%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Pharmacology%2520%2526%2520Translational%2520Science%26atitle%3DCharacterization%252Bof%252Bthe%252BCore%252BRibosomal%252BBinding%252BRegion%252Bfor%252Bthe%252BOxazolidone%252BFamily%252Bof%252BAntibiotics%252BUsing%252BCryo-EM%26aulast%3DWright%26aufirst%3DAlexander%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D30042020%26date%3D19052020%26date%3D13052020%26volume%3D3%26issue%3D3%26spage%3D425%26epage%3D432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mahesh S.  Deshmukh</span> and <span class="hlFld-ContribAuthor ">Nidhi  Jain</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Antibacterial Evaluation of Oxazolidinones with Fused Heterocyclic C-Ring Substructure. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (11)
                                     , 1153-1158. <a href="https://doi.org/10.1021/acsmedchemlett.7b00263" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00263</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00263%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BAntibacterial%252BEvaluation%252Bof%252BOxazolidinones%252Bwith%252BFused%252BHeterocyclic%252BC-Ring%252BSubstructure%26aulast%3DDeshmukh%26aufirst%3DMahesh%2BS.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D29062017%26date%3D28092017%26date%3D05102017%26date%3D09112017%26date%3D28092017%26volume%3D8%26issue%3D11%26spage%3D1153%26epage%3D1158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tao  Yang</span>, <span class="hlFld-ContribAuthor ">Gong  Chen</span>, <span class="hlFld-ContribAuthor ">Zitai  Sang</span>, <span class="hlFld-ContribAuthor ">Yuanyuan  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaoyan  Yang</span>, <span class="hlFld-ContribAuthor ">Ying  Chang</span>, <span class="hlFld-ContribAuthor ">Haiyue  Long</span>, <span class="hlFld-ContribAuthor ">Wei  Ang</span>, <span class="hlFld-ContribAuthor ">Jianying  Tang</span>, <span class="hlFld-ContribAuthor ">Zhenling  Wang</span>, <span class="hlFld-ContribAuthor ">Guobo  Li</span>, <span class="hlFld-ContribAuthor ">Shengyong  Yang</span>, <span class="hlFld-ContribAuthor ">Jingren  Zhang</span>, <span class="hlFld-ContribAuthor ">Yuquan  Wei</span>, and <span class="hlFld-ContribAuthor ">Youfu  Luo</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Teraryl Oxazolidinone Compound (S)-N-((3-(3-Fluoro-4-(4-(pyridin-2-yl)-1H-pyrazol-1-yl)phenyl)-2-oxooxazolidin-5-yl)methyl)acetamide Phosphate as a Novel Antimicrobial Agent with Enhanced Safety Profile and Efficacies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (16)
                                     , 6389-6409. <a href="https://doi.org/10.1021/acs.jmedchem.5b00152" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00152</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00152%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BTeraryl%252BOxazolidinone%252BCompound%252B%252528S%252529-N-%252528%2525283-%2525283-Fluoro-4-%2525284-%252528pyridin-2-yl%252529-1H-pyrazol-1-yl%252529phenyl%252529-2-oxooxazolidin-5-yl%252529methyl%252529acetamide%252BPhosphate%252Bas%252Ba%252BNovel%252BAntimicrobial%252BAgent%252Bwith%252BEnhanced%252BSafety%252BProfile%252Band%252BEfficacies%26aulast%3DYang%26aufirst%3DTao%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D27012015%26date%3D17082015%26date%3D27082015%26date%3D27072015%26volume%3D58%26issue%3D16%26spage%3D6389%26epage%3D6409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laiying  Zhang</span>, <span class="hlFld-ContribAuthor ">Jun  He</span>, <span class="hlFld-ContribAuthor ">Lang  Bai</span>, <span class="hlFld-ContribAuthor ">Shihua  Ruan</span>, <span class="hlFld-ContribAuthor ">Tao  Yang</span>, <span class="hlFld-ContribAuthor ">Youfu  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Ribosome‐targeting antibacterial agents: Advances, challenges, and opportunities. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2021,</strong> <em>41 </em>
                                    (4)
                                     , 1855-1889. <a href="https://doi.org/10.1002/med.21780" title="DOI URL">https://doi.org/10.1002/med.21780</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21780&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21780%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DRibosome%2525E2%252580%252590targeting%252Bantibacterial%252Bagents%25253A%252BAdvances%25252C%252Bchallenges%25252C%252Band%252Bopportunities%26aulast%3DZhang%26aufirst%3DLaiying%26date%3D2021%26date%3D2021%26volume%3D41%26issue%3D4%26spage%3D1855%26epage%3D1889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raed M.  Al-Zoubi</span>, <span class="hlFld-ContribAuthor ">Walid K.  Al-Jammal</span>, <span class="hlFld-ContribAuthor ">Mazhar S.  Al-Zoubi</span>, <span class="hlFld-ContribAuthor ">Robert  McDonald</span>, <span class="hlFld-ContribAuthor ">Ahmad  Zarour</span>, <span class="hlFld-ContribAuthor ">Aksam  Yassin</span>, <span class="hlFld-ContribAuthor ">Abdulla  Al-Ansari</span>. </span><span class="cited-content_cbyCitation_article-title">Copper(
              i
              )-catalyzed regioselective Ullmann-type coupling of primary carbamates and 5-substituted-1,2,3-triiodobenzenes: facile synthesis of 2,3-diiodinated
              N
              -aryl carbamates. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2021,</strong> <em>45 </em>
                                    (19)
                                     , 8432-8439. <a href="https://doi.org/10.1039/D1NJ01332G" title="DOI URL">https://doi.org/10.1039/D1NJ01332G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1NJ01332G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1NJ01332G%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DCopper%252528%252Bi%252B%252529-catalyzed%252Bregioselective%252BUllmann-type%252Bcoupling%252Bof%252Bprimary%252Bcarbamates%252Band%252B5-substituted-1%25252C2%25252C3-triiodobenzenes%25253A%252Bfacile%252Bsynthesis%252Bof%252B2%25252C3-diiodinated%252BN%252B-aryl%252Bcarbamates%26aulast%3DAl-Zoubi%26aufirst%3DRaed%2BM.%26date%3D2021%26date%3D2021%26volume%3D45%26issue%3D19%26spage%3D8432%26epage%3D8439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xinyue  Fang</span>, <span class="hlFld-ContribAuthor ">Yuqiang  Tan</span>, <span class="hlFld-ContribAuthor ">Linghui  Gu</span>, <span class="hlFld-ContribAuthor ">Lutz  Ackermann</span>, <span class="hlFld-ContribAuthor ">Wenbo  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">para
              ‐Selective Palladium‐Catalyzed C−H Difluoroalkylation by Weak Oxazolidinone Assistance. </span><span class="cited-content_cbyCitation_journal-name">ChemCatChem</span><span> <strong>2021,</strong> <em>13 </em>
                                    (7)
                                     , 1738-1742. <a href="https://doi.org/10.1002/cctc.202002056" title="DOI URL">https://doi.org/10.1002/cctc.202002056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cctc.202002056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcctc.202002056%26sid%3Dliteratum%253Aachs%26jtitle%3DChemCatChem%26atitle%3Dpara%252B%2525E2%252580%252590Selective%252BPalladium%2525E2%252580%252590Catalyzed%252BC%2525E2%252588%252592H%252BDifluoroalkylation%252Bby%252BWeak%252BOxazolidinone%252BAssistance%26aulast%3DFang%26aufirst%3DXinyue%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D7%26spage%3D1738%26epage%3D1742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qidi  Kong</span>, <span class="hlFld-ContribAuthor ">Yushe  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in antibacterial agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>35 </em>, 127799. <a href="https://doi.org/10.1016/j.bmcl.2021.127799" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.127799</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.127799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.127799%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DRecent%252Badvances%252Bin%252Bantibacterial%252Bagents%26aulast%3DKong%26aufirst%3DQidi%26date%3D2021%26volume%3D35%26spage%3D127799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cristina D.  Cruz</span>, <span class="hlFld-ContribAuthor ">Pauli  Wrigstedt</span>, <span class="hlFld-ContribAuthor ">Karina  Moslova</span>, <span class="hlFld-ContribAuthor ">Vladimir  Iashin</span>, <span class="hlFld-ContribAuthor ">Heidi  Mäkkylä</span>, <span class="hlFld-ContribAuthor ">Léo  Ghemtio</span>, <span class="hlFld-ContribAuthor ">Sami  Heikkinen</span>, <span class="hlFld-ContribAuthor ">Päivi  Tammela</span>, <span class="hlFld-ContribAuthor ">Jesus E.  Perea-Buceta</span>. </span><span class="cited-content_cbyCitation_article-title">Installation of an aryl boronic acid function into the external section of  -aryl-oxazolidinones: Synthesis and antimicrobial evaluation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>211 </em>, 113002. <a href="https://doi.org/10.1016/j.ejmech.2020.113002" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113002%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInstallation%252Bof%252Ban%252Baryl%252Bboronic%252Bacid%252Bfunction%252Binto%252Bthe%252Bexternal%252Bsection%252Bof%252B-aryl-oxazolidinones%25253A%252BSynthesis%252Band%252Bantimicrobial%252Bevaluation%26aulast%3DCruz%26aufirst%3DCristina%2BD.%26date%3D2021%26volume%3D211%26spage%3D113002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shyamal  Baruah</span>, <span class="hlFld-ContribAuthor ">Merangmenla  Aier</span>, <span class="hlFld-ContribAuthor ">Amrit  Puzari</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorescent probe sensor based on (R)‐(−)‐4‐phenyl‐2‐oxazolidone for effective detection of divalent cations. </span><span class="cited-content_cbyCitation_journal-name">Luminescence</span><span> <strong>2020,</strong> <em>35 </em>
                                    (8)
                                     , 1206-1216. <a href="https://doi.org/10.1002/bio.3830" title="DOI URL">https://doi.org/10.1002/bio.3830</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/bio.3830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fbio.3830%26sid%3Dliteratum%253Aachs%26jtitle%3DLuminescence%26atitle%3DFluorescent%252Bprobe%252Bsensor%252Bbased%252Bon%252B%252528R%252529%2525E2%252580%252590%252528%2525E2%252588%252592%252529%2525E2%252580%2525904%2525E2%252580%252590phenyl%2525E2%252580%2525902%2525E2%252580%252590oxazolidone%252Bfor%252Beffective%252Bdetection%252Bof%252Bdivalent%252Bcations%26aulast%3DBaruah%26aufirst%3DShyamal%26date%3D2020%26date%3D2020%26volume%3D35%26issue%3D8%26spage%3D1206%26epage%3D1216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samanvai Reddy  Tetali</span>, <span class="hlFld-ContribAuthor ">Eswar  Kunapaeddi</span>, <span class="hlFld-ContribAuthor ">Raghu Prasad  Mailavaram</span>, <span class="hlFld-ContribAuthor ">Vinayak  Singh</span>, <span class="hlFld-ContribAuthor ">Pobitra  Borah</span>, <span class="hlFld-ContribAuthor ">Pran Kishore  Deb</span>, <span class="hlFld-ContribAuthor ">Katharigatta N.  Venugopala</span>, <span class="hlFld-ContribAuthor ">Wafa  Hourani</span>, <span class="hlFld-ContribAuthor ">Rakesh Kumar  Tekade</span>. </span><span class="cited-content_cbyCitation_article-title">Current advances in the clinical development of anti-tubercular agents. </span><span class="cited-content_cbyCitation_journal-name">Tuberculosis</span><span> <strong>2020,</strong> <em>125 </em>, 101989. <a href="https://doi.org/10.1016/j.tube.2020.101989" title="DOI URL">https://doi.org/10.1016/j.tube.2020.101989</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tube.2020.101989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tube.2020.101989%26sid%3Dliteratum%253Aachs%26jtitle%3DTuberculosis%26atitle%3DCurrent%252Badvances%252Bin%252Bthe%252Bclinical%252Bdevelopment%252Bof%252Banti-tubercular%252Bagents%26aulast%3DTetali%26aufirst%3DSamanvai%2BReddy%26date%3D2020%26volume%3D125%26spage%3D101989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pedro F.  Dalberto</span>, <span class="hlFld-ContribAuthor ">Eduardo V.  de Souza</span>, <span class="hlFld-ContribAuthor ">Bruno L.  Abbadi</span>, <span class="hlFld-ContribAuthor ">Christiano E.  Neves</span>, <span class="hlFld-ContribAuthor ">Raoní S.  Rambo</span>, <span class="hlFld-ContribAuthor ">Alessandro S.  Ramos</span>, <span class="hlFld-ContribAuthor ">Fernanda S.  Macchi</span>, <span class="hlFld-ContribAuthor ">Pablo  Machado</span>, <span class="hlFld-ContribAuthor ">Cristiano V.  Bizarro</span>, <span class="hlFld-ContribAuthor ">Luiz A.  Basso</span>. </span><span class="cited-content_cbyCitation_article-title">Handling the Hurdles on the Way to Anti-tuberculosis Drug Development. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2020,</strong> <em>8 </em><a href="https://doi.org/10.3389/fchem.2020.586294" title="DOI URL">https://doi.org/10.3389/fchem.2020.586294</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2020.586294&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2020.586294%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DHandling%252Bthe%252BHurdles%252Bon%252Bthe%252BWay%252Bto%252BAnti-tuberculosis%252BDrug%252BDevelopment%26aulast%3DDalberto%26aufirst%3DPedro%2BF.%26date%3D2020%26date%3D2020%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cecilia G.  Carvalhaes</span>, <span class="hlFld-ContribAuthor ">Leonard R.  Duncan</span>, <span class="hlFld-ContribAuthor ">Wen  Wang</span>, <span class="hlFld-ContribAuthor ">Helio S.  Sader</span>. </span><span class="cited-content_cbyCitation_article-title">In Vitro
              Activity and Potency of the Novel Oxazolidinone Contezolid (MRX-I) Tested against Gram-Positive Clinical Isolates from the United States and Europe. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2020,</strong> <em>64 </em>
                                    (11)
                                     <a href="https://doi.org/10.1128/AAC.01195-20" title="DOI URL">https://doi.org/10.1128/AAC.01195-20</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.01195-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.01195-20%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DIn%252BVitro%252BActivity%252Band%252BPotency%252Bof%252Bthe%252BNovel%252BOxazolidinone%252BContezolid%252B%252528MRX-I%252529%252BTested%252Bagainst%252BGram-Positive%252BClinical%252BIsolates%252Bfrom%252Bthe%252BUnited%252BStates%252Band%252BEurope%26aulast%3DCarvalhaes%26aufirst%3DCecilia%2BG.%26date%3D2020%26volume%3D64%26issue%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Théoneste  Umumararungu</span>, <span class="hlFld-ContribAuthor ">Marie Jeanne  Mukazayire</span>, <span class="hlFld-ContribAuthor ">Matabishi  Mpenda</span>, <span class="hlFld-ContribAuthor ">Marie Françoise  Mukanyangezi</span>, <span class="hlFld-ContribAuthor ">Jean Bosco  Nkuranga</span>, <span class="hlFld-ContribAuthor ">Janvier  Mukiza</span>, <span class="hlFld-ContribAuthor ">Emmanuel Oladayo  Olawode</span>. </span><span class="cited-content_cbyCitation_article-title">A review of recent advances in anti-tubercular drug development. </span><span class="cited-content_cbyCitation_journal-name">Indian Journal of Tuberculosis</span><span> <strong>2020,</strong> <em>67 </em>
                                    (4)
                                     , 539-559. <a href="https://doi.org/10.1016/j.ijtb.2020.07.017" title="DOI URL">https://doi.org/10.1016/j.ijtb.2020.07.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijtb.2020.07.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijtb.2020.07.017%26sid%3Dliteratum%253Aachs%26jtitle%3DIndian%2520Journal%2520of%2520Tuberculosis%26atitle%3DA%252Breview%252Bof%252Brecent%252Badvances%252Bin%252Banti-tubercular%252Bdrug%252Bdevelopment%26aulast%3DUmumararungu%26aufirst%3DTh%25C3%25A9oneste%26date%3D2020%26volume%3D67%26issue%3D4%26spage%3D539%26epage%3D559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Esteban  Matador</span>, <span class="hlFld-ContribAuthor ">María  de Gracia Retamosa</span>, <span class="hlFld-ContribAuthor ">David  Monge</span>, <span class="hlFld-ContribAuthor ">Rosario  Fernández</span>, <span class="hlFld-ContribAuthor ">José M.  Lassaletta</span>. </span><span class="cited-content_cbyCitation_article-title">Formaldehyde
              tert
              -butyl hydrazone as a formyl anion equivalent: asymmetric addition to carbonyl compounds. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2020,</strong> <em>56 </em>
                                    (65)
                                     , 9256-9267. <a href="https://doi.org/10.1039/D0CC02660C" title="DOI URL">https://doi.org/10.1039/D0CC02660C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CC02660C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CC02660C%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DFormaldehyde%252Btert%252B-butyl%252Bhydrazone%252Bas%252Ba%252Bformyl%252Banion%252Bequivalent%25253A%252Basymmetric%252Baddition%252Bto%252Bcarbonyl%252Bcompounds%26aulast%3DMatador%26aufirst%3DEsteban%26date%3D2020%26date%3D2020%26volume%3D56%26issue%3D65%26spage%3D9256%26epage%3D9267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark S.  Butler</span>, <span class="hlFld-ContribAuthor ">David L.  Paterson</span>. </span><span class="cited-content_cbyCitation_article-title">Antibiotics in the clinical pipeline in October 2019. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Antibiotics</span><span> <strong>2020,</strong> <em>73 </em>
                                    (6)
                                     , 329-364. <a href="https://doi.org/10.1038/s41429-020-0291-8" title="DOI URL">https://doi.org/10.1038/s41429-020-0291-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41429-020-0291-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41429-020-0291-8%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Antibiotics%26atitle%3DAntibiotics%252Bin%252Bthe%252Bclinical%252Bpipeline%252Bin%252BOctober%252B2019%26aulast%3DButler%26aufirst%3DMark%2BS.%26date%3D2020%26date%3D2020%26volume%3D73%26issue%3D6%26spage%3D329%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Junzhen  Wu</span>, <span class="hlFld-ContribAuthor ">Guoying  Cao</span>, <span class="hlFld-ContribAuthor ">Hailan  Wu</span>, <span class="hlFld-ContribAuthor ">Yuancheng  Chen</span>, <span class="hlFld-ContribAuthor ">Beining  Guo</span>, <span class="hlFld-ContribAuthor ">Xiaojie  Wu</span>, <span class="hlFld-ContribAuthor ">Jicheng  Yu</span>, <span class="hlFld-ContribAuthor ">Kanhong  Ni</span>, <span class="hlFld-ContribAuthor ">Jin  Qian</span>, <span class="hlFld-ContribAuthor ">Li  Wang</span>, <span class="hlFld-ContribAuthor ">Jufang  Wu</span>, <span class="hlFld-ContribAuthor ">Yu  Wang</span>, <span class="hlFld-ContribAuthor ">Hong  Yuan</span>, <span class="hlFld-ContribAuthor ">Jing  Zhang</span>, <span class="hlFld-ContribAuthor ">Yuewen  Xi</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of the Effect of Contezolid (MRX-I) on the Corrected QT Interval in a Randomized, Double-Blind, Placebo- and Positive-Controlled Crossover Study in Healthy Chinese Volunteers. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2020,</strong> <em>64 </em>
                                    (6)
                                     <a href="https://doi.org/10.1128/AAC.02158-19" title="DOI URL">https://doi.org/10.1128/AAC.02158-19</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.02158-19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.02158-19%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DEvaluation%252Bof%252Bthe%252BEffect%252Bof%252BContezolid%252B%252528MRX-I%252529%252Bon%252Bthe%252BCorrected%252BQT%252BInterval%252Bin%252Ba%252BRandomized%25252C%252BDouble-Blind%25252C%252BPlacebo-%252Band%252BPositive-Controlled%252BCrossover%252BStudy%252Bin%252BHealthy%252BChinese%252BVolunteers%26aulast%3DWu%26aufirst%3DJunzhen%26date%3D2020%26volume%3D64%26issue%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li  Li</span>, <span class="hlFld-ContribAuthor ">Hailan  Wu</span>, <span class="hlFld-ContribAuthor ">Yuancheng  Chen</span>, <span class="hlFld-ContribAuthor ">Hong  Yuan</span>, <span class="hlFld-ContribAuthor ">Junzhen  Wu</span>, <span class="hlFld-ContribAuthor ">Xiaojie  Wu</span>, <span class="hlFld-ContribAuthor ">Yingyuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Guoying  Cao</span>, <span class="hlFld-ContribAuthor ">Beining  Guo</span>, <span class="hlFld-ContribAuthor ">Jufang  Wu</span>, <span class="hlFld-ContribAuthor ">Ming  Zhao</span>, <span class="hlFld-ContribAuthor ">Jing  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Population Pharmacokinetics Study of Contezolid (MRX-I), a Novel Oxazolidinone Antibacterial Agent, in Chinese Patients. </span><span class="cited-content_cbyCitation_journal-name">Clinical Therapeutics</span><span> <strong>2020,</strong> <em>42 </em>
                                    (5)
                                     , 818-829. <a href="https://doi.org/10.1016/j.clinthera.2020.03.020" title="DOI URL">https://doi.org/10.1016/j.clinthera.2020.03.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.clinthera.2020.03.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.clinthera.2020.03.020%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Therapeutics%26atitle%3DPopulation%252BPharmacokinetics%252BStudy%252Bof%252BContezolid%252B%252528MRX-I%252529%25252C%252Ba%252BNovel%252BOxazolidinone%252BAntibacterial%252BAgent%25252C%252Bin%252BChinese%252BPatients%26aulast%3DLi%26aufirst%3DLi%26date%3D2020%26volume%3D42%26issue%3D5%26spage%3D818%26epage%3D829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dong-Xiao  Cui</span>, <span class="hlFld-ContribAuthor ">Yue-Dan  Li</span>, <span class="hlFld-ContribAuthor ">Ping  Huang</span>, <span class="hlFld-ContribAuthor ">Zhuang  Tian</span>, <span class="hlFld-ContribAuthor ">Yan-Yan  Jia</span>, <span class="hlFld-ContribAuthor ">Ping-An  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Bifunctional phase-transfer catalysts for synthesis of 2-oxazolidinones from isocyanates and epoxides. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2020,</strong> <em>10 </em>
                                    (21)
                                     , 12360-12364. <a href="https://doi.org/10.1039/D0RA00693A" title="DOI URL">https://doi.org/10.1039/D0RA00693A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA00693A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA00693A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DBifunctional%252Bphase-transfer%252Bcatalysts%252Bfor%252Bsynthesis%252Bof%252B2-oxazolidinones%252Bfrom%252Bisocyanates%252Band%252Bepoxides%26aulast%3DCui%26aufirst%3DDong-Xiao%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D21%26spage%3D12360%26epage%3D12364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adrian  Sevenich</span>, <span class="hlFld-ContribAuthor ">Paulina Sophie  Mark</span>, <span class="hlFld-ContribAuthor ">Torsten  Behrendt</span>, <span class="hlFld-ContribAuthor ">Jonathan  Groß</span>, <span class="hlFld-ContribAuthor ">Till  Opatz</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 2,3-Dihydro-4-pyridones, 4-Quinolones, and 2,3-Dihydro-4-azocinones by Visible-Light Photocatalytic Aerobic Dehydrogenation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>2020 </em>
                                    (10)
                                     , 1505-1514. <a href="https://doi.org/10.1002/ejoc.201900584" title="DOI URL">https://doi.org/10.1002/ejoc.201900584</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201900584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201900584%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252B2%25252C3-Dihydro-4-pyridones%25252C%252B4-Quinolones%25252C%252Band%252B2%25252C3-Dihydro-4-azocinones%252Bby%252BVisible-Light%252BPhotocatalytic%252BAerobic%252BDehydrogenation%26aulast%3DSevenich%26aufirst%3DAdrian%26date%3D2020%26date%3D2019%26volume%3D2020%26issue%3D10%26spage%3D1505%26epage%3D1514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Despoina  Koulenti</span>, <span class="hlFld-ContribAuthor ">Elena  Xu</span>, <span class="hlFld-ContribAuthor ">Andrew  Song</span>, <span class="hlFld-ContribAuthor ">Isaac Yin  Sum Mok</span>, <span class="hlFld-ContribAuthor ">Drosos E.  Karageorgopoulos</span>, <span class="hlFld-ContribAuthor ">Apostolos  Armaganidis</span>, <span class="hlFld-ContribAuthor ">Sotirios  Tsiodras</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Lipman</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging Treatment Options for Infections by Multidrug-Resistant Gram-Positive Microorganisms. </span><span class="cited-content_cbyCitation_journal-name">Microorganisms</span><span> <strong>2020,</strong> <em>8 </em>
                                    (2)
                                     , 191. <a href="https://doi.org/10.3390/microorganisms8020191" title="DOI URL">https://doi.org/10.3390/microorganisms8020191</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/microorganisms8020191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmicroorganisms8020191%26sid%3Dliteratum%253Aachs%26jtitle%3DMicroorganisms%26atitle%3DEmerging%252BTreatment%252BOptions%252Bfor%252BInfections%252Bby%252BMultidrug-Resistant%252BGram-Positive%252BMicroorganisms%26aulast%3DKoulenti%26aufirst%3DDespoina%26date%3D2020%26date%3D2020%26volume%3D8%26issue%3D2%26spage%3D191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Junzhen  Wu</span>, <span class="hlFld-ContribAuthor ">Kun  Wang</span>, <span class="hlFld-ContribAuthor ">Yuancheng  Chen</span>, <span class="hlFld-ContribAuthor ">Hong  Yuan</span>, <span class="hlFld-ContribAuthor ">Li  Li</span>, <span class="hlFld-ContribAuthor ">Jing  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Concentration–response modeling of ECG data from early-phase clinical studies to assess QT prolongation risk of contezolid (MRX-I), an oxazolidinone antibacterial agent. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacokinetics and Pharmacodynamics</span><span> <strong>2019,</strong> <em>46 </em>
                                    (6)
                                     , 531-541. <a href="https://doi.org/10.1007/s10928-019-09650-7" title="DOI URL">https://doi.org/10.1007/s10928-019-09650-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10928-019-09650-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10928-019-09650-7%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacokinetics%2520and%2520Pharmacodynamics%26atitle%3DConcentration%2525E2%252580%252593response%252Bmodeling%252Bof%252BECG%252Bdata%252Bfrom%252Bearly-phase%252Bclinical%252Bstudies%252Bto%252Bassess%252BQT%252Bprolongation%252Brisk%252Bof%252Bcontezolid%252B%252528MRX-I%252529%25252C%252Ban%252Boxazolidinone%252Bantibacterial%252Bagent%26aulast%3DWu%26aufirst%3DJunzhen%26date%3D2019%26date%3D2019%26volume%3D46%26issue%3D6%26spage%3D531%26epage%3D541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Srikanth  Gatadi</span>, <span class="hlFld-ContribAuthor ">Y.V.  Madhavi</span>, <span class="hlFld-ContribAuthor ">Sidharth  Chopra</span>, <span class="hlFld-ContribAuthor ">Srinivas  Nanduri</span>. </span><span class="cited-content_cbyCitation_article-title">Promising antibacterial agents against multidrug resistant Staphylococcus aureus. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>92 </em>, 103252. <a href="https://doi.org/10.1016/j.bioorg.2019.103252" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103252</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103252%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DPromising%252Bantibacterial%252Bagents%252Bagainst%252Bmultidrug%252Bresistant%252BStaphylococcus%252Baureus%26aulast%3DGatadi%26aufirst%3DSrikanth%26date%3D2019%26volume%3D92%26spage%3D103252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tong-Lin  Wang</span>, <span class="hlFld-ContribAuthor ">Hai-Tang  Qi</span>, <span class="hlFld-ContribAuthor ">Xi-Cun  Wang</span>, <span class="hlFld-ContribAuthor ">Zheng-Jun  Quan</span>. </span><span class="cited-content_cbyCitation_article-title">Iodine-catalyzed direct allylation of chiral oxazolidinones by the amide-aldehyde-alkene condensation. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2019,</strong> <em>60 </em>
                                    (37)
                                     , 150927. <a href="https://doi.org/10.1016/j.tetlet.2019.07.018" title="DOI URL">https://doi.org/10.1016/j.tetlet.2019.07.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2019.07.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2019.07.018%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DIodine-catalyzed%252Bdirect%252Ballylation%252Bof%252Bchiral%252Boxazolidinones%252Bby%252Bthe%252Bamide-aldehyde-alkene%252Bcondensation%26aulast%3DWang%26aufirst%3DTong-Lin%26date%3D2019%26volume%3D60%26issue%3D37%26spage%3D150927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Junzhen  Wu</span>, <span class="hlFld-ContribAuthor ">Hailan  Wu</span>, <span class="hlFld-ContribAuthor ">Yu  Wang</span>, <span class="hlFld-ContribAuthor ">Yuancheng  Chen</span>, <span class="hlFld-ContribAuthor ">Beining  Guo</span>, <span class="hlFld-ContribAuthor ">Guoying  Cao</span>, <span class="hlFld-ContribAuthor ">Xiaojie  Wu</span>, <span class="hlFld-ContribAuthor ">Jicheng  Yu</span>, <span class="hlFld-ContribAuthor ">Jufang  Wu</span>, <span class="hlFld-ContribAuthor ">Demei  Zhu</span>, <span class="hlFld-ContribAuthor ">Yan  Guo</span>, <span class="hlFld-ContribAuthor ">Hong  Yuan</span>, <span class="hlFld-ContribAuthor ">Fupin  Hu</span>, <span class="hlFld-ContribAuthor ">Jing  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Tolerability and Pharmacokinetics of Contezolid at Therapeutic and Supratherapeutic Doses in Healthy Chinese Subjects, and Assessment of Contezolid Dosing Regimens Based on Pharmacokinetic/Pharmacodynamic Analysis. </span><span class="cited-content_cbyCitation_journal-name">Clinical Therapeutics</span><span> <strong>2019,</strong> <em>41 </em>
                                    (6)
                                     , 1164-1174.e4. <a href="https://doi.org/10.1016/j.clinthera.2019.04.025" title="DOI URL">https://doi.org/10.1016/j.clinthera.2019.04.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.clinthera.2019.04.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.clinthera.2019.04.025%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Therapeutics%26atitle%3DTolerability%252Band%252BPharmacokinetics%252Bof%252BContezolid%252Bat%252BTherapeutic%252Band%252BSupratherapeutic%252BDoses%252Bin%252BHealthy%252BChinese%252BSubjects%25252C%252Band%252BAssessment%252Bof%252BContezolid%252BDosing%252BRegimens%252BBased%252Bon%252BPharmacokinetic%25252FPharmacodynamic%252BAnalysis%26aulast%3DWu%26aufirst%3DJunzhen%26date%3D2019%26volume%3D41%26issue%3D6%26spage%3D1164%26epage%3D1174.e4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eveline  Torfs</span>, <span class="hlFld-ContribAuthor ">Tatiana  Piller</span>, <span class="hlFld-ContribAuthor ">Paul  Cos</span>, <span class="hlFld-ContribAuthor ">Davie  Cappoen</span>. </span><span class="cited-content_cbyCitation_article-title">Opportunities for Overcoming Mycobacterium tuberculosis Drug Resistance: Emerging Mycobacterial Targets and Host-Directed Therapy. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2019,</strong> <em>20 </em>
                                    (12)
                                     , 2868. <a href="https://doi.org/10.3390/ijms20122868" title="DOI URL">https://doi.org/10.3390/ijms20122868</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms20122868&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms20122868%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DOpportunities%252Bfor%252BOvercoming%252BMycobacterium%252Btuberculosis%252BDrug%252BResistance%25253A%252BEmerging%252BMycobacterial%252BTargets%252Band%252BHost-Directed%252BTherapy%26aulast%3DTorfs%26aufirst%3DEveline%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D12%26spage%3D2868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Garima  Khare</span>, <span class="hlFld-ContribAuthor ">Prachi  Nangpal</span>, <span class="hlFld-ContribAuthor ">Anil K.  Tyagi</span>. </span><span class="cited-content_cbyCitation_article-title">Challenges and Advances in TB Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 463-495. <a href="https://doi.org/10.1007/978-981-32-9413-4_25" title="DOI URL">https://doi.org/10.1007/978-981-32-9413-4_25</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-32-9413-4_25&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-32-9413-4_25%26sid%3Dliteratum%253Aachs%26atitle%3DChallenges%252Band%252BAdvances%252Bin%252BTB%252BDrug%252BDiscovery%26aulast%3DKhare%26aufirst%3DGarima%26date%3D2019%26date%3D2019%26spage%3D463%26epage%3D495%26pub%3DSpringer%2520Singapore%26atitle%3DMycobacterium%252BTuberculosis%25253A%252BMolecular%252BInfection%252BBiology%25252C%252BPathogenesis%25252C%252BDiagnostics%252Band%252BNew%252BInterventions%26aulast%3DHasnain%26aufirst%3DSeyed%2BEhtesham%26date%3D2019%26volume%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yachuang  Wu</span>, <span class="hlFld-ContribAuthor ">Xiudong  Ding</span>, <span class="hlFld-ContribAuthor ">Liang  Ding</span>, <span class="hlFld-ContribAuthor ">Yongsheng  Zhang</span>, <span class="hlFld-ContribAuthor ">Lei  Cui</span>, <span class="hlFld-ContribAuthor ">Lu  Sun</span>, <span class="hlFld-ContribAuthor ">Wei  Li</span>, <span class="hlFld-ContribAuthor ">Di  Wang</span>, <span class="hlFld-ContribAuthor ">Yanfang  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and antibacterial activity evaluation of novel biaryloxazolidinone analogues containing a hydrazone moiety as promising antibacterial agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>158 </em>, 247-258. <a href="https://doi.org/10.1016/j.ejmech.2018.09.004" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.09.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.09.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.09.004%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bantibacterial%252Bactivity%252Bevaluation%252Bof%252Bnovel%252Bbiaryloxazolidinone%252Banalogues%252Bcontaining%252Ba%252Bhydrazone%252Bmoiety%252Bas%252Bpromising%252Bantibacterial%252Bagents%26aulast%3DWu%26aufirst%3DYachuang%26date%3D2018%26volume%3D158%26spage%3D247%26epage%3D258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nurcan  Karaman</span>, <span class="hlFld-ContribAuthor ">Rabeah  Adil Zainel</span>, <span class="hlFld-ContribAuthor ">Handan A.  Kapkaç</span>, <span class="hlFld-ContribAuthor ">Hülya  Karaca Gençer</span>, <span class="hlFld-ContribAuthor ">Sinem  Ilgın</span>, <span class="hlFld-ContribAuthor ">A. Burak  Karaduman</span>, <span class="hlFld-ContribAuthor ">Ayşegül  Karaküçük-İyidoğan</span>, <span class="hlFld-ContribAuthor ">Emine E.  Oruç-Emre</span>, <span class="hlFld-ContribAuthor ">Bedia  Koçyiğit-Kaymakçıoğlu</span>. </span><span class="cited-content_cbyCitation_article-title">Design and evaluation of biological activities of 1,3-oxazolidinone derivatives bearing amide, sulfonamide, and thiourea moieties. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2018,</strong> <em>351 </em>
                                    (9)
                                     , 1800057. <a href="https://doi.org/10.1002/ardp.201800057" title="DOI URL">https://doi.org/10.1002/ardp.201800057</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201800057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201800057%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DDesign%252Band%252Bevaluation%252Bof%252Bbiological%252Bactivities%252Bof%252B1%25252C3-oxazolidinone%252Bderivatives%252Bbearing%252Bamide%25252C%252Bsulfonamide%25252C%252Band%252Bthiourea%252Bmoieties%26aulast%3DKaraman%26aufirst%3DNurcan%26date%3D2018%26date%3D2018%26volume%3D351%26issue%3D9%26spage%3D1800057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">L J  Farrell</span>, <span class="hlFld-ContribAuthor ">R  Lo</span>, <span class="hlFld-ContribAuthor ">J J  Wanford</span>, <span class="hlFld-ContribAuthor ">A  Jenkins</span>, <span class="hlFld-ContribAuthor ">A  Maxwell</span>, <span class="hlFld-ContribAuthor ">L J V  Piddock</span>. </span><span class="cited-content_cbyCitation_article-title">Revitalizing the drug pipeline: AntibioticDB, an open access database to aid antibacterial research and development. </span><span class="cited-content_cbyCitation_journal-name">Journal of Antimicrobial Chemotherapy</span><span> <strong>2018,</strong> <em>73 </em>
                                    (9)
                                     , 2284-2297. <a href="https://doi.org/10.1093/jac/dky208" title="DOI URL">https://doi.org/10.1093/jac/dky208</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/jac/dky208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fjac%2Fdky208%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Antimicrobial%2520Chemotherapy%26atitle%3DRevitalizing%252Bthe%252Bdrug%252Bpipeline%25253A%252BAntibioticDB%25252C%252Ban%252Bopen%252Baccess%252Bdatabase%252Bto%252Baid%252Bantibacterial%252Bresearch%252Band%252Bdevelopment%26aulast%3DFarrell%26aufirst%3DL%2BJ%26date%3D2018%26date%3D2018%26volume%3D73%26issue%3D9%26spage%3D2284%26epage%3D2297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carolyn  Shoen</span>, <span class="hlFld-ContribAuthor ">Michelle  DeStefano</span>, <span class="hlFld-ContribAuthor ">Barry  Hafkin</span>, <span class="hlFld-ContribAuthor ">Michael  Cynamon</span>. </span><span class="cited-content_cbyCitation_article-title">In Vitro
              and
              In Vivo
              Activities of Contezolid (MRX-I) against Mycobacterium tuberculosis. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2018,</strong> <em>62 </em>
                                    (8)
                                     <a href="https://doi.org/10.1128/AAC.00493-18" title="DOI URL">https://doi.org/10.1128/AAC.00493-18</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.00493-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.00493-18%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DIn%252BVitro%252Band%252BIn%252BVivo%252BActivities%252Bof%252BContezolid%252B%252528MRX-I%252529%252Bagainst%252BMycobacterium%252Btuberculosis%26aulast%3DShoen%26aufirst%3DCarolyn%26date%3D2018%26volume%3D62%26issue%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Esteban  Matador</span>, <span class="hlFld-ContribAuthor ">María  de Gracia Retamosa</span>, <span class="hlFld-ContribAuthor ">David  Monge</span>, <span class="hlFld-ContribAuthor ">Javier  Iglesias-Sigüenza</span>, <span class="hlFld-ContribAuthor ">Rosario  Fernández</span>, <span class="hlFld-ContribAuthor ">José M.  Lassaletta</span>. </span><span class="cited-content_cbyCitation_article-title">Bifunctional Squaramide Organocatalysts for the Asymmetric Addition of Formaldehyde
              tert-
              Butylhydrazone to Simple Aldehydes. </span><span class="cited-content_cbyCitation_journal-name">Chemistry - A European Journal</span><span> <strong>2018,</strong> <em>24 </em>
                                    (26)
                                     , 6854-6860. <a href="https://doi.org/10.1002/chem.201801052" title="DOI URL">https://doi.org/10.1002/chem.201801052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201801052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201801052%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520A%2520European%2520Journal%26atitle%3DBifunctional%252BSquaramide%252BOrganocatalysts%252Bfor%252Bthe%252BAsymmetric%252BAddition%252Bof%252BFormaldehyde%252Btert-%252BButylhydrazone%252Bto%252BSimple%252BAldehydes%26aulast%3DMatador%26aufirst%3DEsteban%26date%3D2018%26date%3D2018%26volume%3D24%26issue%3D26%26spage%3D6854%26epage%3D6860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaojie  Wu</span>, <span class="hlFld-ContribAuthor ">Yunfei  Li</span>, <span class="hlFld-ContribAuthor ">Jing  Zhang</span>, <span class="hlFld-ContribAuthor ">Yingyuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Jicheng  Yu</span>, <span class="hlFld-ContribAuthor ">Guoying  Cao</span>, <span class="hlFld-ContribAuthor ">Yuancheng  Chen</span>, <span class="hlFld-ContribAuthor ">Beining  Guo</span>, <span class="hlFld-ContribAuthor ">Yaoguo  Shi</span>, <span class="hlFld-ContribAuthor ">Jun  Huang</span>, <span class="hlFld-ContribAuthor ">Yuran  Cao</span>, <span class="hlFld-ContribAuthor ">Xiaofang  Liu</span>, <span class="hlFld-ContribAuthor ">Jufang  Wu</span>, <span class="hlFld-ContribAuthor ">Mikhail Fedorovich  Gordeev</span>, <span class="hlFld-ContribAuthor ">Hong  Yuan</span>, <span class="hlFld-ContribAuthor ">Wen  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Short-term Safety, Tolerability, and Pharmacokinetics of MRX-I, an Oxazolidinone Antibacterial Agent, in Healthy Chinese Subjects. </span><span class="cited-content_cbyCitation_journal-name">Clinical Therapeutics</span><span> <strong>2018,</strong> <em>40 </em>
                                    (2)
                                     , 322-332.e5. <a href="https://doi.org/10.1016/j.clinthera.2017.12.017" title="DOI URL">https://doi.org/10.1016/j.clinthera.2017.12.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.clinthera.2017.12.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.clinthera.2017.12.017%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Therapeutics%26atitle%3DShort-term%252BSafety%25252C%252BTolerability%25252C%252Band%252BPharmacokinetics%252Bof%252BMRX-I%25252C%252Ban%252BOxazolidinone%252BAntibacterial%252BAgent%25252C%252Bin%252BHealthy%252BChinese%252BSubjects%26aulast%3DWu%26aufirst%3DXiaojie%26date%3D2018%26volume%3D40%26issue%3D2%26spage%3D322%26epage%3D332.e5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manjulika  Shukla</span>, <span class="hlFld-ContribAuthor ">Isha  Soni</span>, <span class="hlFld-ContribAuthor ">Arunava  Dasgupta</span>, <span class="hlFld-ContribAuthor ">Sidharth  Chopra</span>. </span><span class="cited-content_cbyCitation_article-title">Drugs Under Preclinical and Clinical Testing for the Treatment of Infections Caused due to Staphylococcus aureus: An Update. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 239-255. <a href="https://doi.org/10.1007/978-981-13-1577-0_13" title="DOI URL">https://doi.org/10.1007/978-981-13-1577-0_13</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-13-1577-0_13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-13-1577-0_13%26sid%3Dliteratum%253Aachs%26atitle%3DDrugs%252BUnder%252BPreclinical%252Band%252BClinical%252BTesting%252Bfor%252Bthe%252BTreatment%252Bof%252BInfections%252BCaused%252Bdue%252Bto%252BStaphylococcus%252Baureus%25253A%252BAn%252BUpdate%26aulast%3DShukla%26aufirst%3DManjulika%26date%3D2018%26date%3D2018%26spage%3D239%26epage%3D255%26pub%3DSpringer%2520Singapore%26atitle%3DInfectious%252BDiseases%252Band%252BYour%252BHealth%26aulast%3DSingh%26aufirst%3DPrati%2BPal%26date%3D2018%26volume%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ayaan  Saleem</span>, <span class="hlFld-ContribAuthor ">Paulina A.  Kobielska</span>, <span class="hlFld-ContribAuthor ">Klaus  Harms</span>, <span class="hlFld-ContribAuthor ">Maria G.  Katsikogianni</span>, <span class="hlFld-ContribAuthor ">Richard  Telford</span>, <span class="hlFld-ContribAuthor ">Ghenadie  Novitchi</span>, <span class="hlFld-ContribAuthor ">Sanjit  Nayak</span>. </span><span class="cited-content_cbyCitation_article-title">Transition metal complexes of a versatile polyalkoxy oxazolidine-based ligand derived from
              in situ
              cyclization. </span><span class="cited-content_cbyCitation_journal-name">Dalton Transactions</span><span> <strong>2018,</strong> <em>47 </em>
                                    (17)
                                     , 6156-6165. <a href="https://doi.org/10.1039/C7DT04634K" title="DOI URL">https://doi.org/10.1039/C7DT04634K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7DT04634K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7DT04634K%26sid%3Dliteratum%253Aachs%26jtitle%3DDalton%2520Transactions%26atitle%3DTransition%252Bmetal%252Bcomplexes%252Bof%252Ba%252Bversatile%252Bpolyalkoxy%252Boxazolidine-based%252Bligand%252Bderived%252Bfrom%252Bin%252Bsitu%252Bcyclization%26aulast%3DSaleem%26aufirst%3DAyaan%26date%3D2018%26date%3D2018%26volume%3D47%26issue%3D17%26spage%3D6156%26epage%3D6165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew  Spaulding</span>, <span class="hlFld-ContribAuthor ">Khuloud  Takrouri</span>, <span class="hlFld-ContribAuthor ">Pornachandran  Mahalingam</span>, <span class="hlFld-ContribAuthor ">Dillon C.  Cleary</span>, <span class="hlFld-ContribAuthor ">Harold D.  Cooper</span>, <span class="hlFld-ContribAuthor ">Paola  Zucchi</span>, <span class="hlFld-ContribAuthor ">Westley  Tear</span>, <span class="hlFld-ContribAuthor ">Bilyana  Koleva</span>, <span class="hlFld-ContribAuthor ">Penny J.  Beuning</span>, <span class="hlFld-ContribAuthor ">Elizabeth B.  Hirsch</span>, <span class="hlFld-ContribAuthor ">James B.  Aggen</span>. </span><span class="cited-content_cbyCitation_article-title">Compound design guidelines for evading the efflux and permeation barriers of Escherichia coli with the oxazolidinone class of antibacterials: Test case for a general approach to improving whole cell Gram-negative activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (23)
                                     , 5310-5321. <a href="https://doi.org/10.1016/j.bmcl.2017.10.018" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.10.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.10.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.10.018%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DCompound%252Bdesign%252Bguidelines%252Bfor%252Bevading%252Bthe%252Befflux%252Band%252Bpermeation%252Bbarriers%252Bof%252BEscherichia%252Bcoli%252Bwith%252Bthe%252Boxazolidinone%252Bclass%252Bof%252Bantibacterials%25253A%252BTest%252Bcase%252Bfor%252Ba%252Bgeneral%252Bapproach%252Bto%252Bimproving%252Bwhole%252Bcell%252BGram-negative%252Bactivity%26aulast%3DSpaulding%26aufirst%3DAndrew%26date%3D2017%26volume%3D27%26issue%3D23%26spage%3D5310%26epage%3D5321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adamantia  Liapikou</span>, <span class="hlFld-ContribAuthor ">Catia  Cillóniz</span>, <span class="hlFld-ContribAuthor ">Antoni  Torres</span>. </span><span class="cited-content_cbyCitation_article-title">Investigational drugs in phase I and phase II clinical trials for the treatment of community-acquired pneumonia. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2017,</strong> <em>26 </em>
                                    (11)
                                     , 1239-1248. <a href="https://doi.org/10.1080/13543784.2017.1385761" title="DOI URL">https://doi.org/10.1080/13543784.2017.1385761</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543784.2017.1385761&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543784.2017.1385761%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DInvestigational%252Bdrugs%252Bin%252Bphase%252BI%252Band%252Bphase%252BII%252Bclinical%252Btrials%252Bfor%252Bthe%252Btreatment%252Bof%252Bcommunity-acquired%252Bpneumonia%26aulast%3DLiapikou%26aufirst%3DAdamantia%26date%3D2017%26date%3D2017%26volume%3D26%26issue%3D11%26spage%3D1239%26epage%3D1248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul B.  Eckburg</span>, <span class="hlFld-ContribAuthor ">Yigong  Ge</span>, <span class="hlFld-ContribAuthor ">Barry  Hafkin</span>. </span><span class="cited-content_cbyCitation_article-title">Single- and Multiple-Dose Study To Determine the Safety, Tolerability, Pharmacokinetics, and Food Effect of Oral MRX-I versus Linezolid in Healthy Adult Subjects. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2017,</strong> <em>61 </em>
                                    (4)
                                     <a href="https://doi.org/10.1128/AAC.02181-16" title="DOI URL">https://doi.org/10.1128/AAC.02181-16</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.02181-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.02181-16%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DSingle-%252Band%252BMultiple-Dose%252BStudy%252BTo%252BDetermine%252Bthe%252BSafety%25252C%252BTolerability%25252C%252BPharmacokinetics%25252C%252Band%252BFood%252BEffect%252Bof%252BOral%252BMRX-I%252Bversus%252BLinezolid%252Bin%252BHealthy%252BAdult%252BSubjects%26aulast%3DEckburg%26aufirst%3DPaul%2BB.%26date%3D2017%26volume%3D61%26issue%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark S  Butler</span>, <span class="hlFld-ContribAuthor ">Mark AT  Blaskovich</span>, <span class="hlFld-ContribAuthor ">Matthew A  Cooper</span>. </span><span class="cited-content_cbyCitation_article-title">Antibiotics in the clinical pipeline at the end of 2015. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Antibiotics</span><span> <strong>2017,</strong> <em>70 </em>
                                    (1)
                                     , 3-24. <a href="https://doi.org/10.1038/ja.2016.72" title="DOI URL">https://doi.org/10.1038/ja.2016.72</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/ja.2016.72&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fja.2016.72%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Antibiotics%26atitle%3DAntibiotics%252Bin%252Bthe%252Bclinical%252Bpipeline%252Bat%252Bthe%252Bend%252Bof%252B2015%26aulast%3DButler%26aufirst%3DMark%2BS%26date%3D2017%26date%3D2016%26volume%3D70%26issue%3D1%26spage%3D3%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dario  Cattaneo</span>, <span class="hlFld-ContribAuthor ">Jan-Willem  Alffenaar</span>, <span class="hlFld-ContribAuthor ">Michael  Neely</span>. </span><span class="cited-content_cbyCitation_article-title">Drug monitoring and individual dose optimization of antimicrobial drugs: oxazolidinones. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Metabolism & Toxicology</span><span> <strong>2016,</strong> <em>12 </em>
                                    (5)
                                     , 533-544. <a href="https://doi.org/10.1517/17425255.2016.1166204" title="DOI URL">https://doi.org/10.1517/17425255.2016.1166204</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/17425255.2016.1166204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F17425255.2016.1166204%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Metabolism%2520%2526%2520Toxicology%26atitle%3DDrug%252Bmonitoring%252Band%252Bindividual%252Bdose%252Boptimization%252Bof%252Bantimicrobial%252Bdrugs%25253A%252Boxazolidinones%26aulast%3DCattaneo%26aufirst%3DDario%26date%3D2016%26date%3D2016%26volume%3D12%26issue%3D5%26spage%3D533%26epage%3D544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cuong  Vuong</span>, <span class="hlFld-ContribAuthor ">Anthony J.  Yeh</span>, <span class="hlFld-ContribAuthor ">Gordon YC  Cheung</span>, <span class="hlFld-ContribAuthor ">Michael  Otto</span>. </span><span class="cited-content_cbyCitation_article-title">Investigational drugs to treat methicillin-resistant
              Staphylococcus aureus. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2016,</strong> <em>25 </em>
                                    (1)
                                     , 73-93. <a href="https://doi.org/10.1517/13543784.2016.1109077" title="DOI URL">https://doi.org/10.1517/13543784.2016.1109077</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543784.2016.1109077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543784.2016.1109077%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DInvestigational%252Bdrugs%252Bto%252Btreat%252Bmethicillin-resistant%252BStaphylococcus%252Baureus%26aulast%3DVuong%26aufirst%3DCuong%26date%3D2016%26date%3D2015%26volume%3D25%26issue%3D1%26spage%3D73%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jesse A.  Jones</span>, <span class="hlFld-ContribAuthor ">Kristopher G.  Virga</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Gumina</span>, <span class="hlFld-ContribAuthor ">Kirk E.  Hevener</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the rational design and optimization of antibacterial agents. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2016,</strong> <em>7 </em>
                                    (9)
                                     , 1694-1715. <a href="https://doi.org/10.1039/C6MD00232C" title="DOI URL">https://doi.org/10.1039/C6MD00232C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6MD00232C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6MD00232C%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Brational%252Bdesign%252Band%252Boptimization%252Bof%252Bantibacterial%252Bagents%26aulast%3DJones%26aufirst%3DJesse%2BA.%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D9%26spage%3D1694%26epage%3D1715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanfang  Zhao</span>, <span class="hlFld-ContribAuthor ">Mingyan  Jiang</span>, <span class="hlFld-ContribAuthor ">Shunguang  Zhou</span>, <span class="hlFld-ContribAuthor ">Shasha  Wu</span>, <span class="hlFld-ContribAuthor ">Xiaolong  Zhang</span>, <span class="hlFld-ContribAuthor ">Longsheng  Ma</span>, <span class="hlFld-ContribAuthor ">Kai  Zhang</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and structure–activity relationship of oxazolidinone derivatives containing novel S4 ligand as FXa inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>96 </em>, 369-380. <a href="https://doi.org/10.1016/j.ejmech.2015.04.025" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.04.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.04.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.04.025%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bstructure%2525E2%252580%252593activity%252Brelationship%252Bof%252Boxazolidinone%252Bderivatives%252Bcontaining%252Bnovel%252BS4%252Bligand%252Bas%252BFXa%252Binhibitors%26aulast%3DZhao%26aufirst%3DYanfang%26date%3D2015%26volume%3D96%26spage%3D369%26epage%3D380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jian  Meng</span>, <span class="hlFld-ContribAuthor ">Dafang  Zhong</span>, <span class="hlFld-ContribAuthor ">Liang  Li</span>, <span class="hlFld-ContribAuthor ">Zhengyu  Yuan</span>, <span class="hlFld-ContribAuthor ">Hong  Yuan</span>, <span class="hlFld-ContribAuthor ">Cen  Xie</span>, <span class="hlFld-ContribAuthor ">Jialan  Zhou</span>, <span class="hlFld-ContribAuthor ">Chen  Li</span>, <span class="hlFld-ContribAuthor ">Mikhail Fedorovich  Gordeev</span>, <span class="hlFld-ContribAuthor ">Jinqian  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaoyan  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolism of MRX-I, a Novel Antibacterial Oxazolidinone, in Humans: The Oxidative Ring Opening of 2,3-Dihydropyridin-4-One Catalyzed by Non-P450 Enzymes. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism and Disposition</span><span> <strong>2015,</strong> <em>43 </em>
                                    (5)
                                     , 646-659. <a href="https://doi.org/10.1124/dmd.114.061747" title="DOI URL">https://doi.org/10.1124/dmd.114.061747</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/dmd.114.061747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fdmd.114.061747%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520and%2520Disposition%26atitle%3DMetabolism%252Bof%252BMRX-I%25252C%252Ba%252BNovel%252BAntibacterial%252BOxazolidinone%25252C%252Bin%252BHumans%25253A%252BThe%252BOxidative%252BRing%252BOpening%252Bof%252B2%25252C3-Dihydropyridin-4-One%252BCatalyzed%252Bby%252BNon-P450%252BEnzymes%26aulast%3DMeng%26aufirst%3DJian%26date%3D2015%26date%3D2015%26volume%3D43%26issue%3D5%26spage%3D646%26epage%3D659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lili  Yan</span>, <span class="hlFld-ContribAuthor ">Jingjing  Wu</span>, <span class="hlFld-ContribAuthor ">Heng  Chen</span>, <span class="hlFld-ContribAuthor ">Shaowu  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhi  Wang</span>, <span class="hlFld-ContribAuthor ">Hui  Wang</span>, <span class="hlFld-ContribAuthor ">Fanhong  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and in vitro antibacterial activity of novel fluoroalkyl-substituted pyrazolyl oxazolidinones. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2015,</strong> <em>5 </em>
                                    (90)
                                     , 73660-73669. <a href="https://doi.org/10.1039/C5RA11782H" title="DOI URL">https://doi.org/10.1039/C5RA11782H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5RA11782H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5RA11782H%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DSynthesis%252Band%252Bin%252Bvitro%252Bantibacterial%252Bactivity%252Bof%252Bnovel%252Bfluoroalkyl-substituted%252Bpyrazolyl%252Boxazolidinones%26aulast%3DYan%26aufirst%3DLili%26date%3D2015%26date%3D2015%26volume%3D5%26issue%3D90%26spage%3D73660%26epage%3D73669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arianna  Greco</span>, <span class="hlFld-ContribAuthor ">Rossella  De Marco</span>, <span class="hlFld-ContribAuthor ">Sara  Tani</span>, <span class="hlFld-ContribAuthor ">Daria  Giacomini</span>, <span class="hlFld-ContribAuthor ">Paola  Galletti</span>, <span class="hlFld-ContribAuthor ">Alessandra  Tolomelli</span>, <span class="hlFld-ContribAuthor ">Eusebio  Juaristi</span>, <span class="hlFld-ContribAuthor ">Luca  Gentilucci</span>. </span><span class="cited-content_cbyCitation_article-title">Convenient Synthesis of the Antibiotic Linezolid via an Oxazolidine-2,4-dione Intermediate Derived from the Chiral Building Block Isoserine. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2014,</strong> <em>2014 </em>
                                    (34)
                                     , 7614-7620. <a href="https://doi.org/10.1002/ejoc.201402888" title="DOI URL">https://doi.org/10.1002/ejoc.201402888</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201402888&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201402888%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DConvenient%252BSynthesis%252Bof%252Bthe%252BAntibiotic%252BLinezolid%252Bvia%252Ban%252BOxazolidine-2%25252C4-dione%252BIntermediate%252BDerived%252Bfrom%252Bthe%252BChiral%252BBuilding%252BBlock%252BIsoserine%26aulast%3DGreco%26aufirst%3DArianna%26date%3D2014%26date%3D2014%26volume%3D2014%26issue%3D34%26spage%3D7614%26epage%3D7620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wanida  Phetsang</span>, <span class="hlFld-ContribAuthor ">Mark A.T.  Blaskovich</span>, <span class="hlFld-ContribAuthor ">Mark S.  Butler</span>, <span class="hlFld-ContribAuthor ">Johnny X.  Huang</span>, <span class="hlFld-ContribAuthor ">Johannes  Zuegg</span>, <span class="hlFld-ContribAuthor ">Sreeman K.  Mamidyala</span>, <span class="hlFld-ContribAuthor ">Soumya  Ramu</span>, <span class="hlFld-ContribAuthor ">Angela M.  Kavanagh</span>, <span class="hlFld-ContribAuthor ">Matthew A.  Cooper</span>. </span><span class="cited-content_cbyCitation_article-title">An azido-oxazolidinone antibiotic for live bacterial cell imaging and generation of antibiotic variants. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2014,</strong> <em>22 </em>
                                    (16)
                                     , 4490-4498. <a href="https://doi.org/10.1016/j.bmc.2014.05.054" title="DOI URL">https://doi.org/10.1016/j.bmc.2014.05.054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2014.05.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2014.05.054%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DAn%252Bazido-oxazolidinone%252Bantibiotic%252Bfor%252Blive%252Bbacterial%252Bcell%252Bimaging%252Band%252Bgeneration%252Bof%252Bantibiotic%252Bvariants%26aulast%3DPhetsang%26aufirst%3DWanida%26date%3D2014%26volume%3D22%26issue%3D16%26spage%3D4490%26epage%3D4498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria  Krutikov</span>, <span class="hlFld-ContribAuthor ">Judith  Bruchfeld</span>, <span class="hlFld-ContribAuthor ">Giovanni Battista  Migliori</span>, <span class="hlFld-ContribAuthor ">Sergey  Borisov</span>, <span class="hlFld-ContribAuthor ">Simon  Tiberi</span>. </span><span class="cited-content_cbyCitation_article-title">New and repurposed drugs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>,</strong>,, 179-204. <a href="https://doi.org/10.1183/2312508X.10021517" title="DOI URL">https://doi.org/10.1183/2312508X.10021517</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1183/2312508X.10021517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1183%2F2312508X.10021517%26sid%3Dliteratum%253Aachs%26atitle%3DNew%252Band%252Brepurposed%252Bdrugs%26aulast%3DKrutikov%26aufirst%3DMaria%26spage%3D179%26epage%3D204%26pub%3DEuropean%2520Respiratory%2520Society%26atitle%3DTuberculosis%26aulast%3DMigliori%26aufirst%3DGiovanni%2BBattista%26date%3D2018%26volume%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401931e/production/images/medium/jm-2013-01931e_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401931e/production/images/large/jm-2013-01931e_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401931e&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401931e/production/images/medium/jm-2013-01931e_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401931e/production/images/large/jm-2013-01931e_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Linezolid and the new clinical agent, (<i>S</i>)-5-((isoxazol-3-ylamino)methyl)-3-(2,3,5-trifluoro-4-(4-oxo-3,4-dihydropyridin-1(2<i>H</i>)-yl)phenyl)oxazolidin-2-one.<a onclick="showRef(event, 'cit23a'); return false;" href="javascript:void(0);" class="ref cit23a">(23a)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401931e/production/images/large/jm-2013-01931e_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401931e&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401931e/production/images/medium/jm-2013-01931e_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401931e/production/images/large/jm-2013-01931e_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. General structures for trifluorophenyl oxazolidinones of Barbachyn<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and the advanced lead<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> of this series.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401931e/production/images/large/jm-2013-01931e_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401931e&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401931e/production/images/medium/jm-2013-01931e_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401931e/production/images/large/jm-2013-01931e_0004.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Representative Synthesis of Dihydropyridone Oxazolidinones Derivatives: The First Preparation of the New Clinical Agent<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401931e/production/images/large/jm-2013-01931e_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401931e&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) piperidine-4-one hydrochloride, DIEA, NMP, −5 °C to rt, 90%; (ii) trimethylsilyl triflate, TEA, THF, 0 °C to rt, 98%; (iii) allyl methyl carbonate, Pd(OAc)<sub>2</sub>, DMSO, 60 °C, 95%; (iv) Fe, NH<sub>4</sub>Cl, aq EtOH, 100 °C, 95%; (v) isobutyl chloroformate, Py, DCM, 0 °C to rt, 82%; (vi) (<i>R</i>)-oxiran-2-ylmethyl butyrate, LiOBu-t, THF, MeCN, 0 °C to rt, 74%; (vii) MsCl, TEA, DCM, rt, 90%; (viii) <i>tert</i>-butyl isoxazole-3-ylcarbamate, KOBu-t, DMF, rt, 75%; (ix) aq HCl, EtOH, EtOAc, rt, 80%</p></p></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401931e/production/images/medium/jm-2013-01931e_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401931e/production/images/large/jm-2013-01931e_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Hematology for compound <b>7</b> in the human multiple oral dose study: platelet and reticulocyte markers of the myelosuppression toxicity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401931e/production/images/large/jm-2013-01931e_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401931e&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i30">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88660" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88660" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 38 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Rich, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritterhoff, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, R.J. M.D.</span><span> </span><span class="NLM_article-title">A fatal case of aplastic anemia following chloramphenicol (chloromycetin) therapy</span> <span class="citation_source-journal">Ann. Int. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1950</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1459</span><span class="NLM_x">–</span> <span class="NLM_lpage">1467</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm401931e&amp;key=10.7326%2F0003-4819-33-6-1459" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm401931e&amp;key=14790529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm401931e&amp;key=1%3ACAS%3A280%3ADyaG3M%252FitVSkuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1950&pages=1459-1467&author=M.+L.+Richauthor=R.+J.+Ritterhoffauthor=R.J.+M.D.+Hoffmann&title=A+fatal+case+of+aplastic+anemia+following+chloramphenicol+%28chloromycetin%29+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">A fatal case of aplastic anemia following chloramphenicol (chloromycetin) therapy</span></div><div class="casAuthors">RICH M L; RITTERHOFF R J; HOFFMANN R J</div><div class="citationInfo"><span class="NLM_cas:title">Annals of internal medicine</span>
        (<span class="NLM_cas:date">1950</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1459-67</span>
        ISSN:<span class="NLM_cas:issn">0003-4819</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCwygu9vnLPMuCWE5mhx1RfW6udTcc2eYeHPgLYnuME7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaG3M%252FitVSkuw%253D%253D&md5=afb77b43213d214e70aa5987e77cc620</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.7326%2F0003-4819-33-6-1459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7326%252F0003-4819-33-6-1459%26sid%3Dliteratum%253Aachs%26aulast%3DRich%26aufirst%3DM.%2BL.%26aulast%3DRitterhoff%26aufirst%3DR.%2BJ.%26aulast%3DHoffmann%26aufirst%3DR.J.%2BM.D.%26atitle%3DA%2520fatal%2520case%2520of%2520aplastic%2520anemia%2520following%2520chloramphenicol%2520%2528chloromycetin%2529%2520therapy%26jtitle%3DAnn.%2520Int.%2520Med.%26date%3D1950%26volume%3D33%26spage%3D1459%26epage%3D1467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kux, L.</span><span> </span><span class="NLM_article-title">Determination that chloromycetin (chloramphenicol) capsules, 250 mg, were withdrawn from sale for reasons of safety or effectiveness</span>.  <span class="citation_source-journal">Fed. Regist. Not.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span>, Friday, <span class="NLM_month">July</span><span class="NLM_day">13</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2012&author=L.+Kux&title=Determination+that+chloromycetin+%28chloramphenicol%29+capsules%2C+250+mg%2C+were+withdrawn+from+sale+for+reasons+of+safety+or+effectiveness"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKux%26aufirst%3DL.%26atitle%3DDetermination%2520that%2520chloromycetin%2520%2528chloramphenicol%2529%2520capsules%252C%2520250%2520mg%252C%2520were%2520withdrawn%2520from%2520sale%2520for%2520reasons%2520of%2520safety%2520or%2520effectiveness%26jtitle%3DFed.%2520Regist.%2520Not.%26date%3D2012%26volume%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Ross, D. B.</span><span> </span><span class="NLM_article-title">The FDA and the case of Ketek</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">356</span><span class="NLM_x">, </span> <span class="NLM_fpage">1601</span><span class="NLM_x">–</span> <span class="NLM_lpage">1604</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm401931e&amp;key=10.1056%2FNEJMp078032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm401931e&amp;key=17442902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm401931e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksFCgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=2007&pages=1601-1604&author=D.+B.+Ross&title=The+FDA+and+the+case+of+Ketek"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Perspective: the FDA and the case of Ketek</span></div><div class="casAuthors">Ross, David B.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">356</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1601-1604</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxg3oJZMs06LVg90H21EOLACvtfcHk0liQMuI6pyeDFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksFCgtb4%253D&md5=f077976e1f2d38a66f7730fe4e6fb184</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1056%2FNEJMp078032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMp078032%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DD.%2BB.%26atitle%3DThe%2520FDA%2520and%2520the%2520case%2520of%2520Ketek%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2007%26volume%3D356%26spage%3D1601%26epage%3D1604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Paul A Dieppe, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebrahim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jüni, P.</span><span> </span><span class="NLM_article-title">Lessons from the withdrawal of rofecoxib</span> <span class="citation_source-journal">Br. Med. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">329</span><span class="NLM_x">, </span> <span class="NLM_fpage">867</span><span class="NLM_x">–</span> <span class="NLM_lpage">868</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm401931e&amp;key=10.1136%2Fbmj.329.7471.867" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=2004&pages=867-868&author=P.+A.+Paul+A+Dieppeauthor=S.+Ebrahimauthor=P.+J%C3%BCni&title=Lessons+from+the+withdrawal+of+rofecoxib"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1136%2Fbmj.329.7471.867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbmj.329.7471.867%26sid%3Dliteratum%253Aachs%26aulast%3DPaul%2BA%2BDieppe%26aufirst%3DP.%2BA.%26aulast%3DEbrahim%26aufirst%3DS.%26aulast%3DJ%25C3%25BCni%26aufirst%3DP.%26atitle%3DLessons%2520from%2520the%2520withdrawal%2520of%2520rofecoxib%26jtitle%3DBr.%2520Med.%2520J.%26date%3D2004%26volume%3D329%26spage%3D867%26epage%3D868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span>FDA’s Sentinel Initiative; <span class="NLM_publisher-name">U.S. Food and Drug Administration</span>: <span class="NLM_publisher-loc">Silver Spring, MD</span>; <a href="http://www.fda.gov/Safety/FDAsSentinelinitiative/ucm2007250.htm" class="extLink">http://www.fda.gov/Safety/FDAsSentinelinitiative/ucm2007250.htm</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=FDA%E2%80%99s+Sentinel+Initiative%3B+U.S.+Food+and+Drug+Administration%3A+Silver+Spring%2C+MD%3B+http%3A%2F%2Fwww.fda.gov%2FSafety%2FFDAsSentinelinitiative%2Fucm2007250.htm."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DFDA%25E2%2580%2599s%2520Sentinel%2520Initiative%26pub%3DU.S.%2520Food%2520and%2520Drug%2520Administration" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ford, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zurenko, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbachyn, M. R.</span><span> </span><span class="NLM_article-title">The discovery of linezolid, the first oxazolidinone antibacterial agent</span> <span class="citation_source-journal">Curr. Drug Targets Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">199</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm401931e&amp;key=10.2174%2F1568005014606099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm401931e&amp;key=12455414" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&pages=181-199&author=C.+W.+Fordauthor=G.+E.+Zurenkoauthor=M.+R.+Barbachyn&title=The+discovery+of+linezolid%2C+the+first+oxazolidinone+antibacterial+agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.2174%2F1568005014606099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568005014606099%26sid%3Dliteratum%253Aachs%26aulast%3DFord%26aufirst%3DC.%2BW.%26aulast%3DZurenko%26aufirst%3DG.%2BE.%26aulast%3DBarbachyn%26aufirst%3DM.%2BR.%26atitle%3DThe%2520discovery%2520of%2520linezolid%252C%2520the%2520first%2520oxazolidinone%2520antibacterial%2520agent%26jtitle%3DCurr.%2520Drug%2520Targets%2520Infect.%2520Dis.%26date%3D2001%26spage%3D181%26epage%3D199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Brickner, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbachyn, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manninen, P. R.</span><span> </span><span class="NLM_article-title">Linezolid (Zyvox), the first member of a completely new class of antibacterial agents for treatment of serious Gram-positive infections</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1981</span><span class="NLM_x">–</span> <span class="NLM_lpage">1990</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800038g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1981-1990&author=S.+J.+Bricknerauthor=M.+R.+Barbachynauthor=D.+K.+Hutchinsonauthor=P.+R.+Manninen&title=Linezolid+%28Zyvox%29%2C+the+first+member+of+a+completely+new+class+of+antibacterial+agents+for+treatment+of+serious+Gram-positive+infections"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1021%2Fjm800038g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800038g%26sid%3Dliteratum%253Aachs%26aulast%3DBrickner%26aufirst%3DS.%2BJ.%26aulast%3DBarbachyn%26aufirst%3DM.%2BR.%26aulast%3DHutchinson%26aufirst%3DD.%2BK.%26aulast%3DManninen%26aufirst%3DP.%2BR.%26atitle%3DLinezolid%2520%2528Zyvox%2529%252C%2520the%2520first%2520member%2520of%2520a%2520completely%2520new%2520class%2520of%2520antibacterial%2520agents%2520for%2520treatment%2520of%2520serious%2520Gram-positive%2520infections%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1981%26epage%3D1990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Shinabarger, D.</span><span> </span><span class="NLM_article-title">Mechanism of action of the oxazolidinone antibacterial agents</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1195</span><span class="NLM_x">–</span> <span class="NLM_lpage">1202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm401931e&amp;key=10.1517%2F13543784.8.8.1195" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm401931e&amp;key=15992144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm401931e&amp;key=1%3ACAS%3A528%3ADyaK1MXltFGgsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1999&pages=1195-1202&author=D.+Shinabarger&title=Mechanism+of+action+of+the+oxazolidinone+antibacterial+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of action of the oxazolidinone antibacterial agents</span></div><div class="casAuthors">Shinabarger, Dean</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1195-1202</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications</span>)
        </div><div class="casAbstract">A review with 32 refs.  Oxazolidinones represent a new class of synthetic antibacterial agents active against multiply-resistant Gram-pos. pathogens, including methicillin-resistant Staphylococcus aureus (MRSA), penicillin-resistant streptococci and vancomycin-resistant enterococci.  Eperezolid and linezolid are two novel analogs, which have resp. completed Phase I and Phase II clin. testing.  The lack of cross-resistance between oxazolidinones and other antibiotics supports a novel mechanism of action.  Oxazolidinones are protein synthesis inhibitors which target an early step involving the binding of N-formylmethionyl-tRNA to the ribosome.  Binding studies demonstrate that these agents interact with the 50S subunit, but not the 30S subunit of the ribosome.  Crosslinking expts. provide evidence for an interaction with both the 16S rRNA of the small subunit and the 23S rRNA of the large subunit.  Development of resistance in the lab. is slow, resulting in two independently isolated point mutations at G2447U and G2576U of the 23S rRNA.  This review discusses the results of published studies involving oxazolidinone mechanism of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKfanYf7ZBSLVg90H21EOLACvtfcHk0lgVSYzlI7QYIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltFGgsrs%253D&md5=1d77f29c48f50440e68559c712ddc984</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1517%2F13543784.8.8.1195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.8.8.1195%26sid%3Dliteratum%253Aachs%26aulast%3DShinabarger%26aufirst%3DD.%26atitle%3DMechanism%2520of%2520action%2520of%2520the%2520oxazolidinone%2520antibacterial%2520agents%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D1999%26volume%3D8%26spage%3D1195%26epage%3D1202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Jones, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Utsuki, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fumiaki, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turnidge, J. D.</span><span> </span><span class="NLM_article-title">Zyvox annual appraisal of potency and spectrum program: linezolid surveillance program results for 2008</span> <span class="citation_source-journal">Diagn. Microb. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">404</span><span class="NLM_x">–</span> <span class="NLM_lpage">413</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Fjm401931e&amp;key=10.1016%2Fj.diagmicrobio.2009.10.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Fjm401931e&amp;key=19913683" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=404-413&author=R.+N.+Jonesauthor=J.+E.+Rossauthor=J.+M.+Bellauthor=U.+Utsukiauthor=I.+Fumiakiauthor=I.+Kobayashiauthor=J.+D.+Turnidge&title=Zyvox+annual+appraisal+of+potency+and+spectrum+program%3A+linezolid+surveillance+program+results+for+2008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1016%2Fj.diagmicrobio.2009.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.diagmicrobio.2009.10.001%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DR.%2BN.%26aulast%3DRoss%26aufirst%3DJ.%2BE.%26aulast%3DBell%26aufirst%3DJ.%2BM.%26aulast%3DUtsuki%26aufirst%3DU.%26aulast%3DFumiaki%26aufirst%3DI.%26aulast%3DKobayashi%26aufirst%3DI.%26aulast%3DTurnidge%26aufirst%3DJ.%2BD.%26atitle%3DZyvox%2520annual%2520appraisal%2520of%2520potency%2520and%2520spectrum%2520program%253A%2520linezolid%2520surveillance%2520program%2520results%2520for%25202008%26jtitle%3DDiagn.%2520Microb.%2520Infect.%2520Dis.%26date%3D2009%26volume%3D65%26spage%3D404%26epage%3D413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ross, J. E.; Flamm, R. K.; Sader, H. S.; Hogan, P. A.; Jones, R. N.</span><span> </span><span class="NLM_article-title">Report of linezolid activity from the Zyvox annual appraisal of potency and spectrum (ZAAPS) program 2012 (Europe, Latin America, Asia Pacific, Canada)</span>. <span class="NLM_conf-name">53rd Interscience Conference on Antimicrobial Agents and Chemotherapy</span>, <span class="NLM_conf-loc">Denver, CO</span>, <span class="NLM_conf-date">September 10–13, 2013</span>,  <span class="NLM_fpage"> Poster C2–088</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Ross%2C+J.+E.%3B+Flamm%2C+R.+K.%3B+Sader%2C+H.+S.%3B+Hogan%2C+P.+A.%3B+Jones%2C+R.+N.+Report+of+linezolid+activity+from+the+Zyvox+annual+appraisal+of+potency+and+spectrum+%28ZAAPS%29+program+2012+%28Europe%2C+Latin+America%2C+Asia+Pacific%2C+Canada%29.+53rd+Interscience+Conference+on+Antimicrobial+Agents+and+Chemotherapy%2C+Denver%2C+CO%2C+September+10%E2%80%9313%2C+2013%2C+Poster+C2%E2%80%93088."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DJ.%2BE.%26atitle%3DReport%2520of%2520linezolid%2520activity%2520from%2520the%2520Zyvox%2520annual%2520appraisal%2520of%2520potency%2520and%2520spectrum%2520%2528ZAAPS%2529%2520program%25202012%2520%2528Europe%252C%2520Latin%2520America%252C%2520Asia%2520Pacific%252C%2520Canada%2529%26spage%3DPoster%2520C2%25E2%2580%2593088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Pucci, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, K.</span><span> </span><span class="NLM_article-title">Investigational antimicrobial agents of 2013</span> <span class="citation_source-journal">Clin. Microb. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">792</span><span class="NLM_x">–</span> <span class="NLM_lpage">821</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm401931e&amp;key=10.1128%2FCMR.00033-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm401931e&amp;key=24092856" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2013&pages=792-821&author=M.+J.+Pucciauthor=K.+Bush&title=Investigational+antimicrobial+agents+of+2013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1128%2FCMR.00033-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FCMR.00033-13%26sid%3Dliteratum%253Aachs%26aulast%3DPucci%26aufirst%3DM.%2BJ.%26aulast%3DBush%26aufirst%3DK.%26atitle%3DInvestigational%2520antimicrobial%2520agents%2520of%25202013%26jtitle%3DClin.%2520Microb.%2520Rev.%26date%3D2013%26volume%3D26%26spage%3D792%26epage%3D821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Vinh, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubinstein, E.</span><span> </span><span class="NLM_article-title">Linezolid: a review of safety and tolerability</span> <span class="citation_source-journal">J. Infect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">S59</span><span class="NLM_x">–</span> <span class="NLM_lpage">S74</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2009&pages=S59-S74&author=D.+C.+Vinhauthor=E.+Rubinstein&title=Linezolid%3A+a+review+of+safety+and+tolerability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVinh%26aufirst%3DD.%2BC.%26aulast%3DRubinstein%26aufirst%3DE.%26atitle%3DLinezolid%253A%2520a%2520review%2520of%2520safety%2520and%2520tolerability%26jtitle%3DJ.%2520Infect.%26date%3D2009%26volume%3D59%26spage%3DS59%26epage%3DS74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Nagiec, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chosay, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brieland, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, K. L.</span><span> </span><span class="NLM_article-title">Oxazolidinones inhibit cellular proliferation via inhibition of mitochondrial protein synthesis</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_fpage">3896</span><span class="NLM_x">–</span> <span class="NLM_lpage">3902</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&pages=3896-3902&author=E.+E.+Nagiecauthor=L.+Wuauthor=J.+G.+Chosayauthor=D.+E.+Rossauthor=J.+K.+Brielandauthor=K.+L.+Leach&title=Oxazolidinones+inhibit+cellular+proliferation+via+inhibition+of+mitochondrial+protein+synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNagiec%26aufirst%3DE.%2BE.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DChosay%26aufirst%3DJ.%2BG.%26aulast%3DRoss%26aufirst%3DD.%2BE.%26aulast%3DBrieland%26aufirst%3DJ.%2BK.%26aulast%3DLeach%26aufirst%3DK.%2BL.%26atitle%3DOxazolidinones%2520inhibit%2520cellular%2520proliferation%2520via%2520inhibition%2520of%2520mitochondrial%2520protein%2520synthesis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2005%26spage%3D3896%26epage%3D3902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Attassi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hershberger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alam, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zervos, M. J.</span><span> </span><span class="NLM_article-title">Thrombocytopenia associated with linezolid therapy</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">695</span><span class="NLM_x">–</span> <span class="NLM_lpage">698</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm401931e&amp;key=10.1086%2F338403" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm401931e&amp;key=11803505" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm401931e&amp;key=1%3ACAS%3A280%3ADC%252BD38%252FpsVSlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2002&pages=695-698&author=K.+Attassiauthor=E.+Hershbergerauthor=R.+Alamauthor=M.+J.+Zervos&title=Thrombocytopenia+associated+with+linezolid+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Thrombocytopenia associated with linezolid therapy</span></div><div class="casAuthors">Attassi Kinan; Hershberger Ellie; Alam Rabiul; Zervos Marcus J</div><div class="citationInfo"><span class="NLM_cas:title">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">695-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">We evaluated the incidence and clinical characteristics of linezolid-induced thrombocytopenia in 19 patients who were treated with linezolid.  Overall, thrombocytopenia (platelet count, <100,000 platelets/mm(3)) was observed in 32% of patients who received linezolid for >10 days; gastrointestinal bleeding was observed in 1 patient and 4 patients required platelet transfusions.  These data suggest that even patients who are not considered to be at risk for development of thrombocytopenia should be monitored closely if linezolid therapy is continued for >10 days.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSIIyZakd2UiZggzHGM8X5CfW6udTcc2eaAw8D65BgQPbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38%252FpsVSlsA%253D%253D&md5=be07b767a34bffcea4e16105cf1993fa</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1086%2F338403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F338403%26sid%3Dliteratum%253Aachs%26aulast%3DAttassi%26aufirst%3DK.%26aulast%3DHershberger%26aufirst%3DE.%26aulast%3DAlam%26aufirst%3DR.%26aulast%3DZervos%26aufirst%3DM.%2BJ.%26atitle%3DThrombocytopenia%2520associated%2520with%2520linezolid%2520therapy%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2002%26volume%3D34%26spage%3D695%26epage%3D698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tripathi, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tripathi, B. J.</span><span> </span><span class="NLM_article-title">Drug-induced ocular disorders</span> <span class="citation_source-journal">Drug Saf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">141</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm401931e&amp;key=10.2165%2F00002018-200831020-00003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm401931e&amp;key=18217789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm401931e&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjslWlurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2008&pages=127-141&author=J.+Liauthor=R.+C.+Tripathiauthor=B.+J.+Tripathi&title=Drug-induced+ocular+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-induced ocular disorders</span></div><div class="casAuthors">Li, Junping; Tripathi, Ramesh C.; Tripathi, Brenda J.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Safety</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">127-141</span>CODEN:
                <span class="NLM_cas:coden">DRSAEA</span>;
        ISSN:<span class="NLM_cas:issn">0114-5916</span>.
    
            (<span class="NLM_cas:orgname">Wolters Kluwer Health</span>)
        </div><div class="casAbstract">A review.  While beneficial therapeutically, almost all medications have untoward effects on various body tissues and functions, including the eye in which organ toxic reactions are readily detectable.  Every part of the eye and all ocular functions could be affected adversely.  In this review, we describe the most commonly recognized drug-induced ocular disorders, their specific clin. features, the medications that can cause the problem, the differential diagnosis and possible mechanisms of action, as well as guidelines for the management of the adverse reactions.  The eyelids are most frequently involved in drug toxicity that commonly manifests as inflammation, hypersensitivity reaction or dermatitis.  Drug-induced keratoconjunctival disorders present mainly as conjunctival hyperemia (red eye), with or without superficial corneal involvement.  Frequently, drug preservatives in topical ocular medications induce these adverse effects.  Treatment of blepharospasm with Botox may lead to drooping of the eyelids and corneal exposure.  Intraoperative floppy iris syndrome is a drug-induced reaction in patients treated with tamsulosin and who undergo cataract surgery.  Certain sulfa-based drugs can cause swelling of the ciliary body and lead to the development of angle-closure glaucoma.  In addn., adrenergic agents, certain β2-adrenergic agonists and anticholinergic agents may induce pupillary dilation and ppt. angle-closure glaucoma in susceptible patients.  Glucocorticoids administered systemically, topically or intravitreally are known to increase intraocular pressure, which can lead to the development of open-angle glaucoma in susceptible patients.  This painless form of glaucoma has also been assocd. with the use of the anticancer agents docetaxel and paclitaxel.  The toxic effects of systemic and topically applied drugs may manifest as cloudiness of the lens.  Long-term use of glucocorticoids produces a characteristic posterior subcapsular cataract and, although the opacities may remain stationary or progress, they rarely regress upon drug withdrawal.  Systemic administration of phenothiazines or busulfan induce cataractous changes in the anterior or posterior cortex, resp.  Many systemic drugs reach the retina through the vascular supply.  Aminoquinolines induce a characteristic bull's eye maculopathy.  Phenothiazines bind to melanin granules and can cause a severe phototoxic retinopathy.  Typical tamoxifen retinopathy manifests as cryst. deposits in the inner retina.  Some patients treated with retinoids have decreased night vision and abnormal dark-adaptation.  Patients on long-term treatment with linezolid may develop an optic neuropathy (swollen or pale optic disk), sym. painless decrease of visual acuity and color vision, and bilateral visual field defects.  A probable link exists between amiodarone and a bilateral optic neuropathy that is very similar to nonarteritic ischemic optic neuropathy (NAION).  The most common adverse effects of cGMP-specific phosphodiesterase type 5 inhibitors (erectile dysfunction drugs) are changes in color perception, blurry vision and increased light sensitivity; recently these drugs have been also implicated in the development of NAION.  A bilateral, retrobulbar optic neuropathy that manifests as loss of visual acuity or color vision and visual field defect is assocd. with the use of ethambutol.  Many different kinds of medications can cause similar ocular adverse reactions.  Conversely, a single medication may affect more than one ocular structure and cause multiple, clin. recognizable disorders.  Clinicians should be mindful of drug-induced ocular disorders, whether or not listed in product package inserts and, if in doubt, consult with an ophthalmologist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFW-s5JUwWrLVg90H21EOLACvtfcHk0lh-jSRZY1MTtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjslWlurg%253D&md5=4f77e1c0686921aa85cae59048d7bb02</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2165%2F00002018-200831020-00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00002018-200831020-00003%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DTripathi%26aufirst%3DR.%2BC.%26aulast%3DTripathi%26aufirst%3DB.%2BJ.%26atitle%3DDrug-induced%2520ocular%2520disorders%26jtitle%3DDrug%2520Saf.%26date%3D2008%26volume%3D31%26spage%3D127%26epage%3D141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kulkarni, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Priore, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, K.</span><span> </span><span class="NLM_article-title">Linezolid induced toxic optic neuropathy</span> <span class="citation_source-journal">Br. J. Opthalmol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">1664</span><span class="NLM_x">–</span> <span class="NLM_lpage">1665</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Fjm401931e&amp;key=10.1136%2Fbjo.2005.074237" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=8&amp;doi=10.1021%2Fjm401931e&amp;key=16299156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Fjm401931e&amp;key=1%3ACAS%3A280%3ADC%252BD2Mnhs1aqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2005&pages=1664-1665&author=K.+Kulkarniauthor=L.+V.+Del+Prioreauthor=K.+Kulkarni&title=Linezolid+induced+toxic+optic+neuropathy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">Linezolid induced toxic optic neuropathy</span></div><div class="casAuthors">Kulkarni K; Del Priore L V</div><div class="citationInfo"><span class="NLM_cas:title">The British journal of ophthalmology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1664-5</span>
        ISSN:<span class="NLM_cas:issn">0007-1161</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTpfN8oT4Fdi7qxQ2mb9Pu8fW6udTcc2eaAw8D65BgQPbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2Mnhs1aqtw%253D%253D&md5=dfb50fc5f2aab247d733e6ebb8b75209</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1136%2Fbjo.2005.074237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbjo.2005.074237%26sid%3Dliteratum%253Aachs%26aulast%3DKulkarni%26aufirst%3DK.%26aulast%3DDel%2BPriore%26aufirst%3DL.%2BV.%26aulast%3DKulkarni%26aufirst%3DK.%26atitle%3DLinezolid%2520induced%2520toxic%2520optic%2520neuropathy%26jtitle%3DBr.%2520J.%2520Opthalmol.%26date%3D2005%26volume%3D89%26spage%3D1664%26epage%3D1665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rucker, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardenstein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isada, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. S.</span><span> </span><span class="NLM_article-title">Linezolid-associated toxic optic neuropathy</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">595</span><span class="NLM_x">–</span> <span class="NLM_lpage">598</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=595-598&author=J.+C.+Ruckerauthor=S.+R.+Hamiltonauthor=D.+Bardensteinauthor=C.+M.+Isadaauthor=M.+S.+Lee&title=Linezolid-associated+toxic+optic+neuropathy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRucker%26aufirst%3DJ.%2BC.%26aulast%3DHamilton%26aufirst%3DS.%2BR.%26aulast%3DBardenstein%26aufirst%3DD.%26aulast%3DIsada%26aufirst%3DC.%2BM.%26aulast%3DLee%26aufirst%3DM.%2BS.%26atitle%3DLinezolid-associated%2520toxic%2520optic%2520neuropathy%26jtitle%3DNeurology%26date%3D2006%26volume%3D66%26spage%3D595%26epage%3D598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Azamfirei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copotoiu, S.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branzanuic, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szederjesi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copotoiu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berteanu, C.</span><span> </span><span class="NLM_article-title">Complete blindness after optic neuropathy induced by short-term linezolid treatment in a patient suffering from muscle dystrophy</span> <span class="citation_source-journal">Pharmacoepidemiol. Drug Saf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">402</span><span class="NLM_x">–</span> <span class="NLM_lpage">404</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=16&amp;doi=10.1021%2Fjm401931e&amp;key=10.1002%2Fpds.1320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=8&amp;doi=10.1021%2Fjm401931e&amp;key=16998949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=32&amp;doi=10.1021%2Fjm401931e&amp;key=1%3ACAS%3A280%3ADC%252BD2s7ptl2itw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2007&pages=402-404&author=L.+Azamfireiauthor=S.-M.+Copotoiuauthor=K.+Branzanuicauthor=J.+Szederjesiauthor=R.+Copotoiuauthor=C.+Berteanu&title=Complete+blindness+after+optic+neuropathy+induced+by+short-term+linezolid+treatment+in+a+patient+suffering+from+muscle+dystrophy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13cR"><div class="casContent"><span class="casTitleNuber">13c</span><div class="casTitle"><span class="NLM_cas:atitle">Complete blindness after optic neuropathy induced by short-term linezolid treatment in a patient suffering from muscle dystrophy</span></div><div class="casAuthors">Azamfirei Leonard; Copotoiu Sanda-Maria; Branzaniuc Klara; Szederjesi Janos; Copotoiu Ruxandra; Berteanu Cristina</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacoepidemiology and drug safety</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">402-4</span>
        ISSN:<span class="NLM_cas:issn">1053-8569</span>.
    </div><div class="casAbstract">We present a case of severe optic neuropathy following linezolid treatment, which led to complete irreversible blindness, in a patient with progressive muscular dystrophy, treated with linezolid for 16 days for methicillin-resistant Staphylococcus aureus (MRSA) pneumonia.  Interruption of antibiotic therapy did not lead to remission of ocular symptoms.  Administration of linezolid may lead to severe neuropathy even in the case of short-term treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTLwM2fYg7sUpotVjB3IRIyfW6udTcc2ebDcaM1wrUgLrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s7ptl2itw%253D%253D&md5=fed33f2874e780316cf832a2c4da5167</span></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=10.1002%2Fpds.1320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpds.1320%26sid%3Dliteratum%253Aachs%26aulast%3DAzamfirei%26aufirst%3DL.%26aulast%3DCopotoiu%26aufirst%3DS.-M.%26aulast%3DBranzanuic%26aufirst%3DK.%26aulast%3DSzederjesi%26aufirst%3DJ.%26aulast%3DCopotoiu%26aufirst%3DR.%26aulast%3DBerteanu%26aufirst%3DC.%26atitle%3DComplete%2520blindness%2520after%2520optic%2520neuropathy%2520induced%2520by%2520short-term%2520linezolid%2520treatment%2520in%2520a%2520patient%2520suffering%2520from%2520muscle%2520dystrophy%26jtitle%3DPharmacoepidemiol.%2520Drug%2520Saf.%26date%3D2007%26volume%3D16%26spage%3D402%26epage%3D404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span>Prescribing Information for Zyvox, <span class="NLM_edition">LAB-0139-20.0, revised June 2010</span>; <span class="NLM_publisher-name">Pfizer</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Prescribing+Information+for+Zyvox%2C+LAB-0139-20.0%2C+revised+June+2010%3B+Pfizer%3A+New+York%2C+2010."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26jtitle%3DPrescribing%2520Information%2520for%2520Zyvox%26pub%3DPfizer%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Gordeev, M. F.; Prasad, J. V. N.; Luehr, G. W.</span><span> </span><span class="NLM_article-title">7-Fluoro-1,3-Dihydroindol-2-one oxazolidinones as antibacterial agents</span>. PCT WO 2006/106427, <span class="NLM_month">Oct</span><span class="NLM_day">12</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=M.+F.+Gordeev&author=J.+V.+N.+Prasad&author=G.+W.+Luehr&title=7-Fluoro-1%2C3-Dihydroindol-2-one+oxazolidinones+as+antibacterial+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGordeev%26aufirst%3DM.%2BF.%26atitle%3D7-Fluoro-1%252C3-Dihydroindol-2-one%2520oxazolidinones%2520as%2520antibacterial%2520agents%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Choy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colbry, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pamment, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Duine, J.</span><span> </span><span class="NLM_article-title">Development of a synthesis for a long-term oxazolidinone antibacterial</span> <span class="citation_source-journal">Org. Process Res. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">884</span><span class="NLM_x">–</span> <span class="NLM_lpage">887</span></span><div class="citationLinks">[<a href="/doi/10.1021/op8001195" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=884-887&author=A.+Choyauthor=N.+Colbryauthor=M.+Pammentauthor=J.+Van+Duine&title=Development+of+a+synthesis+for+a+long-term+oxazolidinone+antibacterial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fop8001195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop8001195%26sid%3Dliteratum%253Aachs%26aulast%3DChoy%26aufirst%3DA.%26aulast%3DColbry%26aufirst%3DN.%26aulast%3DPamment%26aufirst%3DM.%26aulast%3DVan%2BDuine%26aufirst%3DJ.%26atitle%3DDevelopment%2520of%2520a%2520synthesis%2520for%2520a%2520long-term%2520oxazolidinone%2520antibacterial%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2008%26volume%3D12%26spage%3D884%26epage%3D887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Huband, M. D.; Mullins, L. M.; Pagano, P. J.; Penzie, J. B.; McCurdy, S. P.; Lemmon, M. M.; Gibson, G. W; Leach, K.; Qiu, L.; Vara Prasad, J. V. N.; Renslo, A.; Luehr, G. W.; Jain, R.; Gordeev, M. F.</span><span> </span><span class="NLM_article-title">In vitro and in vivo activity of PF-03315011: a new oxazolidinone antibacterial versus recent bacterial clinical isolates. </span>. <span class="NLM_conf-name">20th European Congress of Clinical Microbiology and Infectious Diseases</span>, <span class="NLM_conf-loc">Vienna</span>, <span class="NLM_conf-date">April 10–13, 2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Huband%2C+M.+D.%3B+Mullins%2C+L.+M.%3B+Pagano%2C+P.+J.%3B+Penzie%2C+J.+B.%3B+McCurdy%2C+S.+P.%3B+Lemmon%2C+M.+M.%3B+Gibson%2C+G.+W%3B+Leach%2C+K.%3B+Qiu%2C+L.%3B+Vara+Prasad%2C+J.+V.+N.%3B+Renslo%2C+A.%3B+Luehr%2C+G.+W.%3B+Jain%2C+R.%3B+Gordeev%2C+M.+F.+In+vitro+and+in+vivo+activity+of+PF-03315011%3A+a+new+oxazolidinone+antibacterial+versus+recent+bacterial+clinical+isolates.+.+20th+European+Congress+of+Clinical+Microbiology+and+Infectious+Diseases%2C+Vienna%2C+April+10%E2%80%9313%2C+2010."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DHuband%26aufirst%3DM.%2BD.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520activity%2520of%2520PF-03315011%253A%2520a%2520new%2520oxazolidinone%2520antibacterial%2520versus%2520recent%2520bacterial%2520clinical%2520isolates.%2520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Dryden, M. S.</span><span> </span><span class="NLM_article-title">Linezolid pharmacokinetics and pharmacodynamics in clinical treatment</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 4</span><span class="NLM_x">) </span> <span class="NLM_fpage">iv7</span><span class="NLM_x">–</span> <span class="NLM_lpage">iv17</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm401931e&amp;key=21521707" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2011&pages=iv7-iv17&issue=Suppl+4&author=M.+S.+Dryden&title=Linezolid+pharmacokinetics+and+pharmacodynamics+in+clinical+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDryden%26aufirst%3DM.%2BS.%26atitle%3DLinezolid%2520pharmacokinetics%2520and%2520pharmacodynamics%2520in%2520clinical%2520treatment%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2011%26volume%3D66%26issue%3DSuppl%25204%26spage%3Div7%26epage%3Div17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Huang, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gortney, J. S.</span><span> </span><span class="NLM_article-title">Risk of serotonin syndrome with concomitant administration of linezolid and serotonin agonists</span> <span class="citation_source-journal">Pharmacotherapy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1784</span><span class="NLM_x">–</span> <span class="NLM_lpage">1793</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=1784-1793&author=V.+Huangauthor=J.+S.+Gortney&title=Risk+of+serotonin+syndrome+with+concomitant+administration+of+linezolid+and+serotonin+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DV.%26aulast%3DGortney%26aufirst%3DJ.%2BS.%26atitle%3DRisk%2520of%2520serotonin%2520syndrome%2520with%2520concomitant%2520administration%2520of%2520linezolid%2520and%2520serotonin%2520agonists%26jtitle%3DPharmacotherapy%26date%3D2006%26volume%3D26%26spage%3D1784%26epage%3D1793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Im, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, S.-H.</span><span> </span><span class="NLM_article-title">Discovery of torezolid as a novel 5-hydroxymethyl-oxazolidinone antibacterial agent</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1027</span><span class="NLM_x">–</span> <span class="NLM_lpage">1039</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=1027-1039&author=W.+B.+Imauthor=S.+H.+Choiauthor=J.-Y.+Parkauthor=S.+H.+Choiauthor=J.+Finnauthor=S.-H.+Yoon&title=Discovery+of+torezolid+as+a+novel+5-hydroxymethyl-oxazolidinone+antibacterial+agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIm%26aufirst%3DW.%2BB.%26aulast%3DChoi%26aufirst%3DS.%2BH.%26aulast%3DPark%26aufirst%3DJ.-Y.%26aulast%3DChoi%26aufirst%3DS.%2BH.%26aulast%3DFinn%26aufirst%3DJ.%26aulast%3DYoon%26aufirst%3DS.-H.%26atitle%3DDiscovery%2520of%2520torezolid%2520as%2520a%2520novel%25205-hydroxymethyl-oxazolidinone%2520antibacterial%2520agent%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D1027%26epage%3D1039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kanafani, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corey, G. R.</span><span> </span><span class="NLM_article-title">Tedizolid (TR-701): a new oxazolidinone with enhanced potency</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">515</span><span class="NLM_x">–</span> <span class="NLM_lpage">522</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=515-522&author=Z.+A.+Kanafaniauthor=G.+R.+Corey&title=Tedizolid+%28TR-701%29%3A+a+new+oxazolidinone+with+enhanced+potency"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKanafani%26aufirst%3DZ.%2BA.%26aulast%3DCorey%26aufirst%3DG.%2BR.%26atitle%3DTedizolid%2520%2528TR-701%2529%253A%2520a%2520new%2520oxazolidinone%2520with%2520enhanced%2520potency%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs.%26date%3D2012%26volume%3D21%26spage%3D515%26epage%3D522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Fang, E.; De Anda, C.; Das, A.; Prokocimer, P.</span><span> </span><span class="NLM_article-title">. Safety profile of tedizolid phosphate compared to linezolid in a Phase 3 ABSSSI study. 52nd Intersci. Conf</span>. <span class="NLM_conf-name">52nd Interscience Conference on Antimicrobial Agents and Chemotherapy</span>, <span class="NLM_conf-loc">San Francisco</span>, <span class="NLM_conf-date">Sept 9–12, 2012</span>,  <span class="NLM_fpage">Poster L1-1664</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Fang%2C+E.%3B+De+Anda%2C+C.%3B+Das%2C+A.%3B+Prokocimer%2C+P.+.+Safety+profile+of+tedizolid+phosphate+compared+to+linezolid+in+a+Phase+3+ABSSSI+study.+52nd+Intersci.+Conf.+52nd+Interscience+Conference+on+Antimicrobial+Agents+and+Chemotherapy%2C+San+Francisco%2C+Sept+9%E2%80%9312%2C+2012%2C+Poster+L1-1664."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DE.%26atitle%3D.%2520Safety%2520profile%2520of%2520tedizolid%2520phosphate%2520compared%2520to%2520linezolid%2520in%2520a%2520Phase%25203%2520ABSSSI%2520study.%252052nd%2520Intersci.%2520Conf%26spage%3DPoster%2520L1-1664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Das, D.; Lambert, A.; Tulkens, P. M.; Muccioli, G. G.; Van Bembeke, F.</span><span> </span><span class="NLM_article-title">Study of the cellular uptake and subcellular distribution of the oxazolidinone tedizolid (TZD) in murine J774 macrophages: lack of association with mitochondria</span>. <span class="NLM_conf-name">52nd Interscience Conference on Antimicrobial Agents and Chemotherapy</span>, <span class="NLM_conf-loc">San Francisco</span>, <span class="NLM_conf-date">Sept 9–12, 2012</span>,  <span class="NLM_fpage">Poster A-1291</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Das%2C+D.%3B+Lambert%2C+A.%3B+Tulkens%2C+P.+M.%3B+Muccioli%2C+G.+G.%3B+Van+Bembeke%2C+F.+Study+of+the+cellular+uptake+and+subcellular+distribution+of+the+oxazolidinone+tedizolid+%28TZD%29+in+murine+J774+macrophages%3A+lack+of+association+with+mitochondria.+52nd+Interscience+Conference+on+Antimicrobial+Agents+and+Chemotherapy%2C+San+Francisco%2C+Sept+9%E2%80%9312%2C+2012%2C+Poster+A-1291."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DD.%26atitle%3DStudy%2520of%2520the%2520cellular%2520uptake%2520and%2520subcellular%2520distribution%2520of%2520the%2520oxazolidinone%2520tedizolid%2520%2528TZD%2529%2520in%2520murine%2520J774%2520macrophages%253A%2520lack%2520of%2520association%2520with%2520mitochondria%26spage%3DPoster%2520A-1291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="note"><p class="first last">This perspective is preceded by several symposium disclosures:</p></div><div class="NLM_citation" id="rightTab-cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zhu, D. M.; Wang, W.; Huang, Y. Q.; Zhang, Y. Y.</span><span> </span><span class="NLM_article-title">Antibacterial spectrum of oxazolidinone MRX-I: potent activity against multidrug-resistant Gram-positive pathogens</span>. <span class="NLM_conf-name">52nd Interscience Conference on Antimicrobial Agents and Chemotherapy</span>, <span class="NLM_conf-loc">San Francisco</span>, <span class="NLM_conf-date">Sept 9–12, 2012</span>,  <span class="NLM_fpage">Poster F-1497</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Zhu%2C+D.+M.%3B+Wang%2C+W.%3B+Huang%2C+Y.+Q.%3B+Zhang%2C+Y.+Y.+Antibacterial+spectrum+of+oxazolidinone+MRX-I%3A+potent+activity+against+multidrug-resistant+Gram-positive+pathogens.+52nd+Interscience+Conference+on+Antimicrobial+Agents+and+Chemotherapy%2C+San+Francisco%2C+Sept+9%E2%80%9312%2C+2012%2C+Poster+F-1497."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DD.%2BM.%26atitle%3DAntibacterial%2520spectrum%2520of%2520oxazolidinone%2520MRX-I%253A%2520potent%2520activity%2520against%2520multidrug-resistant%2520Gram-positive%2520pathogens%26spage%3DPoster%2520F-1497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Huang, Y. Q.; Wang, W.; Li, Y.; Wang, H. L.; Xu, Y. H.; Liu, C.; Zhou, F.; Wang, C. Q.; Liu, J.; Wang, Q.</span><span> </span><span class="NLM_article-title">Antimicrobial profile of MRX-I: resistance and drug combination studies</span>. <span class="NLM_conf-name">52nd Interscience Conference on Antimicrobial Agents and Chemotherapy</span>, <span class="NLM_conf-loc">San Francisco</span>, <span class="NLM_conf-date">Sept 9–12, 2012</span>,  <span class="NLM_fpage">Poster F-1498</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Huang%2C+Y.+Q.%3B+Wang%2C+W.%3B+Li%2C+Y.%3B+Wang%2C+H.+L.%3B+Xu%2C+Y.+H.%3B+Liu%2C+C.%3B+Zhou%2C+F.%3B+Wang%2C+C.+Q.%3B+Liu%2C+J.%3B+Wang%2C+Q.+Antimicrobial+profile+of+MRX-I%3A+resistance+and+drug+combination+studies.+52nd+Interscience+Conference+on+Antimicrobial+Agents+and+Chemotherapy%2C+San+Francisco%2C+Sept+9%E2%80%9312%2C+2012%2C+Poster+F-1498."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.%2BQ.%26atitle%3DAntimicrobial%2520profile%2520of%2520MRX-I%253A%2520resistance%2520and%2520drug%2520combination%2520studies%26spage%3DPoster%2520F-1498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Li, C. R.; Li, G. Q.; Hu, X. X.; Zhang, W. X.; Wang, X. K.; Pang, J.; Lu, X.; Zhai, Q. Q.; Yuan, H.; Gordeev, M. F.; Yang, X. Y.; You, X. F.</span><span> </span><span class="NLM_article-title">Novel oxazolidinone MRX-I is efficacious in mouse models of Gram-positive bacterial infections</span>. <span class="NLM_conf-name">52nd Interscience Conference on Antimicrobial Agents and Chemotherapy</span>, <span class="NLM_conf-loc">San Francisco</span>, <span class="NLM_conf-date">Sept 9–12, 2012</span>,  <span class="NLM_fpage">Poster F-1499</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Li%2C+C.+R.%3B+Li%2C+G.+Q.%3B+Hu%2C+X.+X.%3B+Zhang%2C+W.+X.%3B+Wang%2C+X.+K.%3B+Pang%2C+J.%3B+Lu%2C+X.%3B+Zhai%2C+Q.+Q.%3B+Yuan%2C+H.%3B+Gordeev%2C+M.+F.%3B+Yang%2C+X.+Y.%3B+You%2C+X.+F.+Novel+oxazolidinone+MRX-I+is+efficacious+in+mouse+models+of+Gram-positive+bacterial+infections.+52nd+Interscience+Conference+on+Antimicrobial+Agents+and+Chemotherapy%2C+San+Francisco%2C+Sept+9%E2%80%9312%2C+2012%2C+Poster+F-1499."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DC.%2BR.%26atitle%3DNovel%2520oxazolidinone%2520MRX-I%2520is%2520efficacious%2520in%2520mouse%2520models%2520of%2520Gram-positive%2520bacterial%2520infections%26spage%3DPoster%2520F-1499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Chen, X. Y.; Gao, Z. W.; Yuan, H.; Yuan, Z. Y.; Zhong, D. F.</span><span> </span><span class="NLM_article-title">Pre-clinical pharmacokinetics of MRX-I in rodents and dogs</span>. <span class="NLM_conf-name">52nd Interscience Conference on Antimicrobial Agents and Chemotherapy</span>, <span class="NLM_conf-loc">San Francisco</span>, <span class="NLM_conf-date">Sept 9–12, 2012</span>,  <span class="NLM_fpage">Poster F-1500</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Chen%2C+X.+Y.%3B+Gao%2C+Z.+W.%3B+Yuan%2C+H.%3B+Yuan%2C+Z.+Y.%3B+Zhong%2C+D.+F.+Pre-clinical+pharmacokinetics+of+MRX-I+in+rodents+and+dogs.+52nd+Interscience+Conference+on+Antimicrobial+Agents+and+Chemotherapy%2C+San+Francisco%2C+Sept+9%E2%80%9312%2C+2012%2C+Poster+F-1500."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%2BY.%26atitle%3DPre-clinical%2520pharmacokinetics%2520of%2520MRX-I%2520in%2520rodents%2520and%2520dogs%26spage%3DPoster%2520F-1500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Wang, W.; Wang, Z.; Chang, Y.; Yuan, H.; Yuan, Z. Y.; Zhou, J. L.; Zhong, D. F.</span><span> </span><span class="NLM_article-title">In vitro safety study of MRX-I, a safer oxazolidinone antibacterial agent</span>. <span class="NLM_conf-name">52nd Interscience Conference on Antimicrobial Agents and Chemotherapy</span>, <span class="NLM_conf-loc">San Francisco</span>, <span class="NLM_conf-date">Sept 9–12, 2012</span>,  <span class="NLM_fpage">Poster F-1501</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Wang%2C+W.%3B+Wang%2C+Z.%3B+Chang%2C+Y.%3B+Yuan%2C+H.%3B+Yuan%2C+Z.+Y.%3B+Zhou%2C+J.+L.%3B+Zhong%2C+D.+F.+In+vitro+safety+study+of+MRX-I%2C+a+safer+oxazolidinone+antibacterial+agent.+52nd+Interscience+Conference+on+Antimicrobial+Agents+and+Chemotherapy%2C+San+Francisco%2C+Sept+9%E2%80%9312%2C+2012%2C+Poster+F-1501."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%26atitle%3DIn%2520vitro%2520safety%2520study%2520of%2520MRX-I%252C%2520a%2520safer%2520oxazolidinone%2520antibacterial%2520agent%26spage%3DPoster%2520F-1501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Qiu, Y. L.; Jiang, J. Q.; Huang, H. X.; Hsu, C. H.; Ma, J.; Yuan, H.; Gordeev, M. F.</span><span> </span><span class="NLM_article-title">Acute and repeat dose toxicity of MRX-I in rat</span>. <span class="NLM_conf-name">52nd Interscience Conference on Antimicrobial Agents and Chemotherapy</span>, <span class="NLM_conf-loc">San Francisco</span>, <span class="NLM_conf-date">Sept 9–12, 2012</span>,  <span class="NLM_fpage">Poster F-1502</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Qiu%2C+Y.+L.%3B+Jiang%2C+J.+Q.%3B+Huang%2C+H.+X.%3B+Hsu%2C+C.+H.%3B+Ma%2C+J.%3B+Yuan%2C+H.%3B+Gordeev%2C+M.+F.+Acute+and+repeat+dose+toxicity+of+MRX-I+in+rat.+52nd+Interscience+Conference+on+Antimicrobial+Agents+and+Chemotherapy%2C+San+Francisco%2C+Sept+9%E2%80%9312%2C+2012%2C+Poster+F-1502."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DY.%2BL.%26atitle%3DAcute%2520and%2520repeat%2520dose%2520toxicity%2520of%2520MRX-I%2520in%2520rat%26spage%3DPoster%2520F-1502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Zhang, J.; Wu, X. J.; Huang, J.; Yu, J. C.; Guo, B. N.; Cao, G. Y.; Wu, J. F.; Zhang, K. J.; Yuan, H.; Yuan, Z. Y.; Shi, Y. G.; Zhang, Y. Y.</span><span> </span><span class="NLM_article-title">Single oral dose pharmacokinetics of MRX-I in healthy subjects</span>. <span class="NLM_conf-name">52nd Interscience Conference on Antimicrobial Agents and Chemotherapy</span>, <span class="NLM_conf-loc">San Francisco</span>, <span class="NLM_conf-date">Sept 9–12, 2012</span>,  <span class="NLM_fpage">Poster F-1503</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Zhang%2C+J.%3B+Wu%2C+X.+J.%3B+Huang%2C+J.%3B+Yu%2C+J.+C.%3B+Guo%2C+B.+N.%3B+Cao%2C+G.+Y.%3B+Wu%2C+J.+F.%3B+Zhang%2C+K.+J.%3B+Yuan%2C+H.%3B+Yuan%2C+Z.+Y.%3B+Shi%2C+Y.+G.%3B+Zhang%2C+Y.+Y.+Single+oral+dose+pharmacokinetics+of+MRX-I+in+healthy+subjects.+52nd+Interscience+Conference+on+Antimicrobial+Agents+and+Chemotherapy%2C+San+Francisco%2C+Sept+9%E2%80%9312%2C+2012%2C+Poster+F-1503."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DSingle%2520oral%2520dose%2520pharmacokinetics%2520of%2520MRX-I%2520in%2520healthy%2520subjects%26spage%3DPoster%2520F-1503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Zhang, J.; Wu, X. J.; Huang, J.; Yu, J. C.; Guo, B. N.; Cao, G. Y.; Wu, J. F.; Yuan, H.; Yuan, Z. Y.; Shi, Y. G.; Zhang, Y. Y.</span><span> </span><span class="NLM_article-title">Hematological effect and pharmacokinetics of multiple oral dose MRX-I in healthy subjects</span>. <span class="NLM_conf-name">52nd Interscience Conference on Antimicrobial Agents and Chemotherapy</span>, <span class="NLM_conf-loc">San Francisco</span>, <span class="NLM_conf-date">Sept 9–12, 2012</span>,  <span class="NLM_fpage">Poster F-1504</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Zhang%2C+J.%3B+Wu%2C+X.+J.%3B+Huang%2C+J.%3B+Yu%2C+J.+C.%3B+Guo%2C+B.+N.%3B+Cao%2C+G.+Y.%3B+Wu%2C+J.+F.%3B+Yuan%2C+H.%3B+Yuan%2C+Z.+Y.%3B+Shi%2C+Y.+G.%3B+Zhang%2C+Y.+Y.+Hematological+effect+and+pharmacokinetics+of+multiple+oral+dose+MRX-I+in+healthy+subjects.+52nd+Interscience+Conference+on+Antimicrobial+Agents+and+Chemotherapy%2C+San+Francisco%2C+Sept+9%E2%80%9312%2C+2012%2C+Poster+F-1504."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DHematological%2520effect%2520and%2520pharmacokinetics%2520of%2520multiple%2520oral%2520dose%2520MRX-I%2520in%2520healthy%2520subjects%26spage%3DPoster%2520F-1504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Brickner, S. J.</span><span> </span><span class="NLM_article-title">Oxazolidinone antibacterial agents</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">194</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm401931e&amp;key=1%3ACAS%3A528%3ADyaK28XjslGrurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1996&pages=175-194&author=S.+J.+Brickner&title=Oxazolidinone+antibacterial+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Oxazolidinone antibacterial agents</span></div><div class="casAuthors">Brickner, Steven J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">175-194</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review, with 138 refs., on the antibacterial activity, mechanism of action studies, toxicity issues, and structure-activity relationships of oxazolidinones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokm5Pl0jckp7Vg90H21EOLACvtfcHk0lj3LzFePCnmdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjslGrurc%253D&md5=7f59c1f76d6eebae539904fbf94f770c</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrickner%26aufirst%3DS.%2BJ.%26atitle%3DOxazolidinone%2520antibacterial%2520agents%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D1996%26volume%3D2%26spage%3D175%26epage%3D194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Park, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Britelli, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C. L.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregory, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wuonola, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McRipley, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eberly, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slee, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forbes, M.</span><span> </span><span class="NLM_article-title">Antibacterials. Synthesis and structure–activity studies of 3-aryl-2-oxooxazolidines. 4. Multiply-substituted aryl derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1156</span><span class="NLM_x">–</span> <span class="NLM_lpage">1165</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00084a022" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=1156-1165&author=C.-H.+Parkauthor=D.+R.+Britelliauthor=C.+L.-J.+Wangauthor=F.+D.+Marshauthor=W.+A.+Gregoryauthor=M.+A.+Wuonolaauthor=R.+J.+McRipleyauthor=V.+S.+Eberlyauthor=A.+M.+Sleeauthor=M.+Forbes&title=Antibacterials.+Synthesis+and+structure%E2%80%93activity+studies+of+3-aryl-2-oxooxazolidines.+4.+Multiply-substituted+aryl+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm00084a022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00084a022%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DC.-H.%26aulast%3DBritelli%26aufirst%3DD.%2BR.%26aulast%3DWang%26aufirst%3DC.%2BL.-J.%26aulast%3DMarsh%26aufirst%3DF.%2BD.%26aulast%3DGregory%26aufirst%3DW.%2BA.%26aulast%3DWuonola%26aufirst%3DM.%2BA.%26aulast%3DMcRipley%26aufirst%3DR.%2BJ.%26aulast%3DEberly%26aufirst%3DV.%2BS.%26aulast%3DSlee%26aufirst%3DA.%2BM.%26aulast%3DForbes%26aufirst%3DM.%26atitle%3DAntibacterials.%2520Synthesis%2520and%2520structure%25E2%2580%2593activity%2520studies%2520of%25203-aryl-2-oxooxazolidines.%25204.%2520Multiply-substituted%2520aryl%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26spage%3D1156%26epage%3D1165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hutchinson, D. K.</span><span> </span><span class="NLM_article-title">Oxazolidinone antibacterial agents: a critical review</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1021</span><span class="NLM_x">–</span> <span class="NLM_lpage">1042</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=16&amp;doi=10.1021%2Fjm401931e&amp;key=10.2174%2F1568026033452195" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=8&amp;doi=10.1021%2Fjm401931e&amp;key=12678835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=32&amp;doi=10.1021%2Fjm401931e&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjt1Gltrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=1021-1042&author=D.+K.+Hutchinson&title=Oxazolidinone+antibacterial+agents%3A+a+critical+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26aR"><div class="casContent"><span class="casTitleNuber">26a</span><div class="casTitle"><span class="NLM_cas:atitle">Oxazolidinone antibacterial agents: A critical review</span></div><div class="casAuthors">Hutchinson, Douglas K.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1021-1042</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">This review covers recent developments in several important aspects of research on oxazolidinone antibacterial agents.  Structure-activity relationships are first discussed, emphasizing bioisosteric replacements for the both the oxazolidinone ring and the N-acetylaminomethyl group at C-5.  The oxazolidinones have a mechanism of action that is distinct from other antibacterial agents, whereby protein synthesis is inhibited prior to initiation.  Studies aimed at detg. how the oxazolidinones bind to the bacterial ribosome and interfere with peptidyl transferase activity are described in detail, and are then related to the nature of the changes in the rRNA leading to resistance.  Toxicity of the oxazolidinones remains a crit. issue, in that early lead compds. exhibited lethal toxicity in animal studies.  Preclin. and clin. safety studies of both eperezolid and linezolid are summarized, giving emphasis to histopathol. effects obsd. in early animal studies.  These studies are then related to thrombocytopenia and pancytopenia obsd. in patients treated with linezolid for extended time periods.  Finally, studies to det. the nature and potential severity of drug-drug interactions in patients undergoing linezolid therapy are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLktXTQ9Ws-bVg90H21EOLACvtfcHk0lj3LzFePCnmdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjt1Gltrg%253D&md5=b986cac2af85c8c39d7b271a4930844d</span></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.2174%2F1568026033452195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026033452195%26sid%3Dliteratum%253Aachs%26aulast%3DHutchinson%26aufirst%3DD.%2BK.%26atitle%3DOxazolidinone%2520antibacterial%2520agents%253A%2520a%2520critical%2520review%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2003%26volume%3D3%26spage%3D1021%26epage%3D1042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit26b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Renslo, A. R.</span><span> </span><span class="NLM_article-title">Antibacterial oxazolidinones: emerging structure–toxicity relationships</span> <span class="citation_source-journal">Expert. Rev. Anti-infect. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">565</span><span class="NLM_x">–</span> <span class="NLM_lpage">574</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=16&amp;doi=10.1021%2Fjm401931e&amp;key=10.1586%2Feri.10.26" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=8&amp;doi=10.1021%2Fjm401931e&amp;key=20455685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=32&amp;doi=10.1021%2Fjm401931e&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvVWltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=565-574&author=A.+R.+Renslo&title=Antibacterial+oxazolidinones%3A+emerging+structure%E2%80%93toxicity+relationships"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26bR"><div class="casContent"><span class="casTitleNuber">26b</span><div class="casTitle"><span class="NLM_cas:atitle">Antibacterial oxazolidinones: emerging structure-toxicity relationships</span></div><div class="casAuthors">Renslo, Adam R.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anti-Infective Therapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">565-574</span>CODEN:
                <span class="NLM_cas:coden">ERATCK</span>;
        ISSN:<span class="NLM_cas:issn">1478-7210</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  The oxazolidinones are an important class of synthetic bacterial protein synthesis inhibitors with activity against Gram-pos. and some fastidious Gram-neg. bacteria.  Key toxicol. issues with the class include reversible inhibition of monoamine oxidase enzymes and reversible myelosuppression that can occur in patients treated for longer than the recommended course of therapy.  Recent studies have uncovered the likely mol. mechanism underlying oxazolidinone-related myelosuppression and other toxicities, and these will be discussed here.  Also reviewed are recent reports of structural modifications that can attenuate one or more of the undesired effects of oxazolidinones, while retaining the desired antibacterial effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon96V7VuRPMrVg90H21EOLACvtfcHk0lj3LzFePCnmdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvVWltrY%253D&md5=ccd4e7ac03bc12898efdacf048047850</span></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=10.1586%2Feri.10.26&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Feri.10.26%26sid%3Dliteratum%253Aachs%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26atitle%3DAntibacterial%2520oxazolidinones%253A%2520emerging%2520structure%25E2%2580%2593toxicity%2520relationships%26jtitle%3DExpert.%2520Rev.%2520Anti-infect.%2520Ther.%26date%3D2010%26volume%3D8%26spage%3D565%26epage%3D574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gordeev, M. F.; Upinder, S.; Patel, D. V.; May, P. D.</span><span> </span><span class="NLM_article-title">Antimicrobial 1-aryl dihydropyridone compounds</span>. PCT WO 2004/033449, <span class="NLM_month">Apr</span><span class="NLM_day">22</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=M.+F.+Gordeev&author=S.+Upinder&author=D.+V.+Patel&author=P.+D.+May&title=Antimicrobial+1-aryl+dihydropyridone+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGordeev%26aufirst%3DM.%2BF.%26atitle%3DAntimicrobial%25201-aryl%2520dihydropyridone%2520compounds%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit27b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rhee, J. K.; Im, W. B.; Cho, C. H.; Choi, S. H.; Lee, T. H.</span><span> </span><span class="NLM_article-title">Novel oxazolidinone derivatives</span>. PCT WO 2005/058886, <span class="NLM_month">Jun</span><span class="NLM_day">30</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=J.+K.+Rhee&author=W.+B.+Im&author=C.+H.+Cho&author=S.+H.+Choi&author=T.+H.+Lee&title=Novel+oxazolidinone+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRhee%26aufirst%3DJ.%2BK.%26atitle%3DNovel%2520oxazolidinone%2520derivatives%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Renslo, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luehr, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordeev, M. F.</span><span> </span><span class="NLM_article-title">Recent developments in the identification of novel oxazolidinone antibacterial agents</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">4227</span><span class="NLM_x">–</span> <span class="NLM_lpage">4240</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=4227-4240&author=A.+R.+Rensloauthor=G.+W.+Luehrauthor=M.+F.+Gordeev&title=Recent+developments+in+the+identification+of+novel+oxazolidinone+antibacterial+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26aulast%3DLuehr%26aufirst%3DG.%2BW.%26aulast%3DGordeev%26aufirst%3DM.%2BF.%26atitle%3DRecent%2520developments%2520in%2520the%2520identification%2520of%2520novel%2520oxazolidinone%2520antibacterial%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26spage%3D4227%26epage%3D4240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Barbachyn, M. R.; Harris, C. R.; Vara Prasad, J. V. N.</span><span> </span><span class="NLM_article-title">Substituted 2,3,5-trifluorphenyl oxazolidinones for use as antibacterial agents</span>. PCT WO 2005/113520, <span class="NLM_month">Dec</span><span class="NLM_day">1</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=M.+R.+Barbachyn&author=C.+R.+Harris&author=J.+V.+N.+Vara+Prasad&title=Substituted+2%2C3%2C5-trifluorphenyl+oxazolidinones+for+use+as+antibacterial+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBarbachyn%26aufirst%3DM.%2BR.%26atitle%3DSubstituted%25202%252C3%252C5-trifluorphenyl%2520oxazolidinones%2520for%2520use%2520as%2520antibacterial%2520agents%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Harris, C. R.; Barbachyn, M. R.; Vara Prasad, J. V. N.; Angell, P.; Fusen Han; Sulavik, M. C.; Gibson, G. W.; Gage, G. W.; Lockard, M.; Ford, C. W.; Hamel, J. C.; Stapert, M. D.; Huband, M. D.; Pagano, P. J.; Zurenko, G. E.; Schaadt, R. D.; Yagi, B. H.; Ogden, A. G.; Lepsy, C. S.; Ashton, B.; Hollembaek, J. M.; Brodfuehrer, J. I.; Adams, W. J.; Martin,  Jr., J. P.; Blackburn, A. C.; Spence, J.</span><span> </span><span class="NLM_article-title">Identification of a new trifluorophenyl oxazolidinone, PF-00987296.</span>. <span class="NLM_conf-name">46th Interscience Conference on Antimicrobial Agents and Chemotherapy</span>, <span class="NLM_conf-loc">San Francisco</span>, <span class="NLM_conf-date">Sept 27–30, 2006</span>,  <span class="NLM_fpage">Poster F1–0971</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Harris%2C+C.+R.%3B+Barbachyn%2C+M.+R.%3B+Vara+Prasad%2C+J.+V.+N.%3B+Angell%2C+P.%3B+Fusen+Han%3B+Sulavik%2C+M.+C.%3B+Gibson%2C+G.+W.%3B+Gage%2C+G.+W.%3B+Lockard%2C+M.%3B+Ford%2C+C.+W.%3B+Hamel%2C+J.+C.%3B+Stapert%2C+M.+D.%3B+Huband%2C+M.+D.%3B+Pagano%2C+P.+J.%3B+Zurenko%2C+G.+E.%3B+Schaadt%2C+R.+D.%3B+Yagi%2C+B.+H.%3B+Ogden%2C+A.+G.%3B+Lepsy%2C+C.+S.%3B+Ashton%2C+B.%3B+Hollembaek%2C+J.+M.%3B+Brodfuehrer%2C+J.+I.%3B+Adams%2C+W.+J.%3B+Martin%2C+Jr.%2C+J.+P.%3B+Blackburn%2C+A.+C.%3B+Spence%2C+J.+Identification+of+a+new+trifluorophenyl+oxazolidinone%2C+PF-00987296..+46th+Interscience+Conference+on+Antimicrobial+Agents+and+Chemotherapy%2C+San+Francisco%2C+Sept+27%E2%80%9330%2C+2006%2C+Poster+F1%E2%80%930971."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DC.%2BR.%26atitle%3DIdentification%2520of%2520a%2520new%2520trifluorophenyl%2520oxazolidinone%252C%2520PF-00987296.%26spage%3DPoster%2520F1%25E2%2580%25930971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Parchment, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grieshaber, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sessa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghielmini, M.</span><span> </span><span class="NLM_article-title">Predicting hematological toxicity (myelosuppression) of cytotoxic drug therapy from in vitro tests</span> <span class="citation_source-journal">Ann. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm401931e&amp;key=10.1023%2FA%3A1008245906772" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm401931e&amp;key=9636825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm401931e&amp;key=1%3ACAS%3A280%3ADyaK1czgtVCmtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1998&pages=357-364&author=R.+E.+Parchmentauthor=M.+Gordonauthor=C.+K.+Grieshaberauthor=C.+Sessaauthor=D.+Volpeauthor=M.+Ghielmini&title=Predicting+hematological+toxicity+%28myelosuppression%29+of+cytotoxic+drug+therapy+from+in+vitro+tests"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Predicting hematological toxicity (myelosuppression) of cytotoxic drug therapy from in vitro tests</span></div><div class="casAuthors">Parchment R E; Gordon M; Grieshaber C K; Sessa C; Volpe D; Ghielmini M</div><div class="citationInfo"><span class="NLM_cas:title">Annals of oncology : official journal of the European Society for Medical Oncology / ESMO</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">357-64</span>
        ISSN:<span class="NLM_cas:issn">0923-7534</span>.
    </div><div class="casAbstract">Several clinical oncology units are studying the roles of in vitro hematotoxicology in phase I evaluations.  At the same time, the European Center for the Validation of Alternative Methods (ECVAM) is supporting a validation study of the CFU-GM assay.  It is important that these activities be coordinated so that high performance, optimized technical protocols are used for prospective and retrospective clinical evaluations.  The EROTC, the NCI and ECVAM could provide support for these coordinated efforts.  There is an opportunity for medical oncologists involved in early clinical trials to participate in the evaluation of in vitro tests and their clinical application .  Fundamental to acceptance of these assays by oncologists and regulatory scientists, they must predict clinical outcome for myelosuppressive agents and then improve phase I design and performance.  These achievements would justify more aggressive dose escalation schemes using guidance from in vitro studies without compromising patient safety.  Success in predicting neutropenia might also stimulate the research required to understand how to predict other hematologic toxicities, such as a thrombocytopenia.  The complexity of a validation study in hematotoxicology is that it seeks to predict the level of exposure that causes neutropenia, in contrast to other validation studies that have sought to classify a xenobiotic as toxic or not.  It may be that the clinical relevance of a new assay is not just a yes-no answer.  This important distinction came from the realization that the xenobiotic tolerance in other organ systems of the body must be the same or greater than marrow in order for myelosuppression to be a clinical consequence of exposure.  Pharmacological principles of system exposure and toxicity that are integrated into the prediction model provide the links to clinical oncology.  It is also important to anticipate future applications of in vitro hematotoxicology.  If the maximum tolerated level of drug exposure for human hematopoietic cells can be predicted, then in vitro hematotoxicology could play an important role in new drug discovery.  One concept involves screening for compounds that show efficacy at the IC level that predicts maximum tolerated exposure levels in the human. 'Therapeutic index based' drug discovery has been applied to the tallimustine family with some success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSl_8jLbgQpKEwlCcfExbvbfW6udTcc2ebYK3BJuSYGibntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1czgtVCmtg%253D%253D&md5=1573e2eb4fa7fc341f6d3ea3659cfe45</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1023%2FA%3A1008245906772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1008245906772%26sid%3Dliteratum%253Aachs%26aulast%3DParchment%26aufirst%3DR.%2BE.%26aulast%3DGordon%26aufirst%3DM.%26aulast%3DGrieshaber%26aufirst%3DC.%2BK.%26aulast%3DSessa%26aufirst%3DC.%26aulast%3DVolpe%26aufirst%3DD.%26aulast%3DGhielmini%26aufirst%3DM.%26atitle%3DPredicting%2520hematological%2520toxicity%2520%2528myelosuppression%2529%2520of%2520cytotoxic%2520drug%2520therapy%2520from%2520in%2520vitro%2520tests%26jtitle%3DAnn.%2520Oncol.%26date%3D1998%26volume%3D9%26spage%3D357%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Gordeev, M. F.</span><span> </span><span class="NLM_article-title">Antimicrobial <i>ortho</i>-fluorophenyl oxazolidinones for treatment of bacterial infections</span>. PCT WO 2009/020616, <span class="NLM_month">Feb</span><span class="NLM_day">12</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=M.+F.+Gordeev&title=Antimicrobial+ortho-fluorophenyl+oxazolidinones+for+treatment+of+bacterial+infections"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGordeev%26aufirst%3DM.%2BF.%26atitle%3DAntimicrobial%2520ortho-fluorophenyl%2520oxazolidinones%2520for%2520treatment%2520of%2520bacterial%2520infections%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span>Technical Bulletin “MAO-Glo Assay”; <span class="NLM_publisher-name">Promega Co.</span>: <span class="NLM_publisher-loc">Madison, WI</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Technical+Bulletin+%E2%80%9CMAO-Glo+Assay%E2%80%9D%3B+Promega+Co.%3A+Madison%2C+WI."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26jtitle%3DTechnical%2520Bulletin%2520%25E2%2580%259CMAO-Glo%2520Assay%25E2%2580%259D%26pub%3DPromega%2520Co" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Leach, K. L.</span><span> </span><span class="NLM_article-title">Assay for myelosuppression</span>. PCT WO 2006/097828, <span class="NLM_month">Sept</span><span class="NLM_day">21</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=K.+L.+Leach&title=Assay+for+myelosuppression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLeach%26aufirst%3DK.%2BL.%26atitle%3DAssay%2520for%2520myelosuppression%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Huang, Y.-Q.; Xu, Y.-H.; Liu, S.-C.; Wang, H.-L.; Xu, X.-G.; Guo, Q.-L.; Wu, B.-X.; Gordeev, M. F.; Wang, W.; Yuan, Z. Y.; Wang, M.-G.</span><span> </span><span class="NLM_article-title">Selection and characterization of <i>Staphylococcus aureus</i> mutants with reduced susceptibility to the investigational oxazolidinone MRX-I</span>.  <span class="citation_source-journal">Int. J. Antimicrob. Agents</span>,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.1016/j.ijantimicag.2014.02.008</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm401931e&amp;key=10.1016%2Fj.ijantimicag.2014.02.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=Y.-Q.+Huang&author=Y.-H.+Xu&author=S.-C.+Liu&author=H.-L.+Wang&author=X.-G.+Xu&author=Q.-L.+Guo&author=B.-X.+Wu&author=M.+F.+Gordeev&author=W.+Wang&author=Z.+Y.+Yuan&author=M.-G.+Wang&title=Selection+and+characterization+of+Staphylococcus+aureus+mutants+with+reduced+susceptibility+to+the+investigational+oxazolidinone+MRX-I&doi=10.1016%2Fj.ijantimicag.2014.02.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.ijantimicag.2014.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijantimicag.2014.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.-Q.%26atitle%3DSelection%2520and%2520characterization%2520of%2520Staphylococcus%2520aureus%2520mutants%2520with%2520reduced%2520susceptibility%2520to%2520the%2520investigational%2520oxazolidinone%2520MRX-I%26jtitle%3DInt.%2520J.%2520Antimicrob.%2520Agents%26date%3D2014%26doi%3D10.1016%2Fj.ijantimicag.2014.02.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Slatter, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">L. A. Adams, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiba, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daley-Yates, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feenstra, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koike, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sams, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuette, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, S.</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">907</span><span class="NLM_x">–</span> <span class="NLM_lpage">924</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Slatter%2C+J.+G.%3B+L.+A.+Adams%2C+L.+A.%3B+Bush%2C+E.+C.%3B+Chiba%2C+K.%3B+Daley-Yates%2C+P.+T.%3B+Feenstra%2C+K.+L.%3B+Koike%2C+S.%3B+Ozawa%2C+N.%3B+Peng%2C+G.+W.%3B+Sams%2C+J.+P.%3B+Schuette%2C+M.+R.%3B+Yamazaki%2C+S.Xenobiotica+2002%2C+32%2C+907%E2%80%93924"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSlatter%26aufirst%3DJ.%2BG.%26aulast%3DL.%2BA.%2BAdams%26aufirst%3DL.%2BA.%26aulast%3DBush%26aufirst%3DE.%2BC.%26aulast%3DChiba%26aufirst%3DK.%26aulast%3DDaley-Yates%26aufirst%3DP.%2BT.%26aulast%3DFeenstra%26aufirst%3DK.%2BL.%26aulast%3DKoike%26aufirst%3DS.%26aulast%3DOzawa%26aufirst%3DN.%26aulast%3DPeng%26aufirst%3DG.%2BW.%26aulast%3DSams%26aufirst%3DJ.%2BP.%26aulast%3DSchuette%26aufirst%3DM.%2BR.%26aulast%3DYamazaki%26aufirst%3DS.%26jtitle%3DXenobiotica%26date%3D2002%26volume%3D32%26spage%3D907%26epage%3D924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span>Technical Bulletin “Fluoro-MAOTM Assay”; <span class="NLM_publisher-name">Peninsula Laboratories, Inc. (USA)</span>: <span class="NLM_publisher-loc">San Carlos, CA</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Technical+Bulletin+%E2%80%9CFluoro-MAOTM+Assay%E2%80%9D%3B+Peninsula+Laboratories%2C+Inc.+%28USA%29%3A+San+Carlos%2C+CA."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26jtitle%3DTechnical%2520Bulletin%2520%25E2%2580%259CFluoro-MAOTM%2520Assay%25E2%2580%259D%26pub%3DPeninsula%2520Laboratories%252C%2520Inc.%2520%2528USA%2529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Fang, E.; De Anda, C.; Prokocimer, P.</span><span> </span><span class="NLM_article-title">Safety profile of tedizolid phosphate compared to linezolid in a phase 3 ABSSSI study</span>. <span class="NLM_conf-name">52nd Interscience Conference on Antimicrobial Agents and Chemotherapy</span>, <span class="NLM_conf-loc">San Francisco</span>, <span class="NLM_conf-date">Sept 9–12, 2012</span>,  <span class="NLM_fpage">Poster L1–1664</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Fang%2C+E.%3B+De+Anda%2C+C.%3B+Prokocimer%2C+P.+Safety+profile+of+tedizolid+phosphate+compared+to+linezolid+in+a+phase+3+ABSSSI+study.+52nd+Interscience+Conference+on+Antimicrobial+Agents+and+Chemotherapy%2C+San+Francisco%2C+Sept+9%E2%80%9312%2C+2012%2C+Poster+L1%E2%80%931664."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DE.%26atitle%3DSafety%2520profile%2520of%2520tedizolid%2520phosphate%2520compared%2520to%2520linezolid%2520in%2520a%2520phase%25203%2520ABSSSI%2520study%26spage%3DPoster%2520L1%25E2%2580%25931664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm401931e&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm401931e%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-11" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm401931e" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                691KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679986eeb8043d3c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
